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ABSTRACT 
 
Osseointegration is described as the close contact between bone and an implant 
surface, and the interest on surface engineering has to be understood as an 
important and natural trend. The biological fixation between the dental implant 
surfaces and jaw bones should be considered a prerequisite for the long-term 
success of implant-supported prostheses. In this context, the implant surface 
modifications gained an important and decisive place in implant research over the 
last years. The bone response, which means rate, quantity and quality, are related 
to implant surface properties. For example, the composition and charges are 
critical for protein adsorption and cell attachment. Hydrophilic surfaces seem to 
favor the interactions with biological fluids and cells when compared to the 
hydrophobic ones, and hydrophilicity is affected by the surface chemical 
composition. Various techniques of surface treatments have been studied and 
applied to improve biological surface properties, which favors the mechanism of 
osseointegration. This strategy aims at promoting the mechanism of 
osseointegration with faster and stronger bone formation, to confer better stability 
during the healing process, thus allowing earlier loading of the implant. Some of 
the objectives for the development of implant surface modifications are to improve 
the clinical performance in anatomical sites characterized by poor quantity or 
quality of bone, to accelerate the bone healing and thereby allowing immediate or 
early loading protocols and also stimulating bone growth in order to permit implant 
placement in sites that lack sufficient residual alveolar ridge, thus providing them a 
jumping gap ability, for example. Implant morphology influences bone metabolism: 
rougher surfaces stimulate differentiation, growth and attachment of bone cells, 
and increase mineralization; furthermore, the degree of roughness is important. 
Implants may have "smooth" (machined) or rough surfaces. The main methods 
that are reported in the literature to create implant roughness are acid etching, 
sandblasting, titanium plasma spraying and hydroxyapatite (HA) coating. A current 
tendency is the manufacturing of implants with micro and submicro (nano) 
topography. Furthermore, the bio-functionalization of implants surfaces, by adding 
different substances to improve its biological characteristics, has also been 
recently investigated. 
In this contex, aim of the present project has been focused on dental implant 
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surface modifications in order to improve the clinical performance in areas with 
poor quantity or quality of bone. 
In detail this aim has been reached trough 3 steps: 
1. in vitro studies: 
a) in vitro studies of osteoproperties of glass and titanium surfaces grafted with 
fibronectin sequence motif for integrin binding (Arg-Gly-Asp, RGD)/ human 
vitronectin protein (HVP)  
b) development of an in vitro model to evaluate the degree of implants  
osteointegration by passing in vivo test. 
2. in vivo studies, in big animal model, dogs, of osteointegrative properties of 
implants with different degree of surface modification. 
3. clinical research on short implants, to underline the effect of surface 
modifications on dental implant survival in the long term in the clinic. 
As final results of these studies, we can conclude that there are a huge number of 
types of implant surfaces in the market, from different implant manufacturers, all of 
them claiming to have better clinical results. It is important that the clinician choose 
the surface that have shown the best results in the scientific literature. 
The majority of currently available in vitro and in vivo studies seem to indicate that 
implant surfaces with micro and submicro (nano) topography bring forward 
benefits to the process of interaction between bone cells and implant surfaces, 
accelerating and increasing the quality of bone-to-implant-contact (BIC). 
Finally, based on the state of the art of implant development, it is possible to 
predict that, within some time, implant surfaces coated with substances with 
biomimetic capacity will be available for clinical use. This process of implant bio-
functionalization aims at modulating new bone formation around implants, and it 
represents the next step in implant development. 
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1. INTRODUCTION 
 
1.1 Dental Implant Osseointegration 
 
A dental implant (also known as an endosseous implant or fixture) is a surgical 
device that interfaces with the alveolar bone of the jaws (or skull) to support a 
dental prosthesis such as a crown, bridge, denture, facial prosthesis, or to act as 
an orthodontic anchor (Fig. 1). The basis for modern dental implants is a biologic 
process called osseointegration where materials, such as titanium, form an 
intimate bond to bone. Osseointegration derives from the Greek osteon, bone, and 
the Latin integrare, to make whole. The term refers to the direct structural and 
functional connection between living bone and the surface of a load-bearing 
artificial implant. Osseointegration is also defined as: "the formation of a direct 
interface between an implant and bone, without intervening soft tissue" (1, 2). 
The osseointegration rate of titanium dental implants is related to their composition 
and surface roughness (fig. 2 and 3). Rough-surfaced implants favor both bone 
anchoring and biomechanical stability. Osteoconductive calcium phosphate 
coatings promote bone healing and apposition, leading to the rapid biological 
fixation of implants. Different methods have been used for increasing surface 
roughness or applying osteoconductive coatings to titanium dental implants. 
Surface treatments, such as titanium plasma-spraying, grit-blasting, acid-etching, 
anodization or calcium phosphate coatings, and their corresponding surface 
morphologies and properties have been studied. Most of these surfaces are 
commercially available and have proven clinical efficacy (>95% over 5 years) (3). 
A huge number of the experimental investigations have demonstrated that the 
bone response was influenced by the implant surface topography (evaluated using 
Sa value, that is the arithmetic average of the 3D roughness); smooth (Sa<0.5 µm) 
and minimally rough (Sa 0.5–1 µm) surfaces showed less strong bone responses 
than rougher surfaces. Moderately rough (Sa>1–2 µm) surfaces showed stronger 
bone responses than rough (Sa>2 µm) in some studies (4) (figs. 5-12). 
Finally, osseointegration is the growth action of bone tissue, as it assimilates 
surgically implanted devices or prostheses to be used as either replacement parts 
(e.g., hip) or as anchors (e.g., endosseous dental implants).The direct contact of 
bone and implant surface can be verified microscopically. Osseointegration has 
 8 
enhanced the science of medical bone and joint replacement techniques as well 
as dental implants and improving prosthetics for amputees.  
As recently described by Terheyden H et al (2012) (5) the healing of an osseous 
wound around a dental implant is a coordinated and sequentially organized repair 
mechanism of the organism (6). The main players in this process are cells. Cells 
communicate with each other via exchange of molecules which are read by 
specific receptors on the cell surface. The different cell types appear in a 
chronological sequence with a certain overlap. This sequence is known as the four 
phases of wound healing, a concept that originates from the observation of soft 
tissue healing (7). However, this concept can be transferred to bone healing and, 
in particular, to intraoral bone healing of an implant wound – haemostasis, the 
inflammatory phase, the proliferative phase and finally the remodelling phase. In a 
physiological soft tissue wound, the haemostasis takes minutes to hours, the 
inflammatory phase hours to days, the proliferative phase days to weeks and the 
remodelling phase begins at approximately 3 weeks and lasts for years (7).  
The temporal sequence of bone healing around dental implants has been 
investigated histologically in animals (dogs) (8, 9) and in humans (10, 11). In the 
animal study, the first biopsy showing erythrocytes and inflammatory cells was 
taken after 2 h at the transition between haemostasis and inflammatory phase. 
The second biopsy was taken after 4 days and showed new vessels as well as 
fibroblasts and osteoclasts on the old bone (early proliferative phase). After 1 
week, woven bone had appeared (late proliferative phase). After 2 weeks, a load 
oriented remodelling of the woven bone by osteoclasts was noted in the areas of 
the tips of the threads (early remodelling phase). After 4 weeks, the remodelling at 
the tips of the threads was most intense. After 6 weeks, woven bone formation 
continued and remodelling also took place in the grooves of the implant threads. 
After 8 and 12 weeks, most woven bone was replaced by lamellar bone. In the 
human volunteer study, four time points after 1, 2, 4 and 6 weeks were examined. 
After 1 week in humans, new bone was observed occasionally on the implant 
surface in humans – comparable to what had been seen in the dog study. After 2 
weeks, woven bone formation had increased, but only in the grooves. In contrast 
to the dog study, no marked osteoclastic activity was observed in humans 
(proliferative phase). After 4 weeks, bridging between the parent bone and the 
implant took place in humans. After 6 weeks, first signs of transition to the 
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remodelling phase were noted, 2 weeks later than in the dog. The direct 
comparison of the bone-implant contact rates revealed a delay of at least 2 weeks 
for humans compared with dogs (9). A microarray analysis of the transcriptome of 
the material of the human volunteer study showed genes associated with 
inflammation upregulated at day 4, for angiogenesis at day 7 and for 
skeletogenesis at day 14 (12, 13). Thus, the duration of the phases of bone 
healing around dental implants in humans approximates the duration of the same 
phases in physiological soft tissue healing as a biological constant.  
For Terheyden H et al (2012) (5) the key players in this process are the different 
cell types. We observe coordinated action of several cell types and numerous 
individual cells in the defect. The action of cells is controlled by sequential 
activation of typical genes, which in turn are activated by soluble cytokines 
(soluble protein factors), small molecules (e.g. histamine, prostaglandins etc.) or 
molecules from the extracellular matrix (14). These messenger molecules interact 
with specific receptors on the surface of the cells. Usually, this causes a change of 
the conformation of transmembrane receptor proteins which become enzymatically 
active and start an intracellular second messenger system that amplifies or 
modifies the information and transports it through the nuclear membrane to the 
DNA. The cellular response is then initiated by activation of genes and expression 
of certain proteins, either secretory products or intracellular regulatory proteins.  
Adjacent cells can communicate with each other through direct membrane 
channels. However, over distances, the cells communicate through chemical 
messenger molecules. The most important classes of messenger molecules are 
cytokines and hormones. Cytokines are proteins (interleukins, growth and 
differentiation factors). Hormones are subdivided into peptide hormones (e.g. 
bradykinin), lipid hormones (e.g. prostaglandins or steroid hormones) and amine 
hormones (e.g. histamine). Although there is an overlap between the definitions of 
cytokines and hormones, hormones are usually active in nanomolar 
concentrations and longer ranges, whereas cytokines can be active in femtomolar 
concentrations through very specific protein receptors within a more restricted 
area. In addition, cells receive information through interaction with the extracellular 
matrix, to which they attach with specific receptors (15). On a very local level, 
small molecules like nitric oxide or even ions like calcium play a role in signalling.  
 10
1.2 Haemostasis  
Haemostasis (exudative phase) begins with the surgical trauma exerted by the 
dental implant drill followed by the insertion of the implant (5). The duration of this 
phase is minutes to hours. With the bone trauma matrix proteins, growth and 
differentiation factors which are stored in the bone matrix become soluble and 
active. Usually stored deep in the bone matrix, the factors are unmasked by the 
bone trauma and liberated from their heparin binding domains by heparin 
hydrolases from blood platelets (16). Mechanical crushing of the bone matrix in 
form of bone debris created by the implant drill may facilitate the liberation of such 
molecules from the matrix (10). Bleeding from injured blood vessels lays the 
foundation of the polymerization of fibrinogen to create a first extracellular matrix in 
the defect. The polymerization of fibrinogen is performed by thrombin and initiated 
by platelets (extrinsic system) and the intrinsic clotting cascade (Hageman Factor).  
Immediately after implantation, the implant surface interacts with water molecules 
and ions. This can change the charge pattern of the surface, and bivalent ions like 
calcium can potentially link equally negatively charged partners (a reason for the 
requirement of calcium ions in blood clotting) (17). Ions are followed by plasma 
proteins like albumin, globulins or fibrin. The process of protein adsorption is very 
effective, increasing the concentration of proteins on the surface rapidly by a factor 
of 1000 compared with the surrounding aqueous solution (18). The first proteins to 
bind are those that are present at high concentrations in blood such as albumin. 
These will slowly be replaced by proteins with a lower concentration, but a higher 
affinity for the surface such as vitronectin or fibronectin. In this process, size and 
thus mobility of the proteins also play a role (also referred to as Vroman effect) 
(19). The adsorption of proteins is determined by various factors such as 
properties of proteins and the solid substrate surface as well as environmental 
conditions. With respect to the protein properties, the charge, size, stability of the 
structure, amino acid composition and steric conformation may play a role. 
Proteins with low internal stability (soft) adsorb mainly based on a gain in 
conformational entropy as they change their shape. On hydrophobic surfaces, 
these changes can occur to a great extent and can lead to protein denaturation 
and loss of protein function, as hydrophobic residues usually hidden in the protein 
interior are exposed. To a much smaller extent this also applies to very stable 
(stiff) proteins, but these will only adsorb if there is electrostatic attraction even on 
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hydrophobic surfaces (20). Overall shape also plays a role, as rod-like proteins 
with a higher surface to volume ratio will have more interaction sites and thus bind 
more strongly than globular ones. Thus, hydrophilic titanium surfaces may better 
preserve the protein conformation and function. Clinically, a faster 
osseointegration was observed for ultrahydrophilic surfaces compared with 
standard titanium surfaces (11). On the metal side also, topography and surface 
energy are important factors. Little is known about spatial distribution of these 
properties on a nanometre scale. Patterns may bind and select effective proteins 
more specific than uniform surfaces.  
Through protein absorption, cells are able to attach to the titanium surface. The 
subsequent cell attachment is influenced extensively by this initial coating of the 
titanium with blood proteins (21). Fibronectin, for example, contains cell binding 
sites (RGD sequence) that can interact with cellular adhesion proteins (integrins).  
At the sites of vascular injury, platelets aggregate and form a white thrombus 
closing the vascular leak. Bioactive molecules such as thrombin, ADP, collagen, 
fibrinogen and thrombospondin are generated. Vitronectin bound to the metallic 
surface can bind platelets. These stimuli activate platelets, converting the major 
platelet integrin ανβ3 from a resting state to an active conformation. Integrin 
activation refers to the change required to enhance ligand-binding activity. The 
activated ανβ3 interacts with the fibrinogen and links platelets together in an 
aggregate to form a platelet plug. ανβ3 bound to fibrin generates more intracellular 
signals (outside-in signalling), causing further platelet activation and platelet plug 
retraction. Platelets also bind to collagen with collagenspecific glycoprotein Ia/IIa 
receptors. This adhesion is further strengthened by von Willebrand factor, which 
forms additional links between the platelets glycoprotein Ib/ IX/V and the collagen 
fibrils. Surface bound fibrin on the metal surface of the implant can bind 
thrombocytes over the glycoprotein IIb/IIIa receptor to the titanium implant surface. 
This binding results in activation and degranulation of the thrombocytes. 
Haemostasis is supported by vasoactive substances from the platelets like 
serotonin, which results in vasoconstriction. Also, thromboxane from platelets 
plays a role in the initial vasoconstriction. The release of cytokines from 
degranulating platelets is the beginning of the inflammatory phase.  
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1.3 Inflammatory phase  
Terheyden H et al (2012) (5) report that the inflammatory phase begins 
approximately after 10 min and lasts for the first days after surgery. The phase 
begins with the degranulation of the platelets. The platelets release growth factors 
like transforming growth factor beta (TGF-b), platelet-derived growth factor 
(PDGF), Basic fibroblast growth factor (bFGF). Bradykinin from degranulated 
platelets increases the vascular permeability for fluids, serum proteins and white 
blood cells. Vasodilative histamine derived from the platelets increases blood flow, 
decreases the blood stream velocity and induces hyperaemia. The initial 
vasoconstriction in the haemostatic phase turns into vasodilatation, clinically 
detectable as swelling and warming of the skin overlying the wound.  
In the very early stages of the inflammatory phase, the innate host defence 
systems are activated (22). The innate immune system is activated by unspecific 
molecules of bacterial origin, and is not adaptable. It consists of molecular (e.g. 
complement system) and cellular elements: polymorphonuclear leucocytes (PMN, 
also called neutrophil granulocytes) and macrophages. The complement system is 
a group of glycoproteins which form membrane perforating channels (perforins) 
that damage bacterial cells. Complement C3b binds to bacterial glycoproteins and 
labels (opsonization) bacteria and other foreign bodies for phagocytosis by the 
immune cells. The PMN invade the blood clot by amoeboid migration, squeezing 
through little gaps in the walls of the blood vessels. This process is known as the 
diapedesis. Diapedesis is initiated by loose adhesion of lectins in the inner lining of 
blood vessels. These first bindings are reversible. The leucocytes move to the 
periphery of the blood stream, attach and detach and roll along the inner lining of 
the blood vessel mediated by adhesion of L-selectin on the leucocyte with E-
selectin on the endothelial side. Later, stronger chemical adhesions occur until the 
cells finally attach. Intercellular adhesion molecule-1 (ICAM-1), ICAM-2 (similar to 
immune globulins) and the vascular cell adhesion molecule-1 (VCAM-1) catch the 
granulocyte out of the blood stream, binding to integrins on the leucocyte (22). 
After adhesion, endothelial cells open a small gap, and the granulocyte migrates in 
amoeboid fashion through the gap. PMN produce elastase and collagenase which 
helps them in digesting the basal lamina of the blood vessel and pass beyond the 
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basal lamina. After the cell has left the blood vessel, its further amoeboid migration 
is directed by chemotaxis (22).  
Chemotactic substances for PMN include: fibrinopeptides from fibrin activation 
through thrombin, products from fibrinolysis, complement 5a, leucotriene B4 from 
present PMN, bacterial proteins (N-formyl methionyl peptides), platelet activating 
factor (PAF), tumour necrosis factor alpha (TNF-alpha), Platelet factor 4 (PF4), 
PDGF and interleukin8 (IL-8). Some of these factors are produced from PMN or 
macrophages already present which had antigen contact. If the granulocytes 
encounter large numbers of bacteria, they recruit more PMN by releasing 
proinflammatory cytokines (TNF-alpha, IL-8).  
Thus, abundance of bacteria prolongs and amplifies the cellular immune response. 
PMN kill bacteria through reactive radicals (oxygen species and hydroxygroups, 
chlorine radicals and hypochlorites) which are also toxic for the host cells and the 
healthy tissue surrounding the wound. Thus, a fulminant neutrophil granulocyte 
response can induce loss of healthy surrounding tissues (22).  
Furthermore, PMN secrete digestive enzymes like collagenase and elastase. 
These factors can further enhance the tissue damage in the neighbouring tissues. 
If granulocyte action is prolonged through a high concentration and prolonged 
presence of bacteria in the wound, a toxic wound environment can develop. In a 
toxic wound environment, concentrations of proinflammatory cytokines and toxic 
radicals are high. An elevated activity of the urokinase-type plasminogen activator 
uPA results in plasmin activity, fibrinolysis and degradation of the extracellular 
matrix (23). The fibrin network can dissolve. Under these conditions, the 
concentrations of protective extracellular matrix glycoproteins and proteoglycans 
such as fibronectin and decorin are low. These proteins normally can bind and 
protect growth factors from the digesting proteolytic enzymes. A high 
concentration of these digesting enzymes therefore is typical for a toxic wound 
environment. If the number or virulence of bacteria further increases, the tissues 
can be liquified and pus is formed. The early inflammatory phase within the first 3 
h is rather decisive for the further fate of the wound. High numbers of bacteria 
enhance inflammation. Contaminated foreign bodies in the wound, which unlike 
living tissue have no own defence mechanisms against bacterial colonisation, can 
increase bacterial counts in the wound. To limit the inflammatory phase, the 
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cleanest possible surgical work with low bacterial inoculation is likewise important 
as antibacterial measures including antibiosis and local disinfection. Clean 
conditions help the organism to move as quickly as possible through the 
inflammatory phase into the proliferative phase.  
PMN are relatively short-lived in acute wounds and are replaced by lymphocytes 
and macrophages. The roll of lymphocytes is not well defined in the repair 
process, but they appear to assist by secreting cytokines that are mitogens and 
chemoattractants for fibroblasts, while simultaneously clearing the wound of old 
neutrophils (7). If bacteria have to be eliminated, the number of macrophages 
increases. In presence of bacteria, they secrete proinflammatory cytokines, but 
they can act as a switch to end the inflammatory phase. After having removed 
tissue debris, macrophages secrete angiogenic and fibrogenic growth factors. The 
level of the radical nitric oxide (NO) in the wound formed by inducible nitric oxide 
synthase (iNOS) by macrophages correlates positively with cyclooxygenase 
activity and prostaglandin production, which is necessary for subsequent fibroblast 
activation (24, 25). Under the conditions of a healing wound which was 
successfully cleaned from bacterial contamination these cells secrete TIMPs 
(tissue inhibitors of metalloproteinases). These molecules antagonize the digesting 
enzymes of PMN and therefore protect the extracellular matrix proteins like 
proteoglycans. These in turn can protect growth factors which are stored in the 
extracellular matrix (26). The concentration of growth factors is further increased 
by secretion of growth factors like bFGF and PDGF from macrophages. A high 
concentration of fibronectin allows attachment of fibroblasts via integrin binding 
sites. These cells can hereupon crawl into the wound. This is the beginning of the 
proliferative phase.  
1.4 Proliferative phase  
The transition into the proliferative phase is characterized by the formation of new 
extracellular matrix and by angiogenesis (5). This newly formed tissue is called 
granulation tissue. The duration of this phase ranges from a few days to a few 
weeks.  
Stimulated by FGF from macrophages, fibroblasts from the surrounding healthy 
tissue migrate by amoeboid movement into the blood clot. These cells drill tunnels 
through the provisional extracellular matrix of the fibrin clot by secreting matrix 
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metalloproteinases. The metalloproteinases degrade the blood derived fibrin in the 
clot und uncover integrin binding sites in the fragments. The fibroblasts attach via 
integrins to the RGD peptides of fibronectin and crawl from attachment to 
attachment deeper into the wound (27). To replace the degraded provisional clot 
matrix, they produce insoluble cellular fibronectin and other insoluble proteins of 
the extracellular matrix like collagens, vitronectin, decorin and other proteoglycans. 
The movement of the fibroblasts is directed by the concentration gradient of 
growth factors produced by the macrophages (PDGF, TGF-b, basic FGF, 
connective tissue growth factor (CTGF)).  
In parallel, angiogenesis is stimulated by hypoxia. Hypoxia attracts macrophages 
(28), which are able to survive under hypoxic conditions by adjusting their 
metabolism to an oxygen independent generation of ATP. In macrophages, 
vascular endothelial growth factor (VEGF) expression is stimulated by an 
intracellular transcription factor called hypoxia inducible factor (HIF-1). The 
macrophage is able to function under low oxygen tension (29) and releases VEGF, 
which stimulates the production of endothelial cell precursors and is chemotactic 
for these cells. Furthermore, end products of lipid oxidation, ω-(2-carboxyethyl) 
pyrrole (CEP) and other related pyrroles stimulate endothelial cells over the toll 
like receptor 2 (30). Also, other growth factors like PDGF from platelets and FGF 
from macrophages act angiogenic.  
In response to VEGF, pericytes detach from the outer walls of the vessel. These 
cells use matrix metalloproteinases to digest the basal lamina around the vessels 
(31). The pericytes give rise to the new endothelial progenitor cells, which migrate 
to the place of low oxygen tension where they are chemotactically attracted by the 
chemokine stromal cell derived factor (SDF-1) which is produced by cells in the 
wound (32). This process is called homing of endothelial cells. The cells proliferate 
to form condensed groups and they arrange themselves to form tubes. The room 
needed for that is created by matrix metallo-proteinases. Finally, these newly 
formed tubes are connected to an existing blood vessel. A new vascular loop is 
created and blood can flow through.  
Angiogenesis is the prerequisite for osteogenesis. New bone forms only in close 
connection to blood vessels. The mature bone cell does not survive more than 200 
µm away from a blood vessel. First, the blood vessel develops and then the bone 
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follows, a process called angiogenetic osteogenesis. The formation of new bone 
needs a mechanically stable environment.  
An osteoprogenitor cell attaches to the surface of an implant via integrins. 
Integrins attach to extracellular matrix proteins such as fibronectin via the RGD 
motif. An osteoblast does not directly attach to metal, but to the protein layer on 
top of the implant. The bone precursor cell itself produces insoluble cellular 
fibronectin needed for cellular attachment to titanium (33). After firm attachment to 
the surface, the osteoprogenitor cell that becomes secretory active is called 
osteoblast. As a molecular marker, the osteoblast starts to express osteocalcin 
and alkaline phosphatase.  
Osteoblasts derive from mesenchymal stem cells and there is growing evidence 
that these stem cells are pericytes in the walls of smallest blood vessels (34). The 
precursors of pericytes originate from bone marrow cells (35). Bone 
morphogenetic proteins bind to receptors on the cell surface of the bone precursor 
cells (36). Binding to preformed complexes of receptors I and II will lead to 
activation of the Smad pathway, where the activated SMAD protein ultimately 
binds to DNA and in turn activates SMAD responsive genes like Runx. Bone 
morphogenic proteins (BMP) may also bind to single receptors, which induces 
their oligomerization, caveolae-dependent internalization and the activation of non-
SMAD pathways such as ERK (extracellular signal regulated kinases) and MAPK 
(mitogen activated protein kinase). These will activate ATF2, c-jun or c-fos, which 
regulate BMP target genes like osteopontin, alkaline phosphatase or collagen 
typeI (37).  
It is unclear from where the first BMPs in the wound originate. BMPs are stored in 
the bone matrix, bound in an inactive form to the glycosaminoglycane heparan 
sulphate. This allows the organism to store large quantities of active growth readily 
available and independent of new protein synthesis (16). With bone trauma matrix 
proteins, growth and differentiation factors which are stored in the bone matrix 
become soluble and active. Usually stored deep in the bone matrix, the factors are 
unmasked by the bone trauma and liberated from their heparin binding domains by 
heparin hydrolases from blood platelets (16). Heparan sulphate binding growth 
factors (e.g. BMPs, FGF, PDGF, VEGF) can also be released from the matrix by 
soluble heparin degrading enzymes (heparin hydrolases), which can be released 
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by platelets, lymphocytes or mast cells. The factors can also be released by 
competition with heparin, with proteins that bind to the growth factor or with other 
heparin binding proteins. A number of factors can be released by special 
proteolytic enzymes, e.g. PDGF-B (thrombin) or VEGF (plasmin) or TGF-b 
(multiple serin proteases) (16). The growth factors may be also unmasked or 
synthesized by osteoclasts (38, 39). They are produced by myofibroblasts and 
osteoblasts. BMPs appear in the bone wound after 3 days. Therefore, new bone 
forms with a latency.  
With implant insertion, a dental implant gains primary stability. The implant is 
passively stabilized in the bone wound through friction with the primary bone 
contacts. The denser the host bone is, the more primary bone contacts are 
available and the higher primary stability of the implant will be. Primary stability 
implies that the friction holding the implant is higher than the highest dynamic load 
forces applied. Micromovement caused by load peaks higher than friction hold is 
critical. Micromovement of the implant can grind and slowly smoothen the bone 
surface, reducing the interlock between bone and titanium and ultimately resulting 
in a loss of primary stability. Therefore, it is critical to overload the implant 
occlusally in the early phase. Primary stability is important during the first days 
after implant installation. Under normal conditions the first weeks are a vulnerable 
phase because primary stability can decrease to critical levels before secondary 
stability has developed.  
As early as 1 week after implant, placement new bone formation starts and the 
primary bone contacts are supplemented by newly formed secondary bone 
contacts (8). The first bone that forms after an injury is woven bone. Histologically, 
this bone is characterized by the fact that its collagen fibres are not parallel, but 
randomly oriented. Woven bone usually grows along the existing bone surfaces 
and along the dental implant surface towards the groves of the threads. Bone 
debris created by the implant drill was demonstrated to be important for early bone 
formation, and is incorporated into the immature trabelculae of woven bone (10). 
In the beginning, these bone contacts are not load oriented and randomly 
distributed. In a human volunteer study, new bone apposition amounted to a bone-
implant contact of 62% of the intraosseous implant surface after 6 weeks, 
irrespective whether a SLA (sandblasted large grit and acid etched) or a modified 
ultrahydrophyllic SLA (SLActive) was used. However, the modified ultrahydrophilic 
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surface yielded more bone early contacts after 2 and 4 weeks compared with the 
standard SLA surface (11) (Fig. 8).  
New bone formation begins with the secretion of a collagen matrix by osteoblasts. 
Depending on the process of ossification (endochondral or intramembraneous), 
this can be collagen type II or type III, which is ultimately replaced by collagen type 
I. Bone formation within the alveolar process is a process of intramembranous 
ossification, starting by the secretion of collagen type III. This matrix is 
subsequently mineralized by hydroxyapatite. The exact mechanism of this process 
is still widely debated, but in all probability is based on the concept of 
heterogenous nucleation, where organic or inorganic precursor seeds direct the 
formation of apatite from soluble inorganic ions (40). Opinions diverge on the 
nucleation site and the molecular nature of the nucleator: One theory proposes 
matrix vesicles (small vesicles derived from mineral forming cells such as 
chondroblasts or osteoblasts) as the site of an initial mineralization prerequisite for 
the following secondary mineralization of collagen (41). An alternative view 
proposes direct nucleation of apatite by matrix molecules such as collagen and 
noncollagenous proteins.  
The mineralization process during primary bone formation is rapid, but relatively 
unorganized and not in close association to collagen (extrafibrillar). During the 
following remodelling phase, woven bone is removed by osteoclasts and replaced 
by lamellar bone. Next, in this process nanometre-sized, uniaxially oriented 
hydroxyapatite crystal plates are formed within the collagen fibres (interfibrillar) 
(42). This nanostructural architecture gives rise to the unique mechanical and 
biological properties of bone, making it rigid enough to resist pressure and traction 
forces while maintaining elasticity.  
Removal of the woven bone by osteoclasts is the beginning of remodelling and 
thus the fourth and last phase.  
1.5 Remodelling phase  
One of the cellular key players of the remodelling phase is the osteoclast (5). 
Osteoclasts appear in the wound after a few days. They start to create space for 
new bone formation and remove primary boneimplant contacts. The remodelling 
phase can last several years until most woven bone and old bone from the primary 
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bone contacts is replaced by newly formed and load oriented bone.  
Bone being formed after remodelling is called lamellar bone, named after the 
parallel orientation of its collagen fibres under polarized light. In contrast to woven 
bone which is oriented parallel to the titanium surface in the grooves of the 
threads, lamellar bone attaches rather to the tips of the macrothreads. These 
trabeculae usually attach at the tip of a thread of the implant in a little extended 
foot plate. The trabeculae distribute the occlusal loads to the surrounding bone 
and, if present, neighbouring tooth sockets. The new trabecular network is 
oriented similar to the supporting arches of a gothic church. According to Wolfs 
Law in bone, such a structure is built as light as possible. Therefore, between the 
insertion areas of the trabeculae, non-covered titanium surface areas appear on 
the implant surface. The so-called bone-implant contact can decrease during the 
remodelling phase and usually balances at approximately two-thirds of the surface 
after some time (43, 44).  
Osteoclasts and osteoblasts act interdependently (45, 46). The so-called bone 
balance is necessary, because otherwise, the skeleton would become more 
porous (osteopenic) or denser (osteopetrotic). Both situations can be pathologic. 
At the beginning, osteoclast action depends on osteoblasts which control 
osteoclastsogenesis by the balance between RANKL and its counterpart 
osteoprotegerin, both produced by the osteoblast (47). Osteoblasts secrete 
RANKL, the ligand of the RANK (receptor activator of nuclear factor kappa beta) 
receptor which activates osteoclastogenesis together with M-CSF (macrophage 
colony stimulating factor). RANKL is membrane bound and can be masked by 
soluble osteoprotegerin which is also synthesized by osteoblasts and is a decoy 
receptor for RANKL (48). Thus, osteoprotegerin preserves bone by inhibition of 
osteoclastogenesis. The ratio of RANKL/ osteoprotegerin can be modulated, and 
the osteoblast is the target for various bone enhancing and inhibiting messenger 
molecules including IL-11, sclerostin, prostaglandin E2, parathyroid hormone 
(PTH) related protein, vitamin D and estradiol (39). PTH inhibits osteoprotegerin 
secretion from the osteoblast and thus increases osteoclast activation and bone 
degradation (48). In addition, soluble RANKL and the related messenger molecule 
TNF produced by lymphocytes can upregulate osteoclastogenesis under 
inflammatory situations (49).  
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The origin of osteoclasts is blood borne monocytes. They attach to the walls of the 
blood vessels by SDF-1/CXCR-4 interaction, and SDF-1 is bound to the 
endothelial cells surface (50). By diapedesis, these cells leave the blood stream. 
For the transmigration through the collagen of the basal lamina, they secrete 
matrix metalloproteinase MMP-9 (50). By chemotaxis, the cells are directed 
towards the bone. Soluble SDF-1 was identified as chemo-attracting molecule for 
osteoclast precursors (50), but being originally immune cells also, other 
immunoregulating molecules like IL-8 (cytokine-induced neutrophil 
chemoattractant; CINC-1) and monocyte chemotactic protein (MCP-1/CCL2) were 
demonstrated to be chemoattractive for the osteoclast precursor cells. Precursor 
cells fuse to form multinuclear giant cells. Osteoclast formation requires the 
presence of RANKLigand and M-CSF (51).  
These membrane bound proteins are produced by neighbouring osteoblasts, thus 
requiring direct contact between these cells and osteoclast precursors. 
Proinflammatory cytokines like IL-6 or TNF-alpha can intensify this activation (52). 
There is some evidence that osteoclast precursors, like many other immune cells, 
need a costimulation via the ITAM receptor (immunoreceptor tyrosine-based 
activation motifs) (53).  
The life span of an osteoclast was calculated to average 12 days in humans (54). 
The bone lining cells (terminally differentiated osteoblasts) digest remnants of 
osteoid by collagenases and thereby liberate RGD peptide endings from non-
collagenous bone matrix proteins like osteopontin. The lining cells then detach 
from the bone surface. The so-prepared surface attracts migrating osteoclast 
precursors. The osteoclasts form a structure comparable to a suction cup on the 
bone surface, sealing the margin with a ring of integrin attachments. These 
integrins attach to bone matrix proteins like osteopontin (55). Between the 
osteoclasts and bone, a secluded space is created – the resorption lacuna – to 
protect neighbouring cells from acid and aggressive enzymes and to limit the 
extent of bone resorption. Under the suction cup, the osteoclasts increase the 
surface of their cell membrane by forming microscopic folds, the so-called ruffled 
border, a sign of the actively resorbing osteoclast (39). The cell membrane in the 
folds contains ion pumps that are comparable to gastric ion pumps. Producing 
hydrochloric acid, the acid demineralizes bone matrix and liberates bone collagen. 
Special enzymes, one of which is cathepsin K, digest bone collagen.  
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The coupling of osteoclasts and osteoblast and the molecular mechanism of how 
osteoclasts control and activate osteoblasts to fill up the bone void after resorption 
is still unclear in detail (56). As discussed earlier, growthand differentiation factors 
like BMP, IGF, TGF beta are stored in the bone matrix bound in an inactive form to 
heparan sulphate. They can be liberated from the bone matrix and activated by 
cleavage from the glycosaminoglycan by proteolytic enzymes. These enzymes are 
located on the surface of many cell types including osteoblasts (16). The role of 
the osteoclast in unmasking these factors by their proteases in the resorption 
lacuna is unclear. It is unlikely that these growth factors are transferred in intact 
form through endocytosis and through the osteoclasts cytoplasm. However, it is 
known that osteoclasts express and secrete BMP-6 and may thereby amplify the 
BMP signal which they have received from the degraded matrix (38). BMP-6 and 
the chemokine sphingosine 1 phosphate (S1P) are released on the tissue side by 
the osteoclast (56). BMP-6 is a coupling factor of bone resorption and refill 
involved in the osteoblast recruitment (57). BMP-6 differentiates mesenchymal 
stem cells to osteoblasts to build new bone (58). With other types of messenger 
molecules like ephrin and cardiotropin, osteoclasts may control the osteoblasts 
(45, 39). It has been shown that a bidirectional signalling exists between 
osteoclasts and osteoblasts in direct neighbourhood by the exchange of 
membrane bound ephrinB2 and EphB4 ligands. According to this theory, the 
osteoclasts retract themselves and directly differentiate osteoblasts in direct cell 
contact to fill the void with new bone (59). Osteoblastic precursor cells can sense 
the surface topography in the resorption lacuna by creating pseudopodia and thus 
attain information about how much bone is needed to fill the void (39). At this 
point, there is a scientific parallel to the different osteoconductivity of microand 
nanostructured titanium implant surfaces, which can also be sensed by the 
osteoblasts (60).  
The formation of new osteons and remodelling of cortical bone is organized in 
form of so-called cutting cones. This is mainly a vessel loop with multiple 
osteoclasts on its tip. These groups of osteoclasts dig a tunnel into the old bone. 
The tube behind the tip of the tunnel is conclusively lined by concentric layers of 
newly formed lamellar bone. In the final state, the newly formed unit, containing a 
central blood vessel is called osteone or Haversian system.  
Newly formed bone has to be built in a load oriented fashion. Mechanical stimuli 
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have to be translated into a cytokine signal to control the action of the osteoblast. 
This so-called mechanotransduction is thought to be a task of the osteocyte. The 
osteocyte is buried in bone and has tiny cytoplasmatic processes in nanoscale 
bone channels. According to the fluid shift theory, loading of bone causes 
interstitial pericellular fluid shifts within these channels (61) which stimulate 
primary cilia organs in the cell membrane that in turn induce an intracellular signal 
(62). These signals propagate through cellular junctions to neighbouring 
osteocytes, a network that is called the osteocyte syncytium (63). This 
communication process involves ion streams through gap junctions, small 
messenger molecules like nitric oxide and prostaglandin signalling (64, 65). This 
signalling precedes a protein signalling. Osteocytes can inhibit osteoblasts through 
the messenger sclerostin (66), a soluble inhibitor of canonical Wnt signalling which 
is closely connected to the PTH signal transduction system (66). 
1.6 Introduction to the in vitro, preclinical and clinical studies on 
osseointegration 
The influence of implant surface variation, in terms of surface roughness and 
application of bioactive molecules, is one of the most important field of research in 
the context of dental implants osseointegration 
The features of implant devices and the reactions of bone-derived cells to foreign 
surfaces determine implant success during osseointegration. In an attempt to 
better understand the mechanisms underlying osteoblasts attachment and 
spreading, the first in vitro study was about adhesive peptides containing the 
fibronectin sequence motif for integrin binding (Arg-Gly-Asp, RGD) or mapping the 
human vitronectin protein (HVP). They were grafted on glass and titanium 
surfaces with or without chemically induced controlled immobilization. Several 
experimental studies have made reference to the role of heparin-binding motives 
in the selective binding of osteoblasts [67, 68]. With respect to the various 
extracellular matrix glycoproteins, the FRHRNRKGY peptide mapped on human 
vitronectin promotes osteoblast-like but not human umbilical vein endothelial cell 
(HUVEC) adhesion [69]. Heparin-binding sites of vitronectin and fibronectin are 
adjacent to the tripeptide sequence motif for integrin binding (Arg-Gly-Asp, RGD) 
and show a pattern of charged groups making contact with integral cell membrane 
proteins, namely heparan sulfate proteoglycans. Syndecans and glypicans, 
members of the proteoglycan family, consist of a core protein covalently bound to 
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long side-chain sulfated (heparan sulfate) glycosaminoglycan (GAG) or non-
sulfated (hyaluronic acid) carbohydrates [70]. These membrane structures make 
contact with the extracellular environment through electrostatic and polar bindings, 
largely favoured by the hydrophilic layer described on device surfaces during the 
post-implantation phases. The energy involved in each of these interactions is 
relatively small. Large numbers of proteoglycan molecules are, however, 
expressed on the cellular membrane and the simultaneous cooperation of these 
contacts leads to a strong, even if transient, interaction [71]. Moreover, these 
dynamic interactions occurring in the time scale of milliseconds are required to 
elicit the receptor-mediated intracellular signalling involved in the modulation of 
subsequent cellular adhesion and in the osteoblasts differentiation [72]. Indeed, 
formation of new mineralized bone is a multistep, temporally and spatially 
coordinated process requiring membrane adhesive receptors, such as members of 
the integrin family [72]. The integrin-mediated signalling requires time frames of 
the order of minutes, a time-lag depending on the low densities of both the 
receptors and the ligands and on the lack of their appropriate spatial orientation 
[73]. An ideal implant surface should, therefore, exhibit electrostatic interactions to 
promote early osteoblasts attachment, preventing contact with other cell 
populations while ensuring the specific orientation of cellular receptors leading to 
platform for subsequent long-term cellular binding.  
Tissue engineering procedures can be applied for the study of osseointegration in 
vitro. In vitro experiments can nowadays be based on tissue engineering methods. 
The use of 3D scaffolds loaded with human adipose-derived stem cells (ADSCs) 
has been investigated in the field of bone tissue engineering (74, 75). In this 
context, blocks of hydroxyapatite used as scaffolds provided an excellent porous 
architecture for ADSC spreading, adhesion, growth, and proliferation. In vitro 
ADSC osteo-endothelial commitment, which is a prerogative to mimic native bone, 
was also described (76) The insertion of a dental implant into a natural bone block 
that can be secondarily seeded with stem cells was considered one of the in vitro 
strategies to study osseointegration. 
As described, the events related to the bone-to implant interface are within the 
complex phenomena of healing and bone remodeling, leading to new bone 
formation on the implant surface and to the intimate contact between the two 
opposing surfaces. The bone formation in vivo can be affected by various factors, 
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among them, the distance between the bone wall and the implant, in particular 
towards the buccal, lingual and apical walls. 
Bone bridging in hard tissue defects is dependent on the size of the gap (77). This 
applies to implant dentistry as well and implies that osseointegration may be 
compromised at implants with marginal gaps >1mm in width between the implant 
surface and host bone (for review see: 78, 79). In fact, reports from experiments in 
dogs confirmed this hypothesis (e.g. 80, 81). These studies have demonstrated 
that the coronal level of bone-to-implant contact was dependent on the size of the 
gap between the titanium surface and the hard tissue walls of the recipient site. 
Conversely, other experimental studies showed that also marginal defects >1mm, 
even >2mm around implants may heal similarly to control sites (78, 82). It was 
further observed that new bone formed from the parental bone independently of 
the dimensions of the defects or irrespective of the use of GBR procedures (83, 
84, 85, 86). In the studies cited, primary contact between bone and implants was 
always achieved in order to guarantee primary (mechanical) stability of the 
implant.  
It had previously been demonstrated that defects up to 1mm gave rise to new 
bone formation and bridging the gap with one “single jump” while, in larger defects, 
multiple “jumps” were necessary (77). It has been shown in dogs experiments (83, 
78; 87) that, in the presence of a marginal defect around implants, bone formation 
starts from the lateral and apical bony walls, towards the implant surface. 
However, the front of the newly formed bone does not reach the implant surface in 
the early phase of healing, leaving a space of about 0.4mm occupied by 
connective tissue. After 3-4 weeks of healing, osseointegration processes will start 
from the bottom of the defect, towards the margin of the implant. 
An important role in osteogenesis around implants, and consequently 
osseointegration, is played by primary stability and by the surface characteristics 
of the implant (88, 89, 90, 4). 
Two different patterns of bone formation at implant sites have been described (89, 
91) (figs 12-15). Contact osteogenesis implies bone formation in direct contact 
with the implant surface, and distance osteogenesis implies new bone formation 
on the surfaces of the parent bone. This may subsequently become attached to 
the implant surface as well. When a gap results between the bony wall of the 
implant bed and the implant surface, a series of events occurs (8, 9, 87). A clot will 
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initially fill the space and will be replaced by a provisional connective matrix that 
will act as scaffold for woven bone formation. Contact and distance osteogenesis 
have been described as biological processes that lead to dental implant 
osseointegration (89, 91, 92). The existence of these processes has been studied 
in some animal experiments (93, 8, 9, 83, 84,  87). Contact osteogenesis has been 
described in an experimental study in dogs (9) in which secluded chambers were 
used. Newly formed woven bone was found attached to the implant surfaces and 
occasionally not connected with the parent bone. In another experimental study in 
dogs, marginal defects around implants were used (83). The healing indicated that 
both processes, contact and distance osteogenesis, may have participated in the 
closure of the marginal defects.  
It should be emphasized that in the above mentioned experimental studies initial 
bone contact was provided to the implants by the threads of the implant bodies. 
However, in a rabbit model, implant contact with the parent bone was avoided 
(93). Without such initial contact, osseointegration was not achieved. It has to be 
further realized that a turned implant surface was used in that experiment. This 
fact may have influenced the healing outcomes as well (90, 4). In any case, the 
Carlsson et al experiment showed that either contact or distance osteogenesis 
were not completely impossible, even though with very reduced predictability. 
In the study mentioned (93), a device was applied to assure primary stability of the 
implant, since implant instability has been shown to induce a fibrous encapsulation 
of the implant rather than osseointegration. 
The effect of demineralized bovine bone matrix (DBBM) as a bone substitute and 
filler of marginal defects around implants has been evaluated in several 
experimental (e.g. 95, 96, 97, 98) and clinical studies (e.g. 99, 100). This 
biomaterial appeared to be completely integrated in newly formed bone over time, 
appearing to offer optimal osteoconductivity (96). Nevertheless, the advantages of 
DBBM in improving osseointegration when applied at marginal defects around 
implants is still under debate (97, 101, 102, 103, 104, 105). 
The influence on osseointegration of the quality and condition of the alveolar bone 
in relation to the timing of extraction can affect the pattern of bone healing and 
osseointegration. 
A systematic review (106) has documented that implants installed into alveolar 
sockets immediately after tooth extraction yielded a similar survival rate as 
implants placed in healed alveolar bony ridges. The results obtained were 
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maintained for at least 5 year (107). The use of this surgical approach has been 
scrutinized in several clinical (e.g. 108; 109) and experimental studies (e.g. 102, 
103, 110-118). These studies, however, were not able to confirm the maintenance 
of the vertical and horizontal dimensions of the peri-implant hard tissue, due to the 
alveolar bone resorption taking place after tooth extraction (119, 110). The buccal 
plate of the alveolar extraction socket may be compromised as a consequence of 
the disease process before tooth extraction. As result, a buccal dehiscence may 
occur after implant installation. Several different procedures have been proposed 
to improve the outcomes after healing of such compromised sites (e.g. 120, 121, 
122, 123). In a controlled clinical study (123), implants were installed into molar 
alveolar sockets immediately after tooth extraction, and deproteinized bovine bone 
mineral covered with a collagen membrane was used to fill the residual 
dehiscence buccal defects (test sites). As control sites, implants installed in healed 
molar sites were used. The survival rates were similar in both groups (100%), 
while better results were obtained at the control sites in relation to probing depths 
and clinical attachment levels. In animal experiments, buccal dehiscences were 
produced at extraction sockets and different regenerative methods applied (e.g. 
124, 125, 126, 127,  128, 129, 130, 112). In a experiment in monkeys (130), 
dehiscence-type defects, about? 4 mm large and 6 mm deep, were filled with 
rhBMP-2, while the control sites were left untreated. A vertical bone gain of 
approximately 4 mm was observed in both groups, the difference between test and 
control group not being statistically significant. Also the positioning of the implants 
within the extraction sockets has been shown to affect the final outcome. The 
closer the implant surface was to the outer contour of the bony crest, the higher 
was the supracrestal exposure of the buccal portion of the implant (117, 118, 112, 
131, 132, 133) 
The development of implant surfaces, together with a better understanding of the 
mechanisms the peri-implant bone healing, leads to variation of some clinical 
paradigms. Among these, the need to use implants with a length not less than 10 
mm, especially in case of immediate post extractive implants  
Implants installed into alveolar sockets immediately after tooth extraction have 
been shown to yield predictable outcomes (e.g. 134, 135). Furthermore, a 
systematic review (106) has established the fact that such implants present with 
similar survival rates (estimated annual failure rate: 0.82%) as conventionally 
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placed implants. The use of this procedure reduces the number of surgical 
sessions and may also reduce the time between surgery and prosthetic delivery 
(136). This technique, however, cannot prevent the physiological bone resorption 
that occurs after tooth extraction (108, 137, 106.) 
For this placement modality (type 1; Hämmerle et al. 2004) (136), the need for 
implants that are longer than the remaining extraction sockets has been 
propagated under the assumption that implant stability may be guaranteed in the 
area beyond the apex of the extraction socket (138, 139, 140). Because of the 
presence of anatomical structures such as the maxillary sinus or the inferior 
alveolar nerve, however, bone may not be available beyond the apex of the 
socket. Moreover, it was shown in experimental animals that immediate implants 
became osseointegrated irrespective of their length in relation to the extraction 
socket (118). In these experimental studies, however, the length of the implants 
was at least of 10 mm.  
Moreover, the use of short implants (6 mm) has been reported with good 
outcomes (141, 142, 143) and promising results have been published on the 
installation of short implants in comparison with alveolar bone augmentation 
techniques (144, 145).  
However, the use of short implants (6 mm) in immediate installation has not been 
studied as yet. 
In vitro and preclinical animals studies demonstrate that the development of 
implant surfaces can influence the clinical utilization in human. In particular, the 
overall increase of the implant surface that contacts the alveolar bone – bone to 
implant contact , related to the increase of surface roughness secondary to 
treatments at micro and nanoscale, may allow the treatment of edentulism 
associated with severe alveolar bone atrophy with implants of reduced dimensions 
(eg length of the intraosseous component <10mm). 
Osseointegrated implants have become a viable option for replacing missing teeth 
in totally and partially edentulous patients, as established by systematic reviews, 
especially in the case of single-tooth gaps (146-149). However, in many clinical 
situations, placing long implants could prove difficult as a result of limitations such 
as the location of the mandibular canal, pneumatization of the maxillary sinus, and 
alveolar ridge deficiencies. In patients with severe alveolar resorption, there are 
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different surgical procedures available to facilitate future implant placement. More 
complex implant techniques include the use of bone grafts harvested extraorally or 
intraorally and placed as inlays or onlays, distraction osteogenesis, zygomatic 
implants, transposition of the inferior dental nerve, guided bone regeneration 
(GBR), and maxillary sinus elevation (150-153). 
However, these surgical procedures are case sensitive, technically demanding, 
and time consuming and may increase postoperative morbidity and the total cost 
and duration of the therapy. Minimally invasive surgical techniques are currently 
advocated to reduce patients’ postoperative discomfort and contain the risk of 
complications. The use of short implants was introduced as an alternative 
treatment in patients with limited amounts of bone available. There is no 
consensus in the dental literature on the definition of a short implant: in various 
reviews, it has come in lengths of 7, 8, or <10 mm (141, 154). An implant can also 
be inserted at different levels, so a short implant has also been defined as an 
implant designed to have an intrabony length of 8 mm (141). 
Recent reviews have compared short implants with conventional implants. 
Kotsovilis et al (155)  concluded in their systematic review that short implants (8 or 
10 mm) with rough surfaces are no less effective than implants of conventional 
length (10 mm) with rough surfaces. Romeo et al (156) wrote that the recent 
literature has demonstrated a similar survival rate (SSR) for shortand standard-
length implants. In a systematic review of horizontal and vertical bone 
augmentation techniques for the purposes of dental implant treatment, Esposito et 
al (157) concluded that short implants appear to be a better alternative to vertical 
bone grafting of resorbed jaws. Conversely, when the clinical outcome of short 
implants was discussed, non-homogeneous SSRs were reported (158-161). 
probably because the surface treatment of the implants was not always taken into 
account.  
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2. AIM OF THE THESIS 
Aim of the present thesis has been to focus on dental implant surface 
modifications in order to improve the clinical performance in areas with poor 
quantity or quality of bone. To achieve this objective, the thesis has been 
developed by identifying specific aims for the in vitro, preclinical and clinical 
studies. 
1) In vitro studies: 
a) to better understand the mechanisms underlying osteoblasts 
attachment and spreading, in this study adhesive peptides containing the 
fibronectin sequence motif for integrin binding (Arg-Gly-Asp, RGD) or mapping the 
human vitronectin protein (HVP) were grafted on glass and titanium surfaces with 
or without chemically induced controlled immobilization.  
b) to reproduce the osseointegration process in vitro in order to study the 
dynamic of bone-implant interactions. To this end, a tissue engineering approach 
was used by positioning dental implants into stem cells seeded 3D bone-derived 
scaffolds. The final goal was to overcome the limitations concerning in vitro 
methods, and to complement and eventually replace animal studies in this field. 
 
2) in vivo studies  (in big animal model, dogs, of osteointegrative 
properties of implants with different degree of surface modification).  
a) to evaluate the healing at implants with a moderately rough surface 
placed and stabilized in recipient sites of dimensions deeper and larger than that 
of the implants to avoid any contact between parent bone and the implant surface.  
b) to evaluate the influence on osseointegration of DBBM particles used to 
fill defects of at least 1mm around implants having no primary contact with bone. 
c) to evaluate the influence of bucco-lingual implant positioning into 
extraction sockets on bone formation at buccal alveolar dehiscence defects.  
d) to compare the bone-to-implant contact of 6 mm osseointegrated 
implants with that of 11 mm long implants installed into sockets immediately after 
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tooth extraction.  
 
3) clinical research (on short implants, to underline the effect of surface 
modifications on dental implant survival in the long term in the clinic). 
a) to assess the mediumto long-term prognosis of short implants (7 or 8.5 mm in 
length), with machined (M) and rough (R) surfaces, placed in partially or totally 
edentulous arches, in a retrospective clinical trial. 
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3. MATERIALS AND METHODS 
 
3.1 IN VITRO STUDIES 
 
3.1.1 From Brun et al, 2012. Mechanisms underlying the attachment and 
spreading of human osteoblasts: From transient interactions to focal 
adhesions on vitronectin-grafted bioactive surfaces 
 
Peptide synthesis and surfaces preparation 
 
The vitronectin peptide is mapped on the human vitronectin protein (HVP, 
sequence 351-359: FRHRNRKGY). The RGD peptide is a linear sequence of 
human fibronectin presenting four GRGDSP motifs per chain (RGD, sequence: 
GRGDSPGRGDSPGRGDSPGRGDSPK). The RAD peptide is the control peptide 
with respect to RGD (RAD, sequence: GRADSPGRADSPGRADSPGRADSPK). In 
its sequence the Arg-Gly-Asp motif is substituted with a similar but not adhesive 
motif, Arg-Ala-Asp. Both peptides were synthesized as C-terminal amides using 
the Fmoc Chemistry on Applied Biosystems 431A Instrument, a traditional solid-
phase technique (162). 
Side-chain protected peptides (t-Butyl (tBu), Tyr; 2,2,5,7,8-Pentamethylchromane-
6-sulfonyl (Pmc), Arg; Trityl (Trt), His and Asn; t-butoxycarbonyl (Boc), Lys; tBu, 
Ser) were synthesized using a Sieber Amide resin. The cleavage from the resin 
was obtained by incubation for 15 min in (1) 1% 2,2,2-trifluoroacetic acid 
(TFA)/dichloromethane (DCM) for the full side-chain protected sequences and in 
(2) 10% TFA/DCM for 20 min for the partially deprotected sequences. The 
deprotection method (2) produced the loss of Boc and Trt for HVP and of Boc for 
RGD. The products were ascertained by electrospray ionization/time of flight mass 
spectrometry. To prepare the glass coverslips (1.76 cm2), glasses were washed 
several times in an ultrasonic bath (acetone, 30% ethanol in MilliQ water) and 
treated with 1 N NaOH for 1 h. Glasses were washed in MilliQ water, dried at 100 
°C for 10 min, washed with acetone and dried under vacuum. The glass coverslips 
were then immersed in 2% (3-aminopropyl) triethoxysilane (APTES) in acetone 
solution at 40 "C overnight, washed three times with dichloromethane (DCM), 
acetone and finally with MilliQ water. After drying for 10 min at 100 °C the 
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coverslips were randomly divided into two groups to be used for unspecific or 
specific functionalization. For specific functionalization (sp), silanized glasses were 
incubated for 4 h in 20 ml N-methyl-2-pyrrolidone (NMP) and 2.5 ml 
diisopropylethylamine (DIEA) containing 5 mg glutaric anhydride. The glasses 
were washed three times with NMP and three times with acetone, and then dried 
under vacuum for 1 h. The reaction with side-chain protected peptides was carried 
out for 21 h using 8 mol of protected HVP or protected RGD or protected RAD 
dissolved in 10 ml NMP containing 3.75 mg O-benzotriazole-N,N,N’,N’-
tetramethyl-uroniumhexafluoro-phosphate (HBTU), 1.34 mg N-
hydroxybenzotriazole (HOBt) and 5 µl DIEA. The glasses were washed three 
times with NMP and three times with ethanol, and finally dried under vacuum for 
15 min. The side-chain de-protection was carried out mixing a solution of 10 ml 
TFA with 0.23 ml MilliQ water, 0.1 ml TES, and 0.25 ml 1,2-ethandithiol (EDT) for 
1 h. The glass coverslips were then washed twice in TFA and in acetone, three 
times in MilliQ water and twice in acetone. They were then dried under vacuum for 
15 min. These surfaces carrying specifically immobilized peptides will be hereafter 
referred to as ‘‘HVPsp’’, ‘‘RGDsp’’ and RAD.  
The same protocol was used for unspecific functionalization (unsp). In this case 
the partially deprotected sequences of RGD and HVP were used. These surfaces 
carrying unspecifically immobilized peptides will be hereafter referred to as 
‘‘HVPunsp’’ and ‘‘RGDunsp’’. Titanium (Ti) surfaces were obtained by cutting 
commercially pure cylindrical titanium (Ti grade 2) bars. Ti disks (1.76 cm2) were 
prepared, as described elsewhere (163) and then treated with glutaric anhydride, 
side-chain protected peptides, and TFA, as described for the glass coverslips. The 
morphology of titanium disks was analyzed and reported in Bagno et al (163). 
Briefly the roughness data for sand-blasted and acid attacked disks estimated by 
contact profilometry resulted as follows: Sq (Å) = 25,374.44; Sa (µm) = 2.015; Ssk 
= -0.0675; Sku = 3.06; Sz (Å) = 161,324.8; Sds = (Å-2) = 2.9 x 10-10; Sdr (%) = 
329.02. Roughness parameter values measured on silanized or peptide linked 
surfaces showed no significant difference in surface morphology. 
 
Surface characterization 
 
Radio-labeling procedure 
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Radio-labeling of silanized glass surfaces was performed separately treating each 
sample in triplicate with 600 µl of 0.115 mM [14C] formaldehyde and 10 mM 
NaBH3CN acetonitrile for 4 h at room temperature. The excess radioactive 
solution was removed, and the glasses were washed 10 times with acetonitrile, 
water and then dried using N2. The same procedure was used for the control 
surface obtained by acetylation of silanized samples. Samples were then 
incubated overnight at room temperature with a mixture of toluene (1 ml), acetic 
acid anhydride (100 µl) and pyridine (100 µl). The glasses were rinsed with 
toluene, DCM and ethanol. 
The radioactivity of each sample was measured with a Packard Liquid Scintillation 
Analyzer using 5 ml of scintillation fluid (Packard). Data expressed as counts per 
minute were converted into pmol through a titration curve. 
 
X-ray photoelectron spectroscopy (XPS) measurements 
XPS studies were performed using an instrument of our design equipped with 
preparation and analysis chambers separated by a gate valve. The analysis 
chamber consists of a six-degrees-of-freedom manipulator and 150 mm mean 
radius hemispherical electron analyzer with a five-lens output system combined 
with a 16-channel detector. Si2p, C1s, O1s and N1s core level signals were 
recorded. The reaction yield R for peptide immobilization was calculated from the 
N/Si ratios, as reported by Xiao et al. (164): 
R = [(N/Si) sample – (N/Si) control]/(N/Si) controlX1/NpeptX100, where the (N/Si) 
sample is the measured ratio for HVPsp, HVPunsp, RGDsp or RGDunsp, the 
(N/Si) control is the measured atomic ratio for a silanized surface and Npept refers 
to the nitrogen atoms in a 
peptide molecule (22 for HVP and 38 for RGD). 
 
Atomic force microscopy (AFM) analyses 
Topographical images were obtained by AFM using a commercial Nanoscope IIIa 
multimode microscope (Digital Instruments, Santa Barbara, CA, USA). The device 
was equipped with an <E> calibrated scanner, calibrated using the manufacturer’s 
gratings. All samples were observed in tapping mode (TM) using 0.5–2 Ω cm 
phosphorous n-doped silicon tips mounted on cantilevers with a nominal force 
constant of 40 N m-1 and a resonant frequency of 300 kHz. The applied force was 
varied over a range from several nN up to tens of nN in contact mode. The glass 
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surfaces were examined ex situ after being gently dried. Image analysis was 
carried out using DI software, version 4.23r6. The images were flattened to 
remove background slopes. Film roughness was measured on TM images 
obtained at a scan speed of 1 Hz over scanned areas of 500 x 500 nm2 for a 
minimum of three separate images for each sample obtained from different 
regions. The roughness values are expressed in terms of Ra, Rq and Rmax. In 
particular, Ra expresses the arithmetic average of the absolute values of the 
surface height deviations measured from the mean plane within the cursor box 
using Ra=  . Rq is the standard deviation of the Z values and is calculated 
as Rq=  where Zi is the current Z value and n is the number of points within 
the cursor box. Finally, Rmax is the maximum vertical distance between the 
highest and lowest data points within the cursor box. 
 
Cell culture and assays 
 
Human osteoblasts were obtained using a trephine bur from mandible alveolar 
bone of healthy 54-year-old male subject during a standard procedure for implant 
surgery. The study was approved by the local Ethics Committee (March 2008). 
The patient gave his informed consent to the experimentation. Osteoblasts were 
cultured and differentiated as previously described (165).  Human foreskin 
fibroblasts were purchased from the American Tissue Culture Collection (ATCC, 
Manassas, VA) and cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 20% v/v fetal bovine serum, 1% v/v sodium pyruvate, 1% v/v 
nonessential amino acids and 1% v/v antibiotic–antimycotic solution (all provided 
by Gibco, Milan, Italy). The culture medium was renewed every three days. 
Osteoblasts and fibroblasts were detached using Trypsin–EDTA (Gibco) and used 
between the fifth and tenth passages. 
 
Adhesion study 
Cellular adhesion to glass or Ti-grafted surfaces was evaluated, as described 
elsewhere (163). Briefly, osteoblasts (1 x 105 cells ml-1) were seeded and 
cultured for 2 h on differently functionalized surfaces. Cellular cultures were then 
rinsed three times with phosphate buffer saline (PBS) and then incubated with 200 
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µl of MTT (3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide) solution 
(5 mg ml-1 in PBS, Sigma) at 37 °C for 4 h. Reaction was stopped by adding 0.01 
N HCl in 10% w/v SDS and optical density was recorded at 620 nm using a 
microplate reader (Sunrise; Tecan, Milan, Italy). To quantify adherent cells a 
standard curve was constructed for each experiment. As indicated, human 
osteoblast monolayers were incubated for 10 min at 22 °C with 50 mg ml-1 
heparin (Sigma, Milan, Italy). The cells were then re-suspended in serum-free 
medium (6 x 105 cells ml-1) and pretreated either for 30 min at 4 °C with anti-αvβ3 
integrin antibody (10 µg/1 x 105 cells, Chemicon, Prodotti Gianni, Milan, Italy) or 
for 3 h at 37 °C with 1 U ml-1  of heparinase I, 0.5 U ml-1  of heparinase II and 0.5 
U ml-1  of chondroitinase ABC (all purchased from Sigma Chemical Co., St Louis, 
MO, USA). Control cells were incubated in serum-free medium. Cell viability was 
verified by the trypan blue exclusion test and 1 x 105 osteoblasts were seeded on 
functionalized glass coverslips or Ti dishes. 
 
Imaging assays 
 
Immunocytochemistry 
Osteoblast cells were fixed in paraformaldehyde 4% w/v 10 min at room 
temperature and then washed twice (5 min each) in Trisbuffered saline (TBS). 
Nonspecific binding sites were blocked by incubation with 2% bovine serum 
albumin in TBS for 20 min. Samples were then incubated with mouse polyclonal 
anti-β actin (1 µg ml-1, Sigma) or rabbit polyclonal anti-pospho-FAK-Y397 
antibodies (2 µg ml-1, Santa Cruz Biotechnology, Heidelberg, Germany) for 2 h at 
22 °C. Following extensive washes, immunocomplexes were detected with goat 
anti-mouse IgG Alexa Fluo 555-conjugated or goat anti-rabbit IgG Alexa Fluo 488-
conjugated (Invitrogen Corporation, Milan, Italy). The nuclei were stained with 
TOTO-3 iodide (Invitrogen). Negative controls were performed by omission of 
primary antibodies. The samples were then washed, mounted, analyzed and 
photographed using a Leica TCSNT/SP2 confocal microscope (x63 objective, x2 
zoom). The images were digitally stored using Leica software. 
 
Total internal reflection fluorescence (TIRF) microscopy 
Human osteoblasts (1 x 105 cells ml-1) were cultured for 2 h at 37 °C on glass 
coverslips functionalized with RGD and HVP peptides. The cells were then probed 
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with FM 1-43 fluorescent dye (Invitrogen, Milan, Italy) specifically binding to 
membrane lipids and then examined using an inverted microscope equipped with 
commercial white light TIRF apparatus (Nikon Instruments). The total internal 
reflection (TIR) at the glass coverslip–water interface was obtained using an 
objective based approach (CFl Plan Apochromat TIRF 60x/1.45 oil) with a 
theoretical penetration depth from ~80 to 200 nm. Images were taken starting 1 
min after the probe was added using a 2 megpixel CCD camera DS-2MBWc 
(Nikon Instruments, USA). To ensure optimal conditions, during acquisition cells 
were kept in a top-stage incubator (Tokai Hit, Japan) with temperature and CO2 
levels at 37 °C and 5%, respectively. As described, osteoblast cells seeded onto 
HVP functionalized surfaces were treated for 1 h at 37 °C with 50 µM ML141, 
Cdc42 pharmacological inhibitor, before TIRF analysis (166). 
 
Western blotting 
 
Human osteoblasts cultured for 6 h on functionalized glass surfaces were washed 
with ice-cold PBS and subjected to total protein extraction and Western blot assay 
as previously described (167). 
Phosphorylated FAK was revealed by incubating the PVDF membrane with rabbit 
polyclonal anti-pospho-FAK-Y397 antibody (2 µg ml-1, Santa Cruz) and with 
horseradish peroxidase-conjugated goat anti-rabbit (Sigma). Finally, the enzymatic 
reaction was developed using ECL detection reagents (Santa Cruz Biotechnology) 
and photographed using a VersaDoc imaging system (Bio-Rad). Anti-β-actin 
antibody (Sigma) was used as loading control. 
 
RNA isolation and quantitative real time PCR analysis 
 
Human osteoblasts and fibroblasts cultured for 24 h on different functionalized 
surfaces were subjected to total RNA extraction using the SV Total RNA Isolation 
System kit (Promega, Milan, Italy) according to the manufacturer’s instructions. As 
described, osteoblasts were treated with 100 µM AG82 (Calbiochem, Milan, Italy), 
a pharmacological FAK inhibitor, for 1 h at 37 °C. 2 µg of total RNA were retro-
transcribed using oligo random hexamers and MuLV reverse transcriptase 
(Applied Biosystems, Milan, Italy) to generate cDNA. Gene expression was 
evaluated using quantitative real time RT-PCR using ABI Prism 7700 Sequence 
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Detection System (Applied Biosystems), the TaqMan qPCR Master Mix (Applied 
Biosystems), primers and probes from the Universal Probe Library system (UPL, 
Roche Applied Science, Monza, Italy; Table 1.1). The expression of the target 
genes was normalized to the endogenous levels of glyceraldehyde-3-phospate 
dehydrogenase (GADPH). Gene quantification was carried out using a standard 
curve generated by amplification of 10-fold serial dilutions of the corresponding 
cDNA subcloned into the pGEM-T Vector System (Promega). 
 
Statistical analysis 
 
Data are reported as mean ± SE. Statistical analysis was performed using the 
unpaired Student’s t-test or the one-way ANOVA test followed by a Bonferroni’s 
multicomparison test, using GraphPad Prism 3.03 (San Diego, California, USA). P 
values <0.05 were considered statistically significant. 
 
 
3.1.2 From: A novel in vitro technique to evaluate dental 
implantosseointegration. 
 
Biomaterials 
Dental implant 
Customized cylindrical implants 6.6 mm in length and 3.4 mm in diameter (ZirTi®; 
Zirconium Sand-Blasted Acid-Etched Titanium, Sweden & Martina, Due Carrare, 
Padova, Italy) were utilized (Figure 2.1a). Implant design was characterized by the 
presence of a titanium extension on the coronal side having a 2.5 mm diameter 
and approximately 10mm length, with a screw morphology at its extremity and a 
polished surface close to the body of the implant. In the middle of the extension, a 
polished hexagon was present. 
 
Bone matrix 
Orthoss® Blocks 2x2x1.3 cm (GeistlichPharma AG, Wolhusen, Switzerland) were 
used in this study. Orthoss® is a natural carbonated hydroxyapatite of bovine 
origin. It is a highly osteoconductive material because of its particular structure, 
very similar to human spongeous bone, with interconnected macropores (100-300 
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µm), micropores, and nanopores (10-20 µm), resulting in an higher inner surface 
and excellent hydrophilic property. 
Dental implants were inserted in the bone blocks by means of two customized 
drilling guides (Fig. 2.1b)  with a twist drill (FFT3 300, Sweden & Martina) and 
dedicated drill stops.  
For each experiment, one implant on the 2x2 cm side of one bone block was 
inserted (Fig. 2.1c). 
 
Human stem cells isolation 
Human ADSCs were isolated from the adipose tissue of healthy patients (age, 35–
58 years) who underwent cosmetic surgery procedures. All the patients gave 
written consent. The adipose tissues were digested and the cells were isolated, 
expanded, and seeded following our previous protocol (76). Briefly, the fat was 
washed with Phosphate Buffered Saline (PBS, EuroClone, Milan, Italy) and 
digested using a solution of 0.075% collagenase from Clostridium histolyticum 
type II (Sigma-Aldrich, St. Louis, MO, USA) in Hank's Balanced Salt Solution 
(HBSS, LonzaS.r.l., Milano, Italy), for 3 h at room temperature and in slow 
agitation. At the end of the digestion, the collagenase activity was blocked with an 
equal volume of complete DMEM (cDMEM). cDMEM consisted of Dulbecco’s 
modified Eagle’s medium (DMEM, Lonza, Italy) supplemented with 10% Fetal 
Bovine Serum (FBS, BidachemS.p.A., Milano, Italy) and 1% 
Penicillin/Streptomycin (P/S, EuroClone). After centrifugation for 4 min at 1200 
rpm, the pellet was washed in PBS and filtered with a 70 µM cell strainer (BD 
Biosciences, Mississauga, Ontario, Canada). The cell suspension was 
resuspended in cDMEM, transferred to a 25-cm2 tissue culture flask, then 
incubated at 37°C and 5% CO2 for 3 days.  
 
Cell counting and 3D cultures 
The viable cells were counted using the trypan blue exclusion test. At the 
confluence point, ADSCs were detached from the flasks with a solution of 0.25% 
trypsin ad 0.02% EDTA (EuroClone). After the addition of cDMEM, the cells were 
centrifuged for 4 min at 1200 rpm. The pellet was resuspended in cDMEM, then, 
20 µl of the suspension were added to 80 µl of trypan blue for each culture. Cell 
counting was done using a Burker’s chamber. 
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Cells were seeded at density of 106/cm2 on bone matrix blocksaroundthe dental 
implant in presence of osteo-endothelial differentiation medium (cDMEM 
supplemented with 10 nM dexamethasone;50 µg/ml L-ascorbic acid; 10 mM β-
glycerophosphate; 10 ng/ml di basic Fibroblast Growth Factor; 0.5 ng/ml Vascular 
Endothelial Growth Factor; and 10 ng/ml Endothelial Growth Factor). All the 3D 
cultures were incubated at 37°C and 5% CO2 for 30 days, changing the medium 
every 2 days. 
 
Real-time PCR 
Total RNA was extracted from the ADSCs seeded for 30 days on the bone blocks 
around the dental implant using the TRIzol® Reagent (Invitrogen, Carsbad, CA, 
USA). The samples were quantified with the NanoDrop spectrophotometer 
(NanoDrop™ 1000, Thermo Scientific). For the first-strand cDNA synthesis, 500 
ng of total RNA was reverse transcribed using M-MLV RT (Moloney Murine 
Leukemia Virus Reverse Transcriptase, Invitrogen) according to the 
manufacturer's protocol. 
Human primers were selected for each target gene with Primer 3 software (Table 
2.1). Real-time PCRs were carried out using the designed primers at a 
concentration of 300 nM and FastStart SYBR Green Master (Roche Diagnostics, 
Mannheim, Germany) on a Rotor-Gene 3000 (Corbett Research, Sydney, 
Australia). Thermal cycling conditions were as follows: 15 min denaturation at 
95°C; followed by 40 cycles of 15 s denaturation at 95°C; annealing for 30 s at 
60°C; and 20 s elongation at 72°C. Differences in gene expression were evaluated 
by the 2∆∆Ct method (168) using ADSCs cultured in cDMEM onto tissue culture 
polystyrene as control.Values were normalized to the expression of the GAPDH 
internal reference, whose abundance did not change under our experimental 
conditions. Experiments were performed with 3 different preparations and 
repeated at least 3 times. 
 
Mechanical pull-out test 
The pull-out test measures the force needed to extract an embedded insert from a 
concrete mass. The test was performed in quadruplicate and in three different 
conditions: 
a)non cultivated bone blocks (dry); 
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b)non cultivated bone blocks, soaked in osteo-endothelial differentiation medium 
for 30 days (immersed); 
c) bone blocks loaded with ADSCs in osteo-endothelial differentiation mediumfor 
30 days (cultivated) (fig 2.3). 
Dry (a) and immersed (b) samples were considered as controls. 
Pull-out tests of the implants from the bone blocks (tensile test) were performed 
using a Galdabini SUN 2500 (Cardano al Campo, Italy) uni-axial testing machine 
equipped with a load cell of 25kN. Immediately before the test, a mounter was 
attached to the extension pin of each implant. After alignment and positioning of 
the samples in the testing machine, implants were loaded at room temperature, by 
setting a displacement rate equal to 1,5mm/min (Fig. 2.2). The force was 
measured by a multi-axial load cell (169, 170) and  signals were acquired by 
Cronos-PL 16 data acquisition system (IMC Dataworks, Madison, WI, USA) 
adopting UNI-8 channels with sampling time 20 ms and sampling rate 100 kHz. 
Before the mechanical tests the load cell was calibrated. Before each 
measurement the load cell was balanced.  
 
Scanning Electron Microscopy (SEM) 
SEM analyses were performedon dental implants pulled-out respectively from dry 
bone blocks and from seeded blocks. Samples were fixed with 2.5% 
glutaraldehyde (glutaraldehyde solution Grade I, 25% in H2O; G5882, Sigma 
Aldrich) in 0.1 M cacodylate (sodium cacodylate trihydrate; C0250, Sigma Aldrich) 
buffer for 1 h before critical-point drying followed by gold-palladium coating. All 
micrographs were obtained using a JEOL 6360LV SEM microscope (JEOL, Tokyo, 
Japan). The SEM analysis was carried out at the Interdepartmental Service Center 
C.U.G.A.S. (University of Padova). 
 
Statistical analysis 
One-way analysis of variance (ANOVA) was used for gene expression data 
analyses. A repeated-measures ANOVA with a post-hoc analysis using 
Bonferroni’s correction for multiple comparisons was performed, and t-tests were 
used to determine significant differences (p<0.05). Repeatability was calculated as 
the standard deviation of the difference between measurements. All testing was 
performed using SPSS 16.0 software (SPSS Inc., Chicago, Illinois, USA) (licensed 
by the University of Padova). 
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For mechanical pull out tests, resultant force was computed as the maximum 
value of force during the tensile test. Means ± SD were calculated for each 
condition. One-way ANOVA was used to assess for significant differences for the 
conditions, with statistical significance at P < 0.05. 
 
3.2 IN VIVO STUDIES 
 
3.2.1 PRECLINICAL STUDIES 
 
3.2.1.1 FROM: Sivolella et al., 2012 Osteogenesis at implants without primary 
bone contact – An experimental study in dogs. 
 
Cinical procedures 
The protocol was approved by the institutional Ethic Committee for animal 
research. Six Labrador dogs (average weight 27.6 kg, average age 2.9 years) 
were used. During all surgical procedures, the animals were pre-anesthetized with 
xylazine (1 mg/kg intramuscular [i.m.] Ronpums,Bayer, Sao Paulo, Brazil) and 
ketamine (15 mg/kg i.m. Dopalens, Vetbrands, São Paulo, Brazil) and 
anesthetized with thionembutal (20 mg/kg intravenous [i.v.] Tiopentals, Cristália, 
Itapira, Brazil) During the entire surgery, the animals inhaled O2 and were kept 
with an intravenous infusion of saline. 
The third and fourth premolars as well as the first molars were extracted bilaterally 
in the mandible. After 3 months of healing, muco-periosteal full-thickness flaps 
were elevated and, for the present experiment, the premolar area of the alveolar 
bony crest was selected bilaterally. 
Customized cylindrical implants, 7 mm in length and 2.8 mm in diameter (ZirTi®, 
Zirconium Sandblasted Acid Etched Titanium; Sweden & Martina, Due Carrare, 
Padova, Italy), were installed. The external macromorphology of the implant was 
characterized by the absence of threads and the presence of a modified apical 
region which presented with two opposing flat surfaces (Fig. 3.1a). The aim of 
these flat surfaces was to stabilize the implants into the positioning devices used 
in the experiment. The internal side of the implant contained a thread for the 
placement of customized cover screw. 
Two recipient sites were prepared with wider and longer cylindrical drills compared 
with the implant dimensions (defect sites – test). In the left side of the mandible, 
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the defect site was prepared using a cylindrical drill, 4.2 mm in diameter, to a 
depth of 7.7 mm (small defect) and a second defect site was prepared in the right 
side of the mandible using a drill of 5.2 mm in diameter to a depth of 8.2 mm 
(Large defect; Fig. 3.3a). 
Aiming at avoiding any contact of the implant surface with the bony walls of the 
implant bed after installation (Fig. 3.1b), two customized baskets made of PEEK 
(Polyetheretherketone; Sweden & Martina, Due Carrare, Padova, Italy) were 
fabricated (Fig. 3.2a and b). The baskets had the same external morphology and 
dimensions of the two recipient defect sites and the same internal morphology of 
the implant, but a slightly larger 
diameter. Only the flat surfaces at the apex of the implant were in contact with the 
basket 
to obtain stabilization. Moreover, a notch on the most coronal border, parallel to 
the apical flat surfaces of the implant, served as reference for implant positioning. 
Firstly, at each of the two defects, the corresponding baskets were placed within 
the prepared recipient sites, flush with the mesio-distal bony crest. The notches 
were placed parallel to the mesio-distal direction for histological purposes (Fig. 
3.3b). Subsequently, the implant was positioned within the basket. Straight or L-
shaped plates for bone fixation (Modul System 1.2 – Titanium; Cizeta Surgical, 
Bologna, Italy) with at least four holes were adapted around the bony crest with 
one of the central holes positioned on the implant (Fig. 3.3c). The plate was 
subsequently attached loosely to the implant with a customized cover screw. The 
passive adaptation of the plate on the alveolar crest and on the implant was 
checked and corrected if necessary. Three locations of fixation screws were 
prepared with the dedicated twist drill. The implant/plate unit as well as the plastic 
basket were removed from the recipient defect sites. A customized sterile titanium 
device (Fig. 3.2a–c; Sweden & Martina, Due Carrare, Padova, Italy) with an 
internal chamber with the same morphology and dimensions of baskets, was used 
to stabilize the implant/plate assembly. A calibrated torque screwdriver 
was used to tighten the customized cover screws to 25 Ncm. Care was applied to 
avoid rotation of the plate in respect to the implants and to maintain the 
predetermined orientation of the two flat surfaces at the apical portion of the 
implant. The implant/plate assembly was repositioned in the recipient defects 
sites, and the plates fixed to the alveolar bone using three fixation screws (Fig. 
3.3d) of suitable length (4–12 mm). After implant positioning, a three-dimensional 
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gap between the implant surface and the bony walls of the implant bed was 
obtained that measured 0.7 and 1.2 mm in width at the small and large defects, 
respectively. Possible contacts between the implant and the bone were verified 
using a titanium periodontal probe (PCPGT11,5, STOMA®; Storz am Mark GmbH, 
Emmingen-Liptingen, Germany) at the large defects. At the small defects, a 
customized probe made of a pure titanium wire – grade 1 for laser welding, round 
shaped, 0.4 mm diameter (Dentaurum, Ispringen, Germany) – was used. No 
contacts were verified. 
In the right side of the mandible, an additional recipient canal was prepared in a 
standard way (control site), and the plate for fixation was first adapted at the 
alveolar crest. Meanwhile, the implant was maintained in a basket to simulate a 
similar contact with the PEEK material that was obtained for the defect sites. 
Subsequently, the control implant was installed maintaining the flat surfaces at the 
apex of the implant parallel to the mesio-distal plane. The fixation plate was 
loosely attached to the implant using the customized cover screw, and the 
passivity of the system was checked and corrected if necessary. Three sites for 
fixation screws were prepared with the dedicated twist drill. The implant/plate 
assembly was removed from recipient sites and placed into the titanium device 
(Fig. 3.2c) to tighten the customized cover screw with the calibrated torque 
screwdriver to 25 Ncm. Again, the unit was placed in the experimental site, and 
the plate was finally fixed to the alveolar crest with three fixation screws (Fig. 
3.3c). 
No membranes were used to cover the experimental sites, and the flaps were 
sutured to allow a fully submerged healing.  
 
Postoperative period 
After the surgeries, the animals were given a vitamin compound, anti-
inflammatory/analgesic drugs, and antibiotics. The animals were kept in kennels at 
the university’s field facilities with free access to water and feed of moistened 
balanced dog’s chow. Postoperatively, the wounds were inspected daily for clinical 
signs of complications and cleaning.  
 
Sacrifice 
After 3 months of healing, the animals were first anesthetized and then euthanized 
with an overdose of pentobarbital sodium and subsequently were perfused with a 
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fixative (4% formaldehyde solution) through the carotid arteries. The mandibles 
were retrieved en bloc and the surrounding soft tissues detached. The specimens 
were trimmed and immersed in the fixative solution.  
 
Histological preparation 
Individual blocks containing the implants and the surrounding soft and hard tissues 
were fixed in 4% formaldehyde solution followed by dehydration in a series of 
graded alcohols and finally embedded in resin (LR White® hard grade; London 
Resin Company Ltd, Berkshire, UK). The blocks were cut in a mesio-distal plane 
using a diamond band saw fitted into a precision slicing machine (Exakt®; 
Apparatebau, Norderstedt, Germany) and then, reduced to a thickness of about 50 
lm using a cutting–grinding device (Exakt®; Apparatebau). 
The histological slides were stained with Stevenel’s blue and alizarin red and 
examined under a standard light microscope for histometric analysis. 
 
Histological evaluation 
In a Nikon Eclipse 50i microscope (Nikon Corporation, Tokyo, Japan) at a 
magnification of x100, the following landmarks were identified (Fig. 3.4): the 
shoulder of the implant (IS), the most coronal bone-to-implant contact (B), the 
implant surface (S), and the bony walls of the implant bed (W).  
The following measurements were performed: (i) the vertical distance, parallel to 
the longitudinal axis of the implant, between IS and B (IS-B); (ii) the distance 
between S and W (S-W), and (iii) the width of the dense connective tissue 
attached to the implant (wDCT; Fig. 3.5), measured at levels obtained by dividing 
the length of the surface of the lateral walls of the implants into three parts and of 
the apical region into two parts and measuring the distance S-W and DCT in the 
center of each of these zones. When bone attached to the implant was present, 
these measurements were omitted. The mean value for the eight measurements 
was calculated. (iv) The distance between IS and the most coronal level of DCT 
(IS-DCT) was also measured. 
Moreover, (v) the percentage of mineralized bone-to-implant contact (BIC%) as 
well as (vi) the percentage of DCT (DCT%) in relation to the length of the implant 
surface were assessed. 
 
Data analysis 
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Mean value, standard deviation as well as range were calculated for each 
outcome variable. The primary variables were BIC%, S-W, wDCT, and DCT%. 
The differences for BIC % between the defects and the control sites as well as the 
differences between the defects for S-W, wDCT, and DCT% were analyzed using 
Wilcoxon rank sum test using PASW Statistics 18 (SPSS Inc., Chicago IL, USA). 
The level of significance was set at α = 0.05. 
 
 
 
3.2.1.2 FROM: Sivolella et al., 2013 Deproteinized bovine bone mineral 
particles and osseointegration of implants without primary bone contact: an 
experimental study in dogs. 
 
Clinical procedures 
The protocol was approved by the Institutional Ethic Committee for animal 
research of the University of São Paulo. Six Labrador dogs (average weight 27.6 
kg, average age 2.9 years) were used. During all surgical procedures, the animals 
were pre-anesthetized with Xylazine® (1 mg/kg intramuscularly [i.m.] Ronpum®; 
Bayer, São Paulo, Brazil) and Ketamine® (15 mg/kg i.m. Dopalens; Vetbrands, 
São Paulo, Brazil) and anesthetized with Thionembutal® (20 mg/kg intravenously 
[i.v.] Tiopentals®; Cristália, Itapira, Brazil). During the entire surgery, the animals 
inhaled O2 and were kept with an intravenous infusion of saline. Local standard 
anesthesia was provided before all surgical sessions. 
The third and fourth premolars as well as the first molars were extracted bilaterally 
in the mandible. After 3 months of healing, muco-periosteal full-thickness flaps 
were elevated and, for the present study, the molar area of the alveolar bony crest 
was selected bilaterally as experimental sites. 
A detailed experimental surgical protocol was presented previously. Customized 
cylindrical implants, 7 mm in length and 2.8 mm in diameter (Zir-Ti®; Zirconium 
Sandblasted Acid Etched Titanium, Sweden & Martina, Due Carrare, Padova, 
Italy), were used. The external macro-morphology of the implant was 
characterized by the absence of threads and the presence of a modified apical 
region which presented with two opposing flat surfaces (Fig. 3.1a). The aim of 
these flat surfaces was to stabilize the implants into the positioning devices used 
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in the experiment. The internal side of the implants contained threads for the 
placement of a customized cover screw. 
Two recipient sites were prepared, one at each side of the mandible, using a drill 
of 5.2 mm in diameter to a depth of 8.2 mm to obtain recipient sites wider and 
longer compared with the implant dimensions, aiming at avoiding any contact of 
the implant surface with the pristine bony walls of the implant bed after installation 
(Figs 3.1b and 4.1a). A customized basket made of PEEK (Polyetheretherketone; 
Sweden & Martina) was fabricated. The basket had the same external morphology 
and dimensions of the recipient defect sites and the same internal morphology of 
the implants, but a slightly larger diameter. Only the flat surfaces at the apex of the 
implants were in contact with the basket to obtain stabilization. Moreover, a notch 
on the most coronal border, parallel to the apical flat surfaces of the implants, 
served as reference for implant positioning. 
Firstly (Fig. 4.1b), at each of the two defects, the basket was placed within the 
prepared recipient sites, flush with the mesio-distal bony crest. The notches were 
placed parallel to the mesio-distal direction for histological purposes. Subsequently 
(Fig. 4.1c), the implant was positioned within the basket. Straight or L-shaped 
plates for bone fixation (Module System 1.2 – Titanium, Cizeta Surgical, Bologna, 
Italy) with at least four holes were adapted around the bony crest with one of the 
central holes positioned on the implant. The plate was subsequently attached to 
the implant with a customized cover screw. The passive adaptation of the plate on 
the alveolar crest and on the implant was checked and corrected if necessary. 
Three locations of fixation screws were prepared with the dedicated twist drill. The 
implant/plate unit and the plastic basket were removed from the recipient defect 
sites. A customized sterile titanium device (Sweden & Martina) with an internal 
chamber with the same morphology and dimensions of the baskets was used to 
stabilize the implant/plate assembly. A calibrated torque screwdriver was used to 
tighten the customized cover screws to 25 Ncm. Care was taken to avoid rotation 
of the plate in respect of the implants and to maintain the predetermined 
orientation of the two flat surfaces at the apical portion of the implant.  
In the right side of the mandible (control sites; Figs 4.1d and 4.2a), the 
implant/plate assembly was repositioned in the recipient defects, and the plate 
fixed to the alveolar bone using three fixation screws of suitable length (4–12 mm). 
After implant positioning, a three-dimensional gap between the implant surface 
and the bony walls of the implant bed was obtained that measured 1.2 mm in 
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width. Possible contacts between the implant and the bone were verified using a 
titanium periodontal probe (PCPGT 11.5, STOMA®; Storz am Mark GmbH, 
Emmingen-Liptingen,Germany). No contacts were disclosed. 
In the left side of the mandible (test sites; Fig. 4.2b), DBBM particles (Bio-Oss®, 
granules particles 0.25–1 mm; Geistlich Biomaterials AG, Wolhusen, LU, 
Switzerland) mixed with saline were first placed within the defect to fill about 2 mm 
at the bottom, verified by a probe (Storz am Mark GmbH). Subsequently, the 
implant/plate assembly was repositioned 
in the recipient defect, similarly to the control sites, and the plates were fixed to the 
alveolar bone using three fixation screws of suitable length. Again, the gap 
between the implant surface and the bony walls was checked for verifying possible 
contacts between the implant and the bone using the same periodontal probe. No 
contacts were disclosed. The remaining gap between the implant and the bony 
walls of the defect was filled with DBBM particles, which were gently pressed 
towards the apical portion of the implant with the periodontal probe. 
No membranes were used to cover the experimental or control sites, and the flaps 
were sutured to allow a fully submerged healing. 
 
Postoperative period 
After the surgeries, the animals were given a vitamin compound (1 mL/10Kg, 
Potenay®; Fort Dodge Animal Health, Campinas, Brazil;), anti-
inflammatory/analgesic drugs (1 mL/10Kg, Banamine®; Schering-Plough, Rio de 
Janeiro, Brazil), and antibiotics (0.1 mL/Kg, Pentabiotico®; Fort Dodge Animal 
Health). The animals were kept in kennels and on concrete runs at the university’s 
field laboratory with free access to water and feed of moistened balanced dog’s 
chow. 
A daily inspection of the wounds for clinical signs of complications was performed. 
 
Sacrifice 
After 3 months of healing, the animals were first anesthetized  and then 
euthanized with an overdose of Thiopental® (Cristalia Ltd., Campinas, Brazil) and 
subsequently perfused with a fixative (4% formaldehyde solution) through the 
carotid arteries. The mandibles were retrieved en bloc, and the surrounding soft 
tissues detached. The specimens were trimmed and immersed in the fixative 
solution. 
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Histological preparation 
Individual blocks containing the implants and the surrounding soft and hard tissues 
were fixed in 4% formaldehyde solution followed by dehydration in a series of 
graded alcohols and finally embedded in resin (LR White® hard grade; London 
Resin Company Ltd, Berkshire, UK). The blocks were cut in a mesio-distal plane 
using a diamond band saw fitted into a precision slicing machine (Exakt®; 
Apparatebau, Norderstedt, Germany) and then reduced to a thickness of about 50 
lm using a cutting–grinding device (Exakt®, Apparatebau). 
The histological slides were stained with Stevenel’s blue and alizarin red and 
examined under a standard light microscope for histometric analysis. 
 
Histological evaluation 
In a Nikon Eclipse 50i microscope (Nikon Corporation, Tokyo, Japan) at a 
magnification of x100, the following landmarks were identified (Fig. 4.3): the 
shoulder of the implant (IS), the most coronal mineralized bone-toimplant contact 
(B), the implant surface (S), and the pristine bony walls of the implant bed (W). 
The coronal end of the dense connective tissue (D) attached to the implant surface 
was also indentified. 
The following measurements were taken: the vertical distance at the mesial and 
distal aspects, parallel to the longitudinal axis of the implant, between IS and B 
(IS-B) and IS and D (IS-D); the mean between the mesial and the distal values 
was used for both IS-B and IS-D. The distance between S and W (SW) and the 
width of the dense connective tissue attached to the implant (wDCT; Fig. 4.4) both 
measured at levels obtained by dividing the length of the surface of the lateral 
walls of the implants into three parts and of the apical region into two parts and 
measuring the distance S-W and wDCT in the center of each of these zones. 
When bone attached to the implant was present, these measurements were 
omitted. The mean value for the eight measurements was calculated. The 
percentage of bone filling of the defect was calculated based on the original 
dimensions of the defect (1.2 mm).  
Moreover, the percentage of mineralized bone-to-implant contact (MBIC%) and 
the percentage of dense connective tissue (DCT%) in relation to the length of the 
implant surface were assessed. 
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A point counting procedure was used to determine the composition of the tissue in 
the “defect” region of all test and control sites at x200 magnification. A lattice was 
superposed over the tissues, and the percentage area occupied by mineralized 
bone, bone marrow, connective tissue, and DBBM particles partly integrated into 
the bone and DBBM particles surrounded only by connective tissue was 
determined. 
 
Data analysis 
Mean values, standard deviations, and ranges were calculated for each outcome 
variable. 
The primary variables were MBIC%, S-W, and filling of the defect. Differences 
between test (with DBBM) and control sites were analyzed using Wilcoxon test for 
paired observations using IBM SPSS Statistics 19 (IBM Inc., Chicago, IL, USA). 
The level of significance was set at α = 0.05. 
 
 
 
 
 
3.2.1.3 From Bressan et al., 2013. Healing of buccal dehiscence defects at 
implants installed immediately into extraction sockets – an experimental 
study in dogs 
 
The protocol was submitted to and approved by the local Ethical Committee 
for Animal Research. 
 
Clinical procedures 
Six Labrador dogs (mean weight approximately 27–28 kg and mean age of about 
2 years) were used. During the surgical procedures, the animals were pre-
anesthetized with Xylazine® [1 mg/kg intramuscular (i.m.) Ronpum®; Bayer, São 
Paulo, Brazil] and Ketamine® (15 mg/kg i.m. Dopalens; Vetbrands, São Paulo, 
Brazil) and anesthetized with Thionembutal® [20 mg/kg intravenous (i.v.) 
Tiopentals®; Cristália, Itapira, Brazil]. During the entire surgery, the animals 
inhaled O2 and were kept with an intravenous infusion of saline. 
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The pulp tissue of the mesial roots of 4P4 was removed, the root canals filled with 
gutta-percha and root canal cement (Mtwo®, Endopocket®, Epfill®; Sweden & 
Martina, Due Carrare, Padova, Italy). The crowns were subsequently restored with 
composite (Adonis®; Sweden & Martina). Full thickness flaps were elevated in the 
right side of the mandible, and the buccal and lingual alveolar bony plates were 
exposed. The fourth premolar was hemi-sectioned and the distal root removed 
including the corresponding portion of the crown. The bucco-lingual and mesio-
distal dimensions at the coronal margin as well as the depth of the extraction 
socket were measured using calipers (Castroviejo; KLS Martin Group, Umkirch, 
Germany) and an UNC 15TM probe (Hu-Friedy, Chigaco, IL, USA), respectively. 
The width of the buccal and lingual bony walls was measured at a 1 and 3 mm 
distance apical to the alveolar bony crest using Iwanson calipers (KLS Martin 
Group). Cylindrical titanium implants, 3.5 mm in diameter and 11 mm in length 
(Osseospeed®; Astra Tech, Göteborg, Sweden) with a moderately rough surface 
were used. The recipient sites were prepared in such a way that the implants 
resulted centered in relation to the mesiodistal axes, but in contact with the inner 
part of the buccal bony wall (test sites; buccal positioning). The shoulder (IS) was 
placed  at the same level of the alveolar buccal bony crest. 
In the left side of the mandible, similar surgical procedures and measurements 
were performed. The recipient implant sites, however, were prepared in such a 
way that the implants resulted in contact with the inner side of the lingual bony wall 
(control sites; lingual positioning). After implant installation, the residual horizontal 
gap between the implant surface and the inner contour of the bony crest was 
about 1–1.5 mm at the lingual (test sites) or buccal (control sites) aspects. A 
standardized triangular-shaped buccal dehiscence defect, about 12 micro-threads 
deep (corresponding to about 2.7 mm) and 
3.5mm wide (like the diameter of the implant) in the coronal region (Fig. 5.1a,b), 
was prepared bilaterally using a blade (BD Beaver 376400; BD Ophthalmic 
System, Waltham, MA, USA). An abutment was affixed to the implant and the 
flaps were mobilized and sutured to allow a non-submerged healing using 
interrupted VicrylTM 4-0 sutures (Johnson & Johnson, São José dos Campos, SP, 
Brazil). 
After the surgeries, the animals were givena vitamin compound (Potenay®, 1 
ml/10 kg; Fort Dodge Animal Health, Campinas, SP, Brazil), anti-
inflammatory/analgesic drugs (Banamine®; Schering-Plough Animal Health, 
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Campinas, SP, Brazil; 1 ml/10 kg) and antibiotics (Pentabiotico®, 0.1 ml/kg; Fort 
Dodge Animal Health). The animals were kept in kennels and on concrete runs at 
the university’s field laboratory with free access to water and feed of moistened 
balanced dog’s chow. 
A daily inspection of the wounds for clinical signs of complications and healing 
abutment cleaning was performed. The animals were euthanized 4 months after 
the surgery applying an overdose of Thiopental® (Cristalia Ltd., Campinas, Brazil) 
and were perfused with a fixative (4% formaldehyde solution) through the carotid 
arteries. 
 
Histological preparation 
Individual bone blocks containing the implant and the surrounding soft and hard 
tissues were fixed in 4% formaldehyde solution followed by dehydration in a series 
of graded ethanol solutions, and finally embedded in resin (LR White® hard grade, 
London Resin Company Ltd, Berkshire, UK). The blocks were cut in a bucco-
lingual plane using a diamond band saw fitted in a precision slicing machine 
(Exakt®; Apparatebau, Norderstedt, Germany) and then reduced to a thickness of 
about 50 lm using a cutting–grinding device (Exakt®; Apparatebau). 
The histological slides were stained with Stevenel’s blue and alizarin red and 
examined in a standard light microscope for histometric analysis. 
 
Histological evaluation 
In a Nikon Eclipse 50i microscope (Nikon Corporation, Tokio, Japan) at a 
magnification of x100, the following landmarks were identified (Fig. 5.2a,b): (IS) 
the implant shoulder; (B) the most coronal bone-to-implant contact; (BM) the most 
coronal position of bone-marrow-like structure located above B; (C) the top of the 
adjacent bony crest; (OC) the outer contour of the alveolar ridge at the buccal 
aspect; (S) the implant surface at the buccal aspect at the top of the threads; (PM) 
the top of the peri-implant mucosa; (aJE) the apical portion of the barrier 
(junctional) epithelium.  
The following measurements of the hard and soft tissues were performed parallel 
to the long axis of the implant: the vertical distance between IS and C (IS-C), IS 
and B (IS-B), BM and B (BM-B), and PM and B (PM-B). The vertical distances 
parallel to the long axis between C-B, PM-C, and PM-IS were subsequently 
calculated. 
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Moreover, the following measurements of the hard tissue dimensions were 
performed perpendicular to the long axis of the implant: the horizontal distance 
between IS and C (GAP); the horizontal distance between S and OC (S-OC) at the 
buccal aspect, evaluated at IS (level 0 mm) and then, apically, at each subsequent 
millimeter, up to 5 mm (S-OC0–5 Fig. 5.2a). 
 
Data analysis 
Mean values and standard deviations as well as 25th, 50th (median), and 75th 
percentiles were calculated for each outcome variable. The primary variables were 
IS-B and IS-C for hard tissue and PM-B for soft tissue outcomes. Differences 
between test (buccal positioning) and control (lingual positioning) sites were 
analyzed using Wilcoxon test for paired observations. The level of significance 
was set at α = 0.05. 
 
 
 
 
3.2.1.4 From Bressan et al., 2012. Short implants (6 mm) installed 
immediately into extraction sockets: An experimental study in dogs 
 
Clinical procedures 
The protocol was approved by the institutional Ethic Committee for animal 
research. Six Labrador dogs (mean weight approximately 27–28 kg and mean age 
of about 2 years) were. During all surgical procedures, the animals were pre-
anaesthetized with Xylazine® (1mg/kg intramuscular [i.m.] Ronpum®, Bayer, São 
Paulo, Brazil) and Ketamine® (15mg/kg i.m., Dopalens, Vetbrands, São Paulo, 
Brazil) and anaesthetized with Thionembutal® (20mg/kg intravenous [i.v.] 
Tiopentals®, Cristália,Itapira, Brazil). During the entire surgery, the animals 
inhaled O2 and were kept with an intravenous infusion of saline. 
As described previously (113), the pulp tissue of the mesial roots of 3P3 was 
removed, the root canals filled with gutta-percha and root canal cement (Mtwo®, 
Endopocket®, Epfill®; Sweden & Martina, Due Carrare, Padova, Italy). The 
crowns were subsequently restored with composite (Adonis®; Sweden & Martina). 
Full thickness flaps were elevated in the right side of the mandible, and the buccal 
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and lingual alveolar bony plates were exposed. The third premolar was hemi-
sectioned and the distal root removed 
including the corresponding portion of the crown. The bucco-lingual and mesio-
distal dimensions at the coronal margin as well as the depth of the extraction 
socket were measured using calipers (Castroviejo; KLS Martin Group, Umkirch, 
Germany) and a UNC 15TM probe (Hu-Friedy, Chigaco, IL), respectively. The 
width of the buccal and lingual bony 
walls was measured at a 1and 3-mm distance from the alveolar bony crest using 
Iwanson calipers (KLS Martin Group). A recipient site was prepared and a titanium 
implant, 4 mm in diameter and 11 mm in length (Astra Tech, Osseospeed®, 
Göteborg, Sweden) with a moderately rough surface was installed (control site). 
The implant was placed in the center of the alveolus, with the implant shoulder 
placed at the same level of the alveolar buccal bony crest (Fig. 6.1a). After implant 
installation, the vertical distance between the implant shoulder (IS) and the top of 
the alveolar bony crest (IS-C clinical) as well as the residual horizontal gap (GAP 
clinical) between the implant surface and the internal contour of the bony crest 
were measured with a UNC 15TM probe (Hu-Friedy, Chigaco, IL). A healing 
abutment was affixed to the implant (Fig. 6.1b), and the flaps were mobilized and 
sutured to allow a non-submerged healing using interrupted VicrylTM 4-0 sutures 
(Johnson & Johnson, São José dos Campos, Brazil). The same surgical 
procedures and measurements were performed in the left side of the mandible. 
However, a shorter implant (6 mm long; Astra Tech, Osseospeed®, Göteborg, 
Sweden) with the same diameter (4 mm) was placed (test site). 
After the surgeries, the animals were given a vitamin compound (Potenay®; Fort 
Dodge Animal Health, Campinas, Brazil), antiinflammatory/analgesic drugs 
(Banamine®; Schering-Plough Animal Health) and antibiotics (Pentabiotico®; Fort 
Dodge Animal Health). The animals were kept in kennels and on concrete runs at 
the university’s field laboratory with free access to water and feed of moistened 
balanced dog’s chow. 
A daily inspection of the wounds for clinical signs of complications and healing 
abutment cleaning was performed. The animals were killed 4 months after the 
surgery applying an overdose of Thiopental® (Cristalia Ltd, Campinas, Brazil) and 
were perfused with a fixative (4% formaldehyde solution) through the carotid 
arteries. 
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Histological preparation 
Individual bone blocks containing the implant and the surrounding soft and hard 
tissues were fixed in 4% formaldehyde solution followed by dehydration in a series 
of graded ethanol solutions, and finally embedded in resin (LR White® hard grade; 
London resin Company Ltd, Berkshire, UK). The blocks were cut in a bucco-lingual 
plane using a diamond band saw fitted in a precision slicing machine (Exakt®; 
Apparatebau, Norderstedt, Germany) and then reduced to a thickness of about 50 
µm using a cutting–grinding device (Exakt®; Apparatebau). 
The histological slides were stained with Stevenel’s blue and alizarin red and 
examined under a standard light microscope for histometric analysis. 
 
Histological evaluation 
In a Nikon Eclipse 50i microscope (Nikon Corporation, Tokyo, Japan) at a 
magnification of x100, the following landmarks were identified (Fig. 6.2): the 
implant shoulder (IS), the most coronal bone-to-implant contact (B), the top of the 
adjacent bony crest (C), the top of the peri-implant mucosa (PM), the apical 
portion of the barrier (junctional) epithelium (aJE). 
The following measurements of the hard and soft tissues were performed parallel 
to the long axis of the implant: the vertical distance between IS and B (IS-B), IS 
and C (IS-C), PM and B (PM-B), and PM and aJE (PM-aJE). The horizontal 
distance between IS and C (GAP) was measured as well. The vertical distances 
between PM-C, aJE-B and PM-IS were subsequently calculated. The linear 
distance between PM and aJE (PM-aJE surface) and between aJE and B (aJE-B 
surface) were also measured following the surface of the abutment/implant unit 
(Fig. 6.2). The amount of bone-to-implant contact (BIC% total) was evaluated 
around the all implant surface between the most coronal bone-to-implant contact 
(B) at the buccal and lingual aspects. BIC% was also evaluated at the apical 
portion of the implant (BIC% apical). 
 
Data analysis 
Mean values and standard deviations as well as 25th, 50th (median) and 75th 
percentiles were calculated for each outcome variable. The primary variable was 
BIC% total and BIC% apical. Differences between test (short implants) and control 
(long implants) sites were analyzed using Wilcoxon signed rank test using PASW 
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Statistics 19 (SPSS Inc., Chicago, IL). The level of significance was set at α = 
0.05. 
 
 
 
 
3.2.2 HUMAN STUDY 
 
3.2.1.1 From Sivolella et al. 2012. Splinted and Unsplinted Short Implants in 
Mandibles: A Retrospective Evaluation With 5 to 16 Years of Follow-up 
 
Patient Selection  
The patients involved in the present study were treated at the Dental Clinic of the 
Department of Medicine, Surgery and Dentistry at the University of Padova, Italy. 
Over a period of 16 years (May 1992 – October 2008), a total of 109 patients (27 
men and 82 women) were fitted with 280 implants supporting 135 prostheses, and 
formed the object of this retrospective analysis. The patients ranged between 32 to 
70 years of age (mean 53 years).  
The inclusion criteria were: an adequate bone volume at the implant site (at least 7 
mm for long implants) as assessed by intraoral radiography and clinical 
examination; patients treated with at least 1 short implant (7 or 8.5 mm in length); 
Applegate-Kennedy Classes I and II; good general health at the time of the 
surgical procedure; no local inflammation or mucosal disease; implants with 
opposing natural teeth or fixed prostheses (implants opposing partial or total 
mobile prostheses were ruled out); a minimum follow-up of 5 years. The 
concurrent use of longer implants supporting the restorations was allowable.  
The exclusion criteria were: tobacco habit (more than 10 cigarettes/day); a history 
of radiotherapy to the head and neck region; leukocyte disorders at the time of the 
surgical procedure; uncontrolled diabetes; severe jaw clenching or bruxism; 
inadequate patient compliance; bone grafts or local guided bone regeneration 
(GBR) before implant placement.  
Routinely obtained documentation included: panoramic radiographs taken before 
the treatment and periapical radiographs taken prior to the treatment, at the time of 
implant placement, at the time of prosthetic rehabilitation, and yearly thereafter.  
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The clinical protocol observed for each implant positioned was as follows: in all 
patients a full-thickness mucosal flap was released and the implant was positioned 
after donor site drilling. The flap was closed for a submerged healing. No 
augmentation procedures were performed. The two-stage approach was 
completed after 4 to 6 months of healing, with surgical re-entry, when an 
appropriate transmucosal healing abutment was screwed to the implant. 
Removable prostheses or interim fixed bridges (Maryland bridge) were adjusted if 
necessary. After 2 to 4 weeks of healing, the implants were loaded with temporary 
screw-retained prostheses. The definitive cemented prostheses were positioned 
after one month of provisional functional loading. Zinc oxy-phosphate cement  was 
used to fix the prostheses.  
 
Study Sample  
Two hundred and eighty implants were placed in the mandible for the treatment of 
the 109 selected patients; 44 of them were treated with 145 machined (M) 
implants (with a machined surface*) supporting 47 FFD (full arch fixed dentures), 6 
FPD (fixed partial dentures) and 12 ST (single tooth prostheses); another 44 
patients were fitted with 82 rough (R) implants (with a dual-acid-etched surface – 
Osseotite 3i – Palm Beach Florida USA) supporting 36 FFD, 1 FPD and 18 STs 
(Table 7.1). Both M (25) and R (21) implants were placed in 15 patients, 
supporting 15 FFD.  
In the above-described prosthetic solutions, short implants were splinted to longer 
ones, as reflected in Table 7.1: 57% of FPD prostheses and 60% of implants for 
FPDs were splinted to longer implants and 100% of prostheses and 75% of 
implants for FFDs were splinted to longer implants. In all, 76% of the prostheses 
and 66% of the implants considered in the study were splinted to longer implants.  
The length of the implants was 7 mm in 139 cases and 8.5 mm in 141. The fixture 
diameter was 3.75 mm for 185 implants (88 of them were 8.5 mm long, and 97 
were 7 mm long), and 95 fixtures were 4 mm in diameter (52 of them were 8.5 mm 
long, and 43 were 7 mm long). The features of the implants (surface treatment, 
length and diameter) and their distribution (site) are given in Table 7.2. Seven 
implants placed in 5 patients were not loaded (6 M and 1 R). If a patient could not 
be followed up with consecutive annual examinations, the corresponding implants 
were classified as “dropout implants”.  
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Clinical and Radiographic Assessments  
At follow-up examinations, peri-implant tissues and implant health were assessed 
using the following parameters: (i) suppuration (presence/absence) (171); (ii) 
plaque index (score 0-3) according to Mombelli & Lang (172); (iii) probing pocket 
depth and probing attachment level (173); (iv) bleeding on probing (score 0-3) 
(171); (v) percussion with evidence of metal (functional ankylosis) or dull sound 
(fibrous integration in the area of implant placement) (174); (vi) persistent pain or 
paresthesia.  
All cases showing peri-implant inflammation were treated according to the 
Mombelli and Lang guidelines (172). Intraoral radiographs were taken using the 
parallel technique to control projection geometry using as exposure parameters 
65-90 kV, 7.5-10 mA and 0.22-0.25 s.  
The method used to obtain the intraoral periapical radiographs and upload them in 
the computer was consistent with other reports in the literature (175-177). No 
customized X-ray holder was provided for any of the patients. A standardized 
measurement protocol was used (175-177) and the reference measurement was 
the implant neck diameter, i.e. 3.75 or 4 mm; the measurement system considered 
the perpendicular distance from the implant shoulder (IS) to the first visible bone-
to-implant contact (C) along an ideal line running parallel to the fixture’s 
longitudinal axis; measurements were taken on the mesial and distal sides of each 
implant (figure 7.1). To correct for any dimensional distortion in the X-ray, the 
apparent size of each implant (measured directly on the radiograph) was 
compared with the known implant neck diameter (at the most coronal level of the 
prosthetic interface), and the following equation:  
 
Implant neck diameter on X-ray ÷ True implant neck diameter = MBL on X – ray ÷ 
True MBL 
  
was used to establish reasonably accurately the extent of any vertical bone loss 
on the mesial and distal sides of the implant. MBL measurements were obtained 
by two operators (A.D.F. and E.B.) blinded to each other’s findings.  
Radiographs were taken at the time of loading, 12 months later, and annually 
thereafter; the X-ray images were stored on a PC and analyzed with suitable 
software to measure peri-implant bone resorption (marginal bone loss, MBL) by 
comparing intraoral periapical radiographs obtained at the baseline (at the time of 
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loading) and at latest follow-up evaluation. This analysis was done for each 
implant-supported prosthesis. Measurements started not after implant placement, 
but after loading, because the aim was to measure the trend of marginal bone loss 
(MBL) of the functioning implants (161, 171-177). In fact, the MBL measurement 
before loading could be related to other “external” factors, e.g. bone remodeling, 
peri-implant soft tissue healing or surgical procedure (Figure 7.2). 
 
Implants and Prostheses: Success, Survival and Failure  
The following parameters were used to define implant success, as suggested by 
Albrektsson et al. (178), Buser et al. (179) and Roos et al. (180): (i) bone 
resorption in measurement areas no more than 1 mm during the first year after 
implant placement, and 0.2 mm a year thereafter; (ii) probing depth no more than 
3 mm for each implant site (mesial, distal, buccal, lingual-palatal); (iii) no abutment 
or implant mobility.  
The implant survival rate was calculated considering the following as survivors: (i) 
implants showing clinical and radiographic signs of peri-implantitis (amenable to 
treatment); (ii) implants supporting functional, symptom-free prostheses but 
showing a mean bone loss rate exceeding the limits established for the study (i.e. 
no more than 1 mm during the first year after implant placement, and 0.2 mm a 
year thereafter).  
Clinical mobility was mandatory for implant removal and the corresponding 
implants were regarded as “failures”.  
Prosthetic failure was defined as one of the following conditions: (i) permanent 
prosthetic framework warpage or breakage; (ii) abutment or implant-to-abutment 
connecting screw breakage; (iii) framework-to-abutment fixing screw damage. 
Prosthetic complications were attributed to the following events: (i) prosthesis 
detachment; (ii) abutment-to-framework screw loosening; (iii) permanent porcelain 
veneer warpage or breakage. A prosthesis presenting none of the previous 
conditions (failures or complications) was defined as a “success”; otherwise it was 
defined as a “survivor”.  
 
Statistical Analysis  
The Wilcoxon signed rank test was used to compare the prognosis of the implants 
with different lengths (7 mm vs 8.5 mm), diameters (3.75 mm vs 4 mm) and 
surface treatments  (M vs R). For descriptive data, mean values, standard 
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deviations and frequencies were calculated at patient, prosthesis and implant 
level. The primary outcome variable was MBL. Life-table analyses were 
performed, considering implant loss and implant failure as dichotomous events, as 
explained previously. All tests was performed using a software package. 
Finally, a multilevel model with marginal bone loss as the dependent variable was 
used to determine the relationship between the predictors: implant length (7 vs 8.5 
mm), diameter (3.75 vs 4 mm) and surface treatment (M vs R). A regression 
model was also constructed to analyze factors influencing MBL considering three 
levels: patient, type of implant, and implant site, with changes in bone level relative 
to the implant margin at follow-up as the dependent variable. The normality of the 
residuals at the different levels was also tested. The factors tested were: implant 
length (7 vs 8.5 mm), diameter (3.75 vs 4 mm) and surface treatment (M vs R). 
Regression coefficients were estimated using IGLS (iterative generalized least 
squares). Nested models were tested for significant improvements in model fit by 
comparing the reduction in -2LL (-2 log likelihood) with a chi-squared distribution. 
A statistical package specifically designed for multilevel modeling was used. 
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4. RESULTS 
 
4.1 IN VITRO STUDIES 
 
4.1.1 From Brun et al. 2013. Mechanisms underlying the attachment and 
spreading of human osteoblasts: From transient interactions to focal 
adhesions on vitronectin-grafted bioactive surfaces 
 
Surface characterization and peptide density 
Successful silanization of the glass surface upon reaction with APTES was 
demonstrated using XPS analysis by the presence of N1s signals. On the sample 
surfaces the amine groups were partially protonated (N2/N1 = 0.4 where N2 = 
protonated, N1 = unprotonated nitrogens). Peptide immobilization was 
demonstrated for all functionalized surfaces by: (a) an increase in the C/Si ratio as 
compared to the silanized surface, (b) increase in the C3/C1 ratio, where C3 was 
related to peptide carbons and C1 to aliphatic carbons, (c) increase in the N/Si 
ratio, and (d) decrease in the N2/N1 ratio. The C/Si and N/Si ratios were higher for 
the nonspecifically compared to the specifically immobilized peptides, indicating 
that the quantity of immobilized peptides was higher for the former (HVPunsp 
3.5%, HVPsp 1%, RGDunsp 2%, RGDsp 0.8%, RAD 1.7%), most probably 
because of different steric hindrance between fully protected and partially 
deprotected peptides. As determined by the radiolabeling procedure the peptide 
densities were: HVPunsp = 36.50 pmol cm-2, HVPsp = 6.95 pmol cm-2, RGDunsp 
= 20.85 pmol cm-2, RGDsp = 5.56 pmol cm-2, RAD = 17.7 pmol cm-2. As reported 
elsewhere [19] the peptide density for the titanium disks were HVPsp = 63 pmol 
cm-2, RGDsp = 16 pmol cm-2. As determined by AFM the APTES coating formed 
a relatively flat, continuous, thin film with roughness parameters (Table 1.2) 
consistent with the presence of small aggregates (0.6 nm high) in the z-profile 
analysis (Fig. 1.1A). The covalently grafted RGDsp formed small and dispersed 
surface aggregates with an increased surface roughness (Fig. 1.1B) whereas the 
covalent attachment of HVPsp formed more and larger peptide aggregates (3.5 
nm high, 29 nm wide, Fig. 1.1C). In grafted surfaces, roughness parameters were 
increased as compared to APTES coated surfaces (Table 1.2). RAD glass 
surfaces were characterized by a relatively rough surface (Table 1.2) with 
 61
aggregates of 3.9 nm in high shown by the z-profile analysis (Fig. 1.1D). Following 
unspecific immobilization RGD showed a quite similar roughness and a presence 
of large aggregates (3.9 nm high, Fig. 1.1E) similarly to the RAD surface, while 
HVP formed a relatively flat, continuous, and thin film with sparse aggregates (3.4 
nm high, 25 nm wide, Fig. 1.1F). 
 
Surface topography affects osteoblasts adhesion 
The extracellular matrix composition and structure act as guidance cues during 
cellular migration and wound healing and strictly affect cellular behaviour (12). To 
investigate the effects of RGD and HVP peptides on adhesion and morphology, 
human osteoblast cells were seeded on functionalized glass surfaces for 2 h, a 
time previously reported to ensure optimal adhesion to functionalized surfaces 
(14). Cells were then subjected to immunocytochemistry to investigate expression 
and distribution of β-actin positive fibres. 
As reported in Fig. 1.2A, unspecifically immobilized RGD peptide caused 
widespread and homogeneous distribution of β-actin-related signal in the 
intracellular compartment. However, specifically functionalized RGD fostered the 
organization of β-actin positive fibres leading to an oriented pattern. Following 2 h 
in culture the expression and distribution of β-actin were comparable in osteoblast 
cells seeded onto glasses unspecifically and specifically functionalized with HVP 
peptide. Nevertheless the specific immobilization of HVP increased expression 
and organization of stress fibres after 6 h in culture. 
Cellular attachment was investigated by TIRF microscopy on osteoblasts seeded 
for 2 h on coverslips silanized or functionalized with unspecifically and specifically 
immobilized RGD and HVP peptides. In TIRF the incident light leads to the 
exclusive excitement of the fluorophores lying at 80–200 nm around the aqueous 
medium–glass interface. Osteoblasts stained with FM 1-43 and seeded on 
silanized glass coverslips reported weak fluorescent signal with no area of 
increased dye concentration. Similarly, RGD or HVP unspecifically functionalized 
surfaces showed a homogeneous adhesion pattern with few cellular protrusions 
(Fig. 1.2B). Osteoblasts cultured on coverslips functionalized with specifically 
immobilized RGD or HVP peptides, however, showed a unique distribution of 
fluorescent signals. Indeed, cells seeded on RGDsp proved an increased 
fluorescent intensity and signalling pattern localized to discrete areas of the cell 
membrane consistent with focal adhesion formation (20). Osteoblasts cultured 
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onto HVPsp functionalized glass surfaces were characterized by a dense 
formation of membrane structures protruding from one pole of the cells resembling 
filopodia, i.e. membrane formations at the leading edge of migrating cells involved 
in sensing guidance cues (21). Indeed, HVPsp functionalized glass surfaces 
statistically increased the calculated averaging number of filopodia. Thus, 
evaluating five randomly selected fields from at least four different samples we 
revealed 9.5 ± 0.28 filopodia per cell in HVPsp glass surfaces as compared to 0.95 
± 0.75 filopodia per cell in HVPunsp coverslips (P < 0.001). Silanized glass 
surfaces, RGDsp and RGDunsp grafted coverslips did not statistically increase the 
number of filopodia (average number per cell: 1 ± 0.57, 3.5 ± 1.19, 1.5 ± 0.5, 
respectively). We next evaluated the role of CDC42 a Rho-subfamily GTPase 
protein involved in formation, extension and maintenance of filopodia (22). As 
determined by quantitative RT-PCR, CDC42 mRNA transcript levels significantly 
increased in human osteoblast cells cultured in HVPsp grafted surfaces (P < 0.02, 
Fig. 1.3A). Moreover pre-treatment of osteoblasts with ML141, a pharmacological 
inhibitor of Cdc42, shortened the filopodia developed by osteoblasts cultured in 
HVPsp grafted surfaces (Fig. 1.3B).  
 
HVPsp grafted surfaces induce osteoblasts adhesion through different 
membrane cellular pathways    
In accordance with data obtained by immunocytochemical and TIRF analysis, 
subsequent experiments were performed only on surfaces functionalized with 
specifically immobilized peptides. To evaluate selective cellular adhesion skills, 
human osteoblast and fibroblast cells were seeded onto coverslips specifically 
functionalized with RGD, HVP and mutant (mut) peptide RAD. After 2 h fibroblasts 
adhered to silanized and peptides grafted glass surfaces, showing a higher 
adhesion efficiency on RGDsp functionalized surfaces (P < 0.05 vs. fibroblasts 
seeded on silanized and mut glass, Fig. 1.4A). Osteoblasts adhered more 
efficiently to RGDsp and HVPsp functionalized glasses as compared to silanized 
and mutant supports. HVPsp grafted surfaces, moreover, bound osteoblasts with 
the highest avidity (P < 0.05 vs. RGDsp) and selected osteoblasts adhesion as 
compare to fibroblasts (P < 0.01). 
In an attempt to examine the cellular pathways involved in recognition, attachment 
and cell adhesion to RGDsp or HVPsp functionalized surfaces osteoblasts were 
pre-treated with anti-αvβ3 integrin antibody (αvβ3 Ab) or with a mixture of 
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glycosidases (GAGase), enzymes able to remove the most widespread distributed 
proteoglycans. Following 2 h of culture the adhesion to different functionalized 
glass surfaces was evaluated by the MTT test. As reported above (Fig. 1.4A), 
untreated osteoblast cells adhered more efficiently to RGDsp and HVPsp 
functionalized glass surfaces than to coverslips functionalized with mutant peptide 
(P < 0.05 and P < 0.01, respectively). Pre-treatment with αvβ3 Ab or GAGase did 
not affect cellular attachment to mutant peptide (Fig. 1.4B) while differentially 
influenced osteoblasts adhesion to the RGDsp or HVPsp grafted surfaces, 
meaning that different membrane molecular patterns were involved. Indeed, the 
adhesion of osteoblasts to HVPsp but not to RGDsp grafted coverslips was 
dramatically reduced by GAGase treatment (difference vs. untreated cells: 32201 
± 3026 and 7294 ± 1513, respectively), indicating that proteoglycan-mediated 
interactions are mandatory in cells attachment to HVPsp functionalized surfaces. 
Osteoblasts incubated with anti-αvβ3 Ab escaped not only attachment to RGDsp 
functionalized surfaces but also to HVPsp grafted ones (difference vs. untreated 
cells: 26542 ± 66 and 17615 ± 2831, respectively), suggesting that integrin and 
proteoglycans are both involved in osteoblast attachment to HVPsp peptide. 
 
HVPsp grafted surfaces induce osteogenic phenotype 
As demonstrated by quantitative real-time PCR, RGDsp and HVPsp functionalized 
surfaces induced gene expression associated with the osteoblastic lineage in 
primary human osteoblasts but not in fibroblasts (Fig. 1.5). Human alkaline 
phosphatase (ALPL) mRNA transcript level, a non-bone-specific marker of 
growing cells, was significantly increased in osteoblasts seeded on RGDsp grafted 
glass surface whereas vitronectin (VTN) cDNA increased in osteoblast cells 
cultured on RGDsp and HVPsp surfaces as compare to cells seeded on glasses 
functionalized with mutant peptide (P < 0.05; Fig. 1.5A and B). HVPsp 
functionalized supports exclusively induced osteopontin (SPP1) and runt-related 
transcription factor 2 (RUNX2) gene expressions in human osteoblasts (Fig. 1.5C 
and D). 
 
RGDsp and HVPsp peptides differentially elicit FAK activation in osteoblasts 
To scrutinize the downstream signalling elicited in osteoblasts by integrin αvβ3 or 
proteoglycan-mediated adhesion, cells were cultured on RGDsp and HVPsp 
functionalized glass surfaces for 30 min–6 h. By immunocytochemistry 
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phosphorylated FAK-related signals were barely detectable in osteoblasts seeded 
for 180 min on coverslips functionalized with mutant peptide (Fig. 1.6A). 30 min 
after seeding p-FAK immunoreactivity was, however, evident in cells seeded on 
surfaces functionalized with RGDsp and lasted during the culture period. On 
HVPsp functionalized glasses p-FAK-related signals increased only at 180 min. 
However, as demonstrated by Western blotting analysis (Fig. 1.6B and C) at 
longer culture times (6 h) FAK phosphorylation was more pronounced in 
osteoblasts seeded on coverslips functionalized with HVPsp peptide than in cells 
cultured on RGDsp grafted surfaces. 
In order to evaluate the role of FAK-induced signals in cellular phenotype, 
osteoblasts were incubated with a chemical inhibitor of FAK phosphorylation and 
the osteogenic phenotype was monitored by quantitative RT-PCR. Inhibition of 
FAK significantly reduced the osteogenic-related gene expression in a peptide 
dependent fashion (Table 1.3). 
 
HVPsp peptide retains adhesion and differentiation skills on titanium 
surfaces 
Since bone implants are commonly made of titanium, the following question was 
raised: is the osteoblast behaviour observed on RGDsp and HVPsp functionalized 
glass surfaces also maintained on titanium ones? Adhesion studies were 
performed on titanium supports having the same surface area of glass coverslips 
and functionalized with RGDsp and HVPsp peptides. It was found that following 2 
h of culture, fibroblasts and osteoblasts adhered to Ti supports (Fig. 1.7A) but 
contrary to data reported for glass surfaces (Fig. 1.4A), functionalization of Ti 
surfaces had no effect on fibroblast adhesion. Osteoblast adhesion, however, 
increased on RGDsp and HVPsp grafted Ti surfaces with a significant raise only in 
the osteoblasts seeded on HVPsp grafted Ti surfaces (P < 0.02 vs. non-
functionalized Ti). As assessed by the cellular adhesion test, pretreatment of 
osteoblasts with anti-αvβ3 Ab affected cell adhesion to RGDsp functionalized Ti 
surfaces but not to the HVPsp ones 
while pre-treatment of cells with GAGase reduced adhesion to HVPsp grafted Ti 
(Fig. 1.7B). Finally, RUNX2 and SPP1 mRNA transcript levels increased in 
osteoblasts cultured on peptide grafted Ti surfaces as compared to cells cultured 
on non-functionalized supports or fibroblasts seeded on grafted Ti supports (Table 
1.4). Pre-treatment with anti-αvβ3 Ab or GAGase drastically diminished the SPP1 
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mRNA transcript levels in osteoblasts seeded, respectively, on RGDsp and HVPsp 
functionalized Ti surfaces (Fig. 1.7C). 
 
 
 
 
4.1.2 From A novel in vitro technique to evaluate dental implant 
osseointegration. 
 
The use of dental implants has become wide spread as prosthetic therapy for 
patients with missing teeth. The success of an implant relies on the presence of 
adequate bone quantity and quality at the placement site because the implant 
needs to undergo ‘‘osseointegration’’. In this context, an increased interest in the 
improvement of osseointegration through topographic and chemical dental implant 
surface modifications was observed over the last years (4, 181, 182). 
Bidimensional in vitro studies are usually applied in order to test the 
biocompatibility of the new material before to start with in vivo test direct to 
evaluate the osteointegration of the novel implant surfaces in comparison with 
control ones on cell cultures. These tests attempt to track cell morphology, 
adhesion, migration, synthesis and deposition of extracellular matrix compounds, 
cell death related to potentially toxic effects of some agents derived from the 
biomaterial, histology of the implant osteointegrated,  measurement of BIC (bone 
implant contact) (183, 184). 
Current ethical issues restrict the use of animals for experimental purposes in 
many countries, and encourage to perform preclinical in vitro assays (185), also in 
the field of dental implant osseointegration (182. 183). 
To this view, in this work a novel method to predict dental implant 
osseointegrationin vitro is proposed. Starting from the experience on stem cell 
biology and tissue engineering strategy for the in vitro reconstruction of a bone like 
tissue, available in laboratory (76) we have developed a method to evaluate in 
vitro the osteointegrative properties of implants. This method require 3 phases as 
reported in figure 2.3. 
 
In vitro generation of a scaffold combined with an implant. 
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Customized cylindrical implants were inserted in the bone blocks by means of two 
customized drilling guides (Figure 2.1b)  with a twist drill and dedicated drill stops.  
 
In vitro reconstruction of a 3D bone like tissue. 
ADSc are seeded into a scaffold combined with the implant prepared in the 
previous phase and their commitment into osteogenic line is evaluated by means 
gene expression (Figure 2.4). The expression of the selected genes (ALPL, CD31, 
COL1A1, KDR, RUNX2, and PPARG, and PPAR) was evaluated in relation to the 
expression of a reference gene (GAPDH). Cells seeded on tissue culture 
polystyrene in cDMEM for 30 days were used as control for data normalization.  
The expression of osteoblast markers in ADSCs seeded around the dental 
implants inserted into bone blocks is higher compared to the control condition. 
Similar results were obtained when comparing the expression level of the same 
markers in ADSCs seeded on tissue culture plates in presence of osteo-
endothelial differentiation medium to the control (Figure 2.1). 
 
Mechanical test: pull-out test 
The pull-out test is performed in order to measure the force needed to extract an 
embedded insert from a concrete mass. The test is performed in quadruplicate 
and in three different conditions:a)non cultivated bone blocks (dry); b) non 
cultivated bone blocks, soaked in osteo-endothelial differentiation medium for 30 
days (immersed); c) bone blocks loaded with ADSCs in osteo-endothelial 
differentiation medium for 30 days (cultivated). Dry (a) and immersed (b) 
samplesare considered as controls. 
The results of the mechanical tests, summarized in figure 2.5, show that the 
highest average pull-out strength value was observed in the cultivated group (7.66 
N ±1.30) wheather results for dry and immersed samples were similar (average 
values 1.52 N ± 0.70 and 1.96 ± 0.56, respectively). Interesting, the pull-out force 
increased about 4 times after cultivation. Significant differences were observed for 
cultivated specimens related to the others (P<0.05), and no statistical difference 
was observed between dry and immersed samples (P>0.05).  In order to confirm 
that this pull out force is due to the presence of the cells, we performed  SEM 
analyses on dental implants pulled-out respectively from dry bone blocks (Figure 
2.6a) and from seeded blocks (Figure 2.6b). As can be seen in Figure 2.3b, 
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ADSCs adhering to the surface of the removed implants show an osteoblast 
morphology. 
 
 
 
 
4.2 RESULTS FROM IN VIVO STUDIES 
 
4.2.1 PRECLINICAL STUDIES 
 
4.2.1.1 From Sivolella et al., 2012. Osteogenesis at implants without primary 
bone contact – An experimental study in dogs. 
 
The healing period was uneventful. During the last month, one cover screw at the 
small and two at the large defects as well as three at the control sites were slightly 
exposed to the oral cavity. Cleaning of the cover screw was initiated. No signs of 
chronic inflammation/ 
infection were observed at any of the sites during the experimental period. No 
artifacts occurred, nor were there any tissue blocks destroyed. Hence, test and 
control sites yielded an n = 6. 
At sacrifice, all cover screws were still in place. Moreover, no gaps were 
identifiable between the fixation plate and the implant shoulder as well as between 
the fixation plate and the cover screw. In almost all specimens, at least one 
fixation screw was included in the histological section. All visible fixation screws, 
but one at a control site, demonstrated optimal osseointegration and no signs of 
inflammation. 
In five of six implants at the small defects, a limited amount of bone-to-implant 
contact was found (5.3%) mostly located in the apical half of the implant (Fig. 
3.6a). The most coronal contact of the bone to the implant was, in fact, at 4.4 mm 
apically to the implant shoulder (IS-B). At the large defect sites, only one implant 
showed a small amount of bone in contact with the apical region (ISB = 6.4 mm; 
BIC% = 0.3%), whereas no bone was found in contact in the other sites (Fig. 
3.6b). Conversely, all control implants were osseointegrated in mature bone 
presenting with an IS-B of about 1 mm and a BIC% of 46.1% (Fig. 3.6c). 
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Statistically significant differences were found for BIC% comparing the small and 
large defects, and between defects and controls (Table 3.1). 
The original defects were only partly filled with newly formed bone. A residual 
defect surrounding the implant was found at all sites where the surface was not in 
contact with the bony walls (Fig. 3.6a and b). The walls of the defects (W) were 
composed of mature bone that yielded a cortical nature (Fig. 3.6a and b). The 
width of the residual defects (SW) was 0.39 ± 0.17 and 0.50 ± 0.09 mm at the 
small and large defects, respectively. The difference did not reach statistical 
significance. Considering the original size of the defects, the corresponding fill was 
43.7 ± 24% and 58.7 ± 7.5% at the small and large defects, respectively (Table 
3.2). 
The residual defects contained two connective tissues characterized by two 
different densities (Figs 3.7a–d and 3.8a–d). (i) A layer of dense connective tissue 
(DCT) was observed adherent to the implant surface, coronally located on average 
at 0.34 ± 0.45 and 0.38 ± 0.69 mm from IS (IS-DCT), at the small and large 
defects, respectively. 
DCT was in some specimens seen in continuity with a similar, but thicker tissue, 
above the level of the bony crest. DCT was rich in fibers and fibroblast-like cells, 
both orientated parallel to the surface of the implant. The average width of DCT 
(wDCT) was 0.08 ± 0.04 and 0.10 ± 0.06 mm, at the small and large defects, 
respectively (Table 3.3). The difference was not statistically significant. (ii) A low 
density connective tissue, rich in vessels and characterized by less fibers 
compared with the DCT, was observed in the space between DCT and W. Bone 
marrow was often observed within the residual defect, in continuity with the 
surrounding bone. The percentage of the implant surface covered by DCT (DCT%) 
was 92.8 ± 7.60% and 95.6 ± 5.7% at the small and large defects, respectively 
(Table 3.3). The difference did not yield statistical significance.  
DCT was also observed in some areas at the control implant surfaces (Fig. 3.9a), 
similar to that at the defect sites (Fig. 3.9b). 
 
 
 
4.2.1.2 From Sivolella et al., 2013. Deproteinized bovine bone mineral 
particles and osseointegration of implants without primary bone contact: an 
experimental study in dogs. 
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The healing was uneventful. During the last month, two cover screws at the control 
were slightly exposed to the oral cavity. Cleaning of the cover screw was initiated. 
No signs of chronic inflammation/infection were observed at any of the sites during 
the experimental period. No artifacts occurred, nor were there any tissue blocks 
destroyed. Hence, test and control sites yielded an n = 6. 
At the histological evaluation, all cover screws were still in place (Fig. 4.5a-l). 
Moreover, no gaps were identifiable between the fixation plates and the implant 
shoulders as well as between the fixation plates and the cover screws. In almost 
all specimens, at least one fixation screw was included in the histological section. 
All visible fixation screws demonstrated no loosening or fracture, and 
histologically, optimal osseointegration and no signs of inflammation were evident. 
Histological linear measurements are reported in Table 4.1. The average of IS-B 
was 0.96 ± 2.35 mm and 0.54 ± 1.31 mm for control and test sites, respectively (P 
> 0.05). The mean mineralized bone-to-implant contact percentage (MBIC%) was 
approximately 4% both at the control and at the test sites, and hence, no 
statistically significant differences could be detected. Mineralized bone-to implant 
contact was only observed in two of the twelve implants, in one control (Figs 4.5f 
and 4.6a) and in one test implant (Figs 4.5h and 4.6b), respectively, in which a 
similar MBIC% was found (~24%). 
The original defects were only partly filled with newly formed bone. A residual 
defect surrounding the implant was found at all sites where the surface was not in 
contact with the pristine bony walls. The average distance S-W was 0.48 ± 0.12 
mm and 0.88 ± 0.41 mm at the control and test sites, respectively, the difference 
being statistically significant. Considering that the original gap of 1.2 mm, the 
percentage of the defect fill was 60.0 ± 9.7% and 26.8 ± 34.1% for control and test 
sites, respectively, obviously mirroring a statistically significant higher degree of 
filling of the former in comparison with that of the latter sites. 
A layer of dense connective tissue was observed adherent to most of the implant 
surfaces (Figs 4.6b,c and 4.7a-d). The average IS-D was 1.44 ± 1.84 mm and 0.36 
± 0.66 mm for control and test sites, respectively (p > 0.05). The percentage of 
dense connective tissue adherent to the surface in relation to the length of the 
implant was similar, 84.9 ± 17.8% and 88.5 ± 16.7% for control and test sites, 
respectively.  
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The dense connective tissue was, in some specimens, in continuity with a similar, 
but thicker connective tissue, above the level of the bony crest. The average 
wDCT was the same for both the control and the test implants (0.12 mm). 
Table 4.2 reports the morphometric data. Mineralized bone, bone marrow, and 
connective tissue were evaluated. Moreover, in the test group, DBBM particles 
partly integrated into the bone and DBBM particles surrounded only by connective 
tissue were also assessed (Figs 4.6b, d, and 4.7a-d). No statistically significant 
differences were observed between control and test sites for any of the 
morphometric parameters, except for the percentage of bone marrow, which was 
greater in the control (37.2 ± 12.8%) compared with the test sites (12.9 ± 9.9%).  
 
 
4.2.1.3 From Bressan et al., 2013. Healing of buccal dehiscence defects at 
implants installed immediately into extraction sockets – an experimental 
study in dogs 
 
Clinical evaluation  
The dimensions of the alveolar extraction sockets are reported in Table 5.1. No 
statistically significant differences were found for any of the variables evaluated 
between test and control sites.  
During the healing period, no complications were observed, and all implants were 
available for histological analysis.  
 
Histological evaluation 
No artifacts occurred during the histologic preparation, and hence, test and control 
sites yielded an n = 6. 
The data related to the hard tissues measurements are reported in Table 5.2.  
A partial regeneration of the buccal bony crest was found both at the test and 
control sites (Fig. 5.3a,b). At the test sites, where the implants were positioned 
buccally, the distance IS-C was 1.71 ± 1.20 mm. However, bone-to-implant 
contact level was found at a similar apical limit of the 2.7 mm deep original defect 
as documented by the distance IS-B (2.50 ± 1.21 mm). At the control sites, a more 
coronal level of the bony crest (IS-C = 0.68 ± 0.63 mm) as well as of the coronal 
border of osseointegration (IS-B 1.69 ± 0.99 mm) were observed compared with 
test sites. The differences yielded statistical significance. Marginally remaining 
 71
bone defects were found buccally and lingually, both at the test and control sites. 
The depth of the residual buccal defects was slightly lower at the test (0.78 ± 0.85 
mm) compared with the control sites (1.01 ± 1.17 mm). The difference did not 
reach statistical significance. At the lingual aspect, the depths of the remaining 
defects were higher at the test (2.09 ± 1.01 mm) compared with the control sites 
(1.01 ± 0.48 mm), the difference being statistically significant. In most instances, 
the defects were occupied in their apical portion by a bone-marrow-like tissue in 
direct contact with the implant surface (Fig. 5.4a–c). The mean distances between 
B and BM ranged between about 0.3–0.6 mm. The horizontal width of the defects 
ranged between 0.36–0.42 mm at the buccal and 0.39–0.81 mm at the lingual 
aspects. None of the differences were statistically significant. 
The mean values of S-OC0–5 both at the test and control sites after 4 months of 
healing are reported in Fig. 5.5. A wider width of the bony ridge at the buccal 
aspect was found at the control than at the test sites. No statistically significant 
differences were found at any of the levels evaluated.  
The data related to the soft tissue dimensions are reported in Table 5.3. The soft 
tissues were well developed around the abutment/fixture unit, and scarce 
inflammatory infiltrates were found within the connective peri-implant tissues. The 
dimensions of the peri-implant mucosa in relation to PM-C were similar in the two 
groups. Also, the distance PM-B was similar at the buccal aspect while, at the 
lingual aspect, a higher value was observed at the test (4.69 ± 1.20 mm) 
compared with the control sites (4.01 ± 0.68 mm), even though the difference did 
not yield statistical significance. The top of the mucosa (PM) was located more 
coronally at the control compared with the test sites with respect to IS, both at the 
buccal (3.41 vs. 2.56 mm, respectively) and lingual aspects (3.53 vs. 3.00 mm, 
respectively). None of the differences reached a statistical significance.  
 
 
 
4.2.1.4 From Bressan et al., 2012. Short implants (6 mm) installed 
immediately into extraction sockets: An experimental study in dogs 
 
Clinical evaluation 
The dimensions of the alveolar extraction sockets are reported in Table 6.1. The 
buccolingual dimensions were 4.2 ± 0.3 and 4.8 ± 0.8 mm at the test and control 
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sites, respectively. The difference did not reach statistical significance. The width 
of the buccal bony crest 1 mm below the top of the crest was lower at the test 
compared with the control sites. The difference was statistically significant.  
After implant installation, the implant shoulder was located deeper in relation to the 
top of the lingual bony crest of 0.6 ± 0.5 and 0.6 ± 0.9 mm at the test and control 
sites, respectively (IS-C clinical; Table 6.2). 
Small horizontal gaps (GAP clinical) occurred at the control sites between the 
implant surface and the inner contour of the alveolar bony crest (Table 6.2). At the 
test site, the horizontal GAP was minimal (0.1 mm). The difference to the control 
sites did not reach statistical significance. 
During the healing period, no complications were observed and all implants were 
available for histological analysis.  
 
Histological evaluation 
No artifacts occurred during the histologic preparation; hence, test and control 
sites yielded an n = 6. 
The implants appeared to be well integrated into mature bone (Fig. 6.3a and b). 
BIC % total was slightly higher at the test compared with the control sites (54.4 ± 
14.2% and 49.0 ± 20.2% (Table 6.3). The difference, however, was not statistically 
significant. The apical region of the implant presented with newly formed bone 
attached to the surface both at the test and control sites (Fig. 6.4a –d). The BIC%-
apex was about 33% and 21% at the test and control sites, respectively.  Again, 
the difference did not reach statistical significance. 
Both at the test and control sites, the bony walls were partly resorbed at the buccal 
and lingual aspects (Table 6.3). The bony crest (C) as well as the most coronal 
bone-to-implant contact point (B) were located more apically at the test compared 
with the control sites. However, the differences did not reach statistical 
significance both at the buccal and lingual sites. 
Small residual defects were detectable around the marginal portion of the implant 
(GAP, Table 6.3). 
The soft tissues appeared to be well adapted around the neck of the implant and 
the healing abutment. No inflammatory infiltrates were found within the connective 
peri-implant tissue. The dimensions of the peri-implant mucosa were similar in 
both groups (Table 6.4). 
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When the straight vertical measurements (assessed in the long axis of the implant) 
of the peri-implant soft tissues were compared with the measurements assessed 
along the surface of the implant, statistically significant differences were revealed, 
with the latter assessment always being greater than the former (Table 6.4). 
 
 
 
4.2.2 HUMAN STUDIES 
 
4.2.2.1 From Sivolella et al. 2012. Splinted and Unsplinted Short Implants in 
Mandibles: A Retrospective Evaluation With 5 to 16 Years of Follow-up 
 
 
As at the time of data collection (2009), 7 implants were removed before loading 
and were considered as “early failures”: 6 of them were 7 mm long (with diameters 
of 3.75 mm and 4 mm in 3 and 4 cases, respectively); and 1 was 8.5 mm long 
(and 3.75 mm in diameter). The mean follow-up for the 280 implants was 9 years 
(range 5-16 years). Complications were observed for 8 implants in 8 patients, 
involving clinical signs of peri-implantitis in all 8 cases. Causal mechanical 
treatment and local antibiotic therapy were administered, followed by guided bone 
regeneration in 2 cases, using bovine bone mineral and collagen membrane to 
treat the peri-implant defects. No further pathological progression of bone loss was 
observed at subsequent follow-up visits for 4 implants, while the other 4 implants 
had to be removed (Table 7.3).  
During the follow-up, 14 patients with 39 implants (corresponding to 13.9% of the 
implants placed) and 14 prostheses were lost to follow-up and considered as 
“dropouts”.  
The reasons for dropping out were death in 3 cases, while the other 11 patients 
could not be reached.  
A multilevel model analysis was performed to explore the covariates influencing 
bone loss at the implant site, starting from an empty model that included no 
covariates (Table 7.4), which generated a mean value of 1.45 mm for bone loss 
and a total unexplained variance of 0.45 (42% attributed to variability between 
sites, 36% between implants, and 22% between patients). None of the predictors 
considered in the final model (years of follow-up, opposing teeth, implant diameter, 
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implant length, implant surface treatment) had a significant impact on bone loss 
between the baseline and the follow-up examinations. There were no statistically 
significant differences between the variables. Since MBL measurements were 
obtained by two operators blinded to each other’s findings, the correlation between 
the two measurements was calculated with Pearson’s correlation test (r=1). A p 
value of 0.05 was detected using years of follow-up as a covariate, with a mean 
yearly bone loss of 0.04 mm. For all the short implants considered, the mean MBL 
was 1.38 mm (SD 0.45 mm) on the mesial side of the fixture, and 1.36 (SD 0.5 
mm) on the distal side. The MBL findings relating to M and R implants are given in 
Table 7.5. 
Survival and success rates (SSR and SR) were calculated using life-table analysis 
for the M and R short implants (Table 7.6). For the M fixtures, the 16-year SSR 
was 95.7%, and the corresponding SR was 93.9%. For the R fixtures, the 16-year 
SSR and SR were 97.2 and 95.2%, respectively.  
The SSR for M implants was not significantly lower (p=0.17) than for R implants 
after 16 years of use, while the 16-year SR was slightly lower for M than for R 
implants, though the difference was not statistically significant (p=0.47).  
No significant difference emerged when Wilcoxon’s signed rank test was used to 
compare the long-term prognosis (at 10 and 16 years) between different lengths (7 
mm vs 8.5 mm), diameters (3.75 mm vs 8.5 mm) and surface treatments (M vs R), 
for which the calculated p-values were respectively: p =0.38 (lengths), p =0.34 
(diameters) and p=0.47 (surface treatments).  
The following prosthetic complications were recorded. There were 8 cases of 
decementation: the prostheses were fixed in place again with zinc phosphate 
cement or zinc-eugenol oxide cement. Veneer chipping occurred on 21 partial 
prostheses: 2 were STs, 15 were FPDs, and 4 were FFDs; only 14 of these 
prostheses were removed, veneered and put back in place. Two abutment screws 
worked loose: after decementing the 2 ST prostheses, the screws were torqued 
again according to the manufacturer’s recommendations and the occlusal contact 
was checked again. There were 2 cases of abutment screw breakage concerning 
2 ST prostheses: after removing the crowns, the broken screws were removed and 
replaced; the 2 abutments were placed in position and the single crowns were 
attached with zinc phosphate or zinc-eugenol oxide cement. No prosthetic failures 
were observed during the follow-up. On the whole, 33 prosthetic complications 
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were recorded in 29 patients. The prosthetic success rates were thus 75.7% and 
77.3% for patients and prostheses, respectively. 
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5. DISCUSSION 
 
The presented studies lead to numerous issues for discussion. 
During osseointegration the interaction of cells with foreign surfaces is mainly 
regulated by the physicochemical properties of the material. Indeed hydrophilic, 
positively charged and nanostructured substrates make adhesion sites more 
accessible to membrane receptors (186). HVPand RGD-grafted surfaces were 
characterized by XPS and AFM analysis and subsequently tested for the selective 
attachment and spread of human osteoblast cells. The images obtained by 
immunocytochemistry and TIRF microscopy (Figs. 1.2 and 1.6) indicate that, 
unlike unspecifically immobilized sequences, specifically immobilized RGD and 
HVP peptides affect the membrane imprint and the stress fibre organization. 
However, the different peptide densities obtained on unspecifically and specifically 
functionalized glass surface did not completely rule out the influence of peptide 
concentrations on the observed cellular behavior. In our study osteoblasts attach 
at RGDunsp and HVPunsp grafted glass surfaces (peptide density >20 pmol cm-2) 
without forming focal adhesions whereas on RGDsp and HVPsp grafted surfaces 
(peptide density <7 pmol cm-2) cells adhere through focal contacts spreading with 
well-organized stress fibres (Fig. 1.2). Our data apparently disagree with other 
reports. For example, Shahal and colleagues have recently pinpointed that only 
RGD densities higher than 23 pmol cm-2 induce cellular spread and peripheral 
actin organization (187). Nevertheless, since the RGD peptides considered in this 
study presents four RGD motifs per chain the densities of active motifs on both 
unspecifically and specifically functionalized surfaces are, indeed, very close to the 
previously reported threshold concentration (187). Moreover, despite the different 
peptide densities the cellular adhesion capability evaluated in specifically 
functionalized titanium surfaces was similar or even improved as compared to 
specifically functionalized glass surfaces (Figs. 1.4 and 1.7), suggesting that the 
enhanced performance of the surfaces might result from the projections of amino 
acidic chains properly interacting with devoted cellular membrane structures (187). 
In this setting different nanoroughness of material surfaces might greatly influence 
cell attachment. Thus, nano-scale surfaces features of differently etching materials 
modulate surface free energy and wettability and finally decrease fibroblast 
adhesion but tether osteoblasts (189). Moreover nanostructure with features 
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usually below 100 nm influences the clusterization of membrane structures 
involved in attachment and critically controls spatial adhesion of cells (188).  
Two broad categories of adhesion sites can be distinguished as ‘‘focal complexes’’ 
associated with lamellipodia and filopodia supporting protrusion and traction at the 
cell front and as ‘‘focal adhesions’’ at the termini of stress fibre bundles that serve 
in longer term anchorage (190). In our study, human osteoblasts cultured for 2 h 
on HVPsp grafted coverslips develop filopodia (Fig. 1.2B) highly dynamic 
cytoplasmic extensions provided of sensory and mechanical roles (187) whereas 
RGDsp peptide tethers cells on glass and titanium surfaces mainly through 
integrin receptors. It is widely recognized that surface-dependent differences in 
membrane structures binding regulate cellular responses and modulate 
osteoblastic differentiation (191). Indeed, integrin-mediated cellular adhesion 
induces mitogen-activated protein kinase (MAPK) and focal adhesion kinase 
(FAK) (192). FAK autophosphorylation (p-FAK) connects the membrane adhesion 
patches to the actin cytoskeleton acting as gatekeepers for extracellular signals 
regulating cell adhesion, differentiation, bone regeneration and mechano-
transduction (193). Unlike RGDsp, HVPsp peptide blunts p-FAK expression within 
3 h of cultures (Fig. 1.6A), consistent with downregulated FAK and Rho expression 
during filopodia extension (194). Nevertheless, HVPsp grafted surfaces finally 
support stable osteoblasts differentiation (Figs. 1.5–7). Our experimental 
observations strongly support the hypothesis that the simultaneous grafting of both 
bioactive peptides could exert synergistic effects, thus promoting the specific bond 
of human osteoblasts compelling to differentiation.  
The development of in vitro techniques for the study of implant osseointegration 
find new applications in three-dimensional tissue engineering models. 
Our results demonstrate that when we insert an implant in a scaffold enriched with 
ADSCs (namely “live scaffold”) committed into osteoblastic like phenotype 
(confirmed by gene expression analyses), the cells colonize the implant surface 
with osteoblast-like morphology as revealed by SEM images. The presence of 
osteoblasts adhering to dental implant surfaces is also described in retrieved 
implants in vivo animal and human studies. Subsequent Pull-out test confirmed 
that if the implants are inserted in a live scaffolds, we need a significant higher 
force to extract the implants compared to the controls represented by a scaffolds 
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on which cells were not present. Pull-out tests were performed to evaluate the 
implant stability, related to contact between dental implant surface and the 
cellularized mineral matrix. They are mainly applicable for non-threaded cylinder 
type implants, whereas most of clinically available fixtures are of threaded design, 
and their interfacial failures are dependent on shear stress (195). In the present 
study, an increased stability of moderately rough cylindrical flat implants over time 
was achieved, due to the spreading, the proliferation, and the differentiation of 
ADSCs cultured in the 3D scaffolds in the presence of osteo-endothelial 
differentiation medium. In fact, average pull-out strength value resulted increasing 
about 4 times after cultivation when compared to controls (dry and immersed). 
Results confirmed the achieved osseointegration in vitro in the test samples and 
were consistent with the presence of osteoblasts revealed by gene expression. 
Pull-out tests have been widely performed in vitro using polyurethane blocks, 
which simulate mechanical properties of human bone (196). They have been used 
for mechanical tests on orthopedic implants (197) and on dental implants (198, 
199, 200, 201). However, solid rigid polyurethane blocks can be used as an 
alternative for human jaw bone to determine the primary stability of the implants, 
but cannot evaluate the secondary stability related to the dynamic process of 
osseointegration.  Thus, in vivo investigations are needed to detect the extent of 
bone formation along the implant surface. Ex vivo mechanical tests (torque, pull-
out, push-out) usually measure the amount of force or torque to interface failure of 
implants in bone. In a rabbit tibial dental implant healing model, Seong and co-
workers found that failure load at pull-out test was significantly correlated 
withsecondary implant stability (202). Their results agrees with studies done by 
Baker et al. (203). They investigated in short-term healing in the rabbit tibia two 
different implant surfaces. The dual-etched surface demonstrated a more rapid 
rate of pull-out strength gain than the machined surface and remained significantly 
stronger throughout the 8 weeks of the study, even though in both the groups the 
pull-out force increased over time in relation to secondary implant stability 
To the best of our knowledge, no study has been published using a 3D tissue-
engineered bone model to evaluate dental implant osseointegration in vitro, for 
this, mechanical pull-out data, acquired with the presented novel method, are not 
comparable with others in current both in vitro and in vivo studies.  
There is not doubts that our in vitro studies have not been able to reproduce the 
dynamic environment that involves the in vivo bone-implant interaction, and that 
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our results have to be confirmed in animal models,but we can assume that 
osseointegration, defined as the close structural and functional contact between 
bone and implant (204), Is achieved in this 3D in vitro tissue-engineered bone 
model.  
The same moderately rough implant surface used in the study on osseointegration 
in the in vitro three-dimensional tissue engineering model, was used for the study 
on peri-implant bone formation in animal experimental conditions. 
The first in vivo experiment evaluated the healing at implants placed into two 
standardized defects of different sizes larger than the dimensions of the implant in 
order to avoid contact with the implant bed after installation. After three months of 
healing, only small areas of bone were found in contact with the implant surface, 
mainly located in the apical half of the implant. BIC% for the total implant 
circumference was, however, higher at the small compared to the large defects. 
The fact that no initial contact between the implant bed and the surface of the 
implant was assured at implant installation means that the direct bone-to-implant 
contact observed in the present study may be interpreted as contact osteogenesis 
(89). Obviously, the implant surface used in the present study provided a 
microstructure that was conducive to osseointegration, as demonstrated in the 
control sites and also in the defects sites, even though to a limited extent. 
Although unlikely, it cannot be excluded that the bony contact with the implant 
observed in the present study at the defect sites may have originated as a result of 
a proliferation from parent bone, i.e. distance osteogenesis (89). 
The results from the present study are in agreement with another experiment in 
rabbits (93) in which cylindrical titanium implants with three different diameters 
were inserted into the center of 3.7mm standardized holes prepared in the tibia of 
rabbits. The implants were stabilized by the use of a plate anchored to the 
surrounding bone. One implant had the same diameter of the hole, while two had 
reduced diameters so that, after implant placement, residual three-dimensional 
gaps of different dimensions (0.35mm and 0.85mm) occurred between the lateral 
walls of the defect and the implant surface. It was shown that, after 4 and 12 
weeks of healing, only the implants in contact with the bony walls yielded a proper 
integration. This indicated the necessity of initial bone contact for the 
osseointegration process. It has to be stressed, however, that the cp titanium 
implants installed in that model were machined with no additional surface 
treatment. 
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In the present experiment, 0.7mm and 1.2mm wide defects around implants were 
obtained. The defects <1mm presented the condition to allow the newly formed 
bone to cross the gap by one single jump (osteogenic jumping distance; 77, 205, 
78) while, in the larger defects, more jumps were needed by the woven bone to 
bridge the gap. Nevertheless, also in the small defects a very low degree of 
osseointegration was observed. 
Another experiment (94) on implants without initial bone contact was performed on 
the mandibular ramus of rats. A rigid hemispheric non-resorbable capsule was 
fixed onto the ramus with screws. A hole was prepared in the middle portion of the 
capsule, and an implant with a rough (SLA) surface was placed through the hole. 
In one side of the mandible (control) a contact was obtained between the apex of 
the implant and the bone surface of the ramus, while, on the contralateral side, the 
implant apex was placed not in contact with the bone (test). At the test sites, no 
bone was formed at any time of healing intervals from 1-9 months while, at the 
control sites, newly formed bone in contact with the implant was observed 
increasing over time, and filling a secluded space underneath the capsule. It was 
argued that the lack of osseointegration at the test sites was due to implant micro-
mobility that facilitated the formation of a layer of loose and fibrous connective 
tissue interposed between newly formed bone and the implant surface. 
In the present study, efforts were made to obtain a secure primary stability of all 
implants using positioning devices. In fact, the fixation plate was accurately 
adapted to the alveolar crest in order to achieve a passive, but intense stability. 
Three fixation screws were used in all sites to assure a three-dimensional fixation. 
This, in turn, means that micro-movements were unlikely to occur. In fact, 5 out of 
6 at the small and 1 out of 6 implants at the large defects presented bone in 
contact with the implants, even though to a limited extent. To assure that contact 
of the implant surface with the bed was avoided circumferentially at the time of 
installation precise instruments were used for the installation of the implants and 
the circumferential gap was checked applying a titanium periodontal probe. 
Nevertheless, it cannot be excluded that the initial gap (S-W distance) was 
reduced in some regions, thus favoring bone formation in the peri-implant gap. 
In the present model, membranes to cover the entrance of the circumferential 
defects were not applied. This means that the defects were not in themselves 
secluded. Moreover, the flaps were repositioned on the top of the defects to allow 
a fully sub-merged healing. It can be speculated that connective tissue from the 
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supracrestal region migrated between the bony walls and the implant surface 
interfering with the osseointegration process. After three months, the defects were 
filled with newly formed bone that did not reach the implant surface in its entire 
length. A space from the implant of about 0.4-0.5mm filled with connective tissue 
was maintained. A similar pattern of healing was previously described in an 
experimental study in dogs (83). Recipient sites, 10mm in length and 2.8mm in 
width, were prepared. The most coronal 5mm of the recipient sites were widened 
and implants were installed. A circumferential marginal gap, 5mm deep and 
1.25mm wide, was obtained. Membranes were placed on the experimental sites. 
After 1 month of healing, the marginal defects were filled with newly formed bone 
that was, however, attached to the implant surface only in the apical portion of the 
defects. A 0.4mm thick connective tissue, similar to that of the present study, was 
found to be interposed between the front of the newly formed bone and the implant 
surface. A similar outcome was described in a subsequent experiment in dogs in 
which marginal defects of different sizes were prepared around implants and no 
membranes were applied (87). Again, connective tissue, comparable in dimension 
and characteristics to that observed in the present study, was found interposed 
between the newly formed bone and the implant. 
In the previously described studies (83, 87), only 1-2 months of healing were 
allowed. It should be emphasized, however, that in a similar experiment in dogs, 
an almost complete resolution of the defects was found after 4 months of healing 
independently of whether or not membranes had been used (78). 
In the present study, the residual defects at the test sites contained two connective 
tissues characterized by two different densities. The layer of dense connective 
tissue (DCT), approximately 0.08-0.10mm in width, was observed adherent to 
most of the implant surface (about 93-96%). This tissue was described previously 
in other experiments in dogs (83, 87) and it was suggested that this condensed 
connective tissue may represent an osteoid that, over time, may become 
mineralized and hence, integrated to the implant surface. In the present study, 
however, the presence of a DCT did not favorite osseointegration after three 
months of healing. 
In the studies described above (83, 87), osseointegration within the defect initiated 
where the implant was primarily embedded into the parent bone, that is in the 
region of the implant adjacent to the base of the defect, and then proliferated 
coronally on the implant surface. This may have a clinical relevance in relation to 
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implants installed into fresh extraction sockets or in chronic bone defects or in 
conjunction with sinus floor elevation. 
The second in vivo experiment evaluated osseointegration at implants placed at a 
distance of at least 1.2mm from the pristine implant bed. The resulting 
circumferential defect was left to fill with either a blood coagulum alone or was 
additionally filled with demineralized bovine bone mineral (DBBM), at the control 
and test sites, respectively. A minimal percentage of mineralized bone-to-implant 
contact (MBIC%= 4%) was found, irrespective of the use of DBBM particles. The 
minimal MBIC% found in the present study for the control sites confirmed the 
results of the previous study with the same design. It is evident from the present 
and the previous study that the size of the circumferential defect, and the initial 
contact with the recipient bony walls, had a determining role for the formation of a 
direct bone to implant contact. This is also in agreement with a similar 
experimental study in rabbits (93).  
In the present study, great care was applied to obtain a primary implant stability. 
The importance of this prerequisite for the osseointegration process of implants 
has also been documented in a rat model (94). 
The application of DBBM at the bottom and into the circumferential large defect at 
the test sites in the present study did not influence the minimal osseointegration. In 
fact, none of the linear variables evaluated showed statistically significant 
differences with the exception of those related to filling of the defect. In essence, 
the distance between the front of the newly formed bone and the implant surface 
reflected a better filling of the defect at the control (S-W 0.5mm) compared to the 
test (S-W 0.9mm) sites. Also, the percentage of defect filling with newly formed 
bone was about 60% and 27% at the control and test sites, respectively. It may be 
speculated that the filling of the large circumferential defects with DBBM may have 
impinged on the healing process by jeopardizing the development of the vascular 
structures necessary for bone formation (206) and hence, connective tissue 
proliferated into the gap from the coronal regions of the mucosae. 
While at the control sites, the periphery of the remaining bony defect reflected the 
shape of the implants, in the apical regions of the test sites it represented a “pear-
shape” where the DBBM particles were mainly surrounded by connective tissue. 
However, this often appeared to be denser when in contact with the graft 
indicating that the mineralization process may have been initiated, but certainly not 
finished. It may be speculated that the observation period of 3 months may not 
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have been enough for new bone formation on the surface of DBBM particles, since 
those were only partly embedded into mature bone. Moreover, some particles 
were found beyond the dimensions of the original defect. This is indicative for the 
fact that the graft particles may have been pushed into the bone marrow spaces at 
the time of surgery. When packing of DBBM particles is too dense, this would 
result in limitations in capillary growth and neo-angiogenesis (207, 208, 209). 
Furthermore, the risk of crushing DBBM particles and loosing the trabecular 
architecture when using force, hereby altering the DBBM resorption pattern, is also 
possible (210). Dense packing may also result in a higher percentage of DBBM 
particles occupying the defect (211)  
In the present study, the percentage of DBBM particles in the defects after 3 
months was about 35%. This, in turn, denotes a denser packing of the graft 
material compared to results of other studies in which 13-31% of residual DBBM 
percentage was found (95, 211, 97, 112). Despite the possibility of having densely 
packed the biomaterial in the present study, 13% of the evaluated area was 
occupied by graft particles integrated in bone, hereby confirming the 
osteoconductive properties of DBBM (96). Although not evaluated in detail, in 
some of the areas where DBBM appeared to be present in a high percentages 
(Figs. 4.5H and L), a good integration of the biomaterial was achieved, while in 
other specimens that showed lower percentages of DBBM (Fig. 4.5 I and K), a low 
integration of the biomaterial was found. 
Rarely, DBBM particles were found in contact with the implant surface, a fact that 
was already shown in other experimental studies in animals (97, 95, 96). 
Both at the control and test sites, a dense layer of connective (DCT) tissue was 
found, surrounding completely the implant, with the exception of the areas that 
yielded osseointegration. The presence of this DCT has been reported previously 
(83, 212, 87, 84) The function of this tissue is still unclear. It has been shown that 
such tissue formed new bone during healing, and consequently, it was proposed 
that the tissue may represent an osteoid tissue that, over time, may become 
mineralized (83). In agreement with the previous study the presence of a DCT was 
not associated with any osseointegration after 3 months of healing in the present 
study, however.  
It has been demonstrated that, at marginal defects around implants, bone formed 
from the lateral pristine bony walls and the base of the defect during the first 
months of healing reaching a distance from the implant surface of about 0.4mm 
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(83, 87). Osseointegration, however, started from the parent bone at the base of 
the defects, and migrating coronally during the subsequent months of healing (83, 
84, 87). The fact that osseointegration started from the parent bone primarily in 
contact with the implant surface was also shown in several other studies (9, 85, 
86,  213). 
In the present study, DBBM particles did not improve bridging of the defect and did 
not favor osseointegration. This fact is in agreement with results from other 
experimental studies (97, 98, 214, 215). Nevertheless, DBBM particles were partly 
integrated in newly formed bone. This has been explained to the higher affinity of 
the forming bone to the graft surface compared to that of the implant surface 
(216). 
In the present study, no membranes were used to create a secluded space of the 
defects. Consequently, the osseointegration process of an implant with a large 
circumferential defect under the principle of guided tissue regeneration cannot be 
discussed. 
It may very well be speculated that if an occlusive membrane protected a 
circumferential defect of a remarkable size, it may be completely filled and the 
implant osseointegrated. Moreover, the influence of DBBM in such a situation 
would have to be explored. 
Another dental implant surface (Osseospeed®; Astra Tech) was used in our 
animal studies on peri-implant bone healing and osseontegration in animal 
experimental models where selective bone defects were created in critical 
conditions such as post extraction alveolar bone. 
The Osseospeed surface is obtained as well as with the sandblasting procedure 
also with a procedure of chemical type: fluoridation. The titanium surface once 
sandblasted, is treated with fluoride ions. In vivo tests have demonstrated that the 
presence of dioxide titanium with a negative charge, favours the deposition of 
calcium ions onto the implant, which in turn show a great affinity with the 
phosphate groups contained in many organical molecules (proteins, glycans, etc.). 
the presence of fluoride ions on the implant surface facilitate and strengthen such 
biological mechanisms; fluoride as a matter of fact (being highly electronegative), 
increases the speed of sedimentation of the calcium ions and causes an increase 
in the density of the bone trabecular structure, by stimulating the activity of the 
osteoprogenitor cells and the alkaline phopshatase, too. It is demonstrated, in 
vitro, the presence of weak secondary bonds between calcium ions and groups of 
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phosphate on a TiOblast surface; whilst such bonds become of a strong covalent 
type if the surface itself is coated with fluoride ions which are released in the 
surrounding space following the establishment of such bond (217). 
The third animal experiment evaluated the influence of the positioning of the 
implant within the extraction socket in the presence of a standardized artificially 
created buccal bony defect.  
The implants at the test sites were placed in a buccal positioning within the 
extraction sockets, while, at the control sites, the position was lingual. The bony 
crest, after 4 months of healing, was located at about 1.7 and 0.7 mm apically to 
the implant margin at the test and control sites, respectively. This, in turn, means 
that a bone gain of the buccal bony crest of about 1 and 2 mm compared with the 
original depth of the defect (2.7 mm) was observed at the test and control sites, 
respectively. Despite the presence of the buccal dehiscence, and the absence of 
any regenerative procedures, the level of the buccal bony crest after the healing at 
the test sites was similar to that reported in other experimental studies in which 
implants of the same diameter were installed in the center of a fresh extraction 
socket (e.g. 117, 118). Also at the control sites, the position of the bony crest was 
at a similar level corresponding to those of another experimental study (117) in 
which the implants were placed in a lingual position.  
At the buccal aspect of the control sites, a higher volume of regenerated bone 
within the bony crest as well as a more coronal level of osseointegration within the 
defect was observed compared with the test sites. The importance of the 
positioning of the implant within the extraction socket was already specified both in 
clinical (132) and in animal experiments (117, 118, 133). In the present study, a 
buccal defect was prepared at the experimental sites. Other animal experiments 
produced similar buccal dehiscence defects at implants installed in sockets 
immediately after tooth extraction (112, 124-130). Most of these studies, however, 
used augmentation procedures with or without membranes. The results reported 
were generally superior at sites where regenerative procedures were applied. 
However, at control sites, where no treatment was rendered, some bone formation 
was also observed, although to a limited extent (124, 126, 127, 130). In an 
experiment in dogs (129), implants were installed immediately into extraction 
sockets. In one side of the mandible, 3 9 3 mm large dehiscence defects were 
made, while, in the contra lateral side, no defects were created. After 4 months of 
healing, a bone gain at the defect sites ranged from 0.3 to 0.8 mm. It should be 
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emphasized, however, that the implants used in that experiment were wider than 
the extraction sockets, so that the buccal surface of the implants was very close to 
or exceeding the profile of the extraction socket. In contrast, the implant profile of 
the present experiment was maintained within the contour of the buccal alveolar 
bony ridge at the test sites as well. Consequently, a regeneration of the bony crest 
of 1.3 and 2.3 mm was observed at the test and control sites, respectively. This 
difference may be explained by the different distances between the implant 
surface and the outer contour of the buccal bony ridge. In experiments in dogs 
(112, 118), implants with a diameter similar to that of the sockets were installed 
immediately after tooth extraction, and the healing was compared with that of 
implants of smaller diameter, placed in the center of the alveolus. After implant 
installation, the distance between the implant surface and the outer contour of the 
bony ridge was larger at the small compared with the large diameter implants. 
After 4 months of healing, the levels of the bony crest and of the coronal end of 
osseointegration were closer to the implant margin at the smaller diameter implant 
sites. It was concluded that the distance between the implant surface and the 
outer contour of the buccal alveolar bony crest influenced the degree of resorption 
of the buccal bony plate (112).  
Buccal dehiscence-type defects have also been studied at implants installed in 
healed alveolar ridges  (218-226). In experiments in dogs, the healing of buccal 
acute defects of 3–4 mm of height was studied at implants with a moderately 
rough modified surface (223, 226) without the use of regenerative procedures. It 
was shown that implants with a moderately rough modified surface may promote 
bone regeneration and osseointegration within the defect after 8–12 weeks of 
healing.  
In the present study, residual marginal defects occurred after 4 months of healing. 
While at the buccal aspect, defects of similar amplitude were observed at the test 
and control sites, at the lingual aspects deeper defects were found at the test (2.1 
mm; buccal positioning) compared with the control sites (1.0 mm; lingual 
positioning). The difference was statistically significant. This is in agreement with 
the data from an animal experiment (111) in which the healing of artificially 
circumferential marginal defects (artificial defect) around implants was compared 
with that of implants installed into sockets immediately after tooth extraction 
(natural defect). Despite the fact that bony crest resorption was higher at the 
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natural compared with the artificial defects, remaining marginal defects were still 
present after 4 months of healing that were deeper at the natural compared with 
the artificial defects. At the lingual sites, the depth of the remaining defects was 
about 0.9 and 2.2 mm at the artificial and natural defects, respectively.  
However, it must be anticipated that the application of a barrier covering the initial 
defects, with or without the use of a filler material (114, 102), may have resulted in 
a better filling of the defects and hence, an influence of implant positioning could 
not have been visualized.  
A soft tissue, similar to bone marrow, was often found occupying the apical portion 
of the defects and in close contact with the implant surface. This bone-marrow-like 
tissue was delimited in the coronal region by the peri-implant soft tissue. In some 
specimens, in the coronal region of the defects, a layer of dense connective tissue, 
similar to that described in previous animal studies in dogs (83), was found 
interposed between the bone-marrow-like tissue and the implant surface. This 
bonemarrow-like tissue may develop in the following period of healing into a 
mineralized bone that may become attached to the implant surface, and 
consequently improving the coronal level of osseointegration. This may also 
explain the gain of bone level attachment observed on radiographs during the first 
year of healing in a clinical study (107) in which implants were installed into alveoli 
immediately after tooth extraction. 
The fourth animal experiment evaluated the influence on the healing of hard and 
soft tissues at short and long implants (6 mm vs. 11 mm) installed into sockets 
immediately after tooth extraction.  
A slightly higher, though not statistically significant, osseointegration was found at 
the test (short implants) compared with the control sites (54.4% vs. 49.0%). This 
tendency of higher bone-to-implant contact for shorter implants may be due to the 
fact that the control implants were installed deeper into the alveolar bone reaching 
an area with higher trabecular alveolar bone density than the test implants that 
with their apical extension generally reached the center of the alveolar process. 
This region is usually of a looser trabecular morphology resulting in very little 
pressure being applied during implant installation. Consequently, bone formation 
may be initiated immediately without any prior resorption occasionally observed in 
dense alveolar bone (227).  
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As the residual bony housing of the extracted tooth was similar in the test and the 
control sites (approximately 11 mm), the control implant filled the alveolus in its 
entire length, while the short test implant left a space of approximately 5 mm filled 
with coagulum after installation. Obviously, no pressure was applied to the apical 
outline of the test implant, while at the control sites, the apical outline of the 
implants was prepared into alveolar bone. Again, this difference in location of the 
tip of the implant may have influenced the osseointegration process. The fact that 
the proportion of bone to implant contact at the apical termination of the test 
implant was 33% vs. 21% at the apical termination of the control implants would 
support a concept of improved osseointegration in areas with looser trabecular 
bony.  
Bone resorption was observed both at the marginal buccal and lingual aspects. 
This buccal resorption was about 2.0 and 1.2 mm at the test and control sites, 
respectively. Considering the initial positioning of the implant shoulder in relation to 
the lingual bony crest, the corresponding lingual resorption was about 1.0 and 0.8 
mm at the test and control sites, respectively.  
The resorption of the alveolar bony crest after installation of implants immediately 
into extraction sockets has been documented in several clinical (108, 109) and 
experimental studies  (111, 113, 137, 118, 228, 229). It is important to emphasize 
that the positioning of the implant within the extraction socket influences both the 
buccal and the lingual bony crest resorption. In an experiment in dogs (117), 
implants were installed into the distal alveoli of the third premolars immediately 
after tooth extraction. In the control sites, the implants were placed in the center of 
the alveolus while, at the test sites, the implants were installed more lingually and 
apically. After 4 months of healing, less buccal bone resorption had occurred at 
the test compared with the control sites. However, more lingual bone resorption 
was observed at the test compared with the control sites. While at the control sites 
the buccal bone resorption was larger compared with lingual aspects, the 
resorption at the test sites was similar for the two aspects. This, in turn, means 
that the positioning of the implant affects bone resorption both buccally and 
lingually.  
In the present experiment, more buccal bone resorption was observed at the test 
compared with the control sites (difference 0.8 mm), even though this difference 
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was not statistically significant. This outcome may be explained by the various 
coronal sizes of the extraction sockets. A smaller initial buccal gap was observed 
at the test compared with the control sites. Moreover, the width of the bony crest 
was smaller at the test compared with the control sites. This resulted in a lower 
distance between the implant surface and the outer contour of the buccal bony 
crest at the test compared with the control sites. This observation may have 
established the conditions for a higher bone resorption on the buccal aspects.  
The distance of the implant surface in relation to the outer contour of the bony 
crest (OC; 108) has been recognized as an important factor affecting the final 
position of the bucco-lingual bony walls in respect to the implant margin (109, 117, 
118, 131, 132). In an experiment in dogs (118), larger implants that filled 
completely the alveolus were compared with narrower implants installed in the 
center of the extraction sockets. This, in turn, means that the surface of the 
implant was closer to the outer contour of the bony crest (OC) at the test 
compared with the control sites. After 4 months of healing, a higher degree of bony 
crest resorption was observed at the wider compared with the narrower implant 
sites, both at the buccal and lingual aspects. A similar experiment subsequently 
performed in dogs (229) confirmed these findings.  
The difference of the distances IS-B and ISC between test and control sites should 
be considered with caution because of the fact that the dimensions of the alveoli 
were slightly different. For this reason, these two distances were not considered as 
primary outcome variables. The use of a randomized side selection (right or left) 
as test or control sites might have decreased the influence of this confounding 
factor. The BIC% performed between the two references points B (most coronal 
bone-to-implant contact) at the buccal and lingual aspects was used as primary 
outcome variable.  
The top of the peri-implant mucosa (PM) at the buccal aspect was located more 
apically in relation to the implant shoulder (IS) at the test compared with the 
control sites, but the dimensions of the mucosae were similar for test and control 
sites. This is related to the position of the buccal bone located more apically at the 
test compared with the control sites.  
Assessing the height of the mucosal cuff in two ways (vertical and surface 
assessment) revealed significant differences irrespective of the length of the 
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implants installed. The surface measurements were always larger than the vertical 
measurements. It is noteworthy to realize that the majority of these differences are 
found within the connective tissue adaptation to the implant rather than in the area 
of the barrier (junctional) epithelium, the latter yielding a dimension of typically 
2.0–2.5 mm (232). The differences between the connective tissue adaptation 
measurements assessed by the two different methods has to be explained on the 
basis of the geometry at the implant should which — in the implants installed in the 
present study — followed a concept of “platform switching”.  
The validation of the moderately rough implant surface in vitro and in vivo models 
has led over time to the increasing use of implant with smaller size than the 
standard used in past. In particular, the use of short implants, with intraosseous 
longitudinal dimension less than 10mm, represents today the first choice in the 
clinical treatment of edentulism associated with severe alveolar atrophy. 
In the past, short implants in the posterior maxilla or mandible were associated 
with lower prosthesis SSRs (156, 157). Several reasons were put forward to 
explain this situation. One reason could be that, compared with longer implants of 
comparable diameter, there is less boneto-implant contact when short implants are 
used, simply because the surface area of the implant is smaller; peri-implant 
inflammation associated with MBL could lead to a loss of implant stability more 
easily for a short implant than for a standard one. Short implants are also generally 
placed more posteriorly, where alveolar bone quality is relatively poor, especially 
in the maxilla.  
In contrast, the present study reported 16-year SSRs and SRs of 95.7% and 
93.9%, respectively, for M short implants and 97.2% and 95.2% for R short 
implants. None of the variables considered (implant surface, length, or diameter) 
were found to influence implant survival significantly, and none of them were 
statistically associated with implant failure. This result could be because some 
failures (seven ‘‘early’’ failures and four after loading) reduced the power of the 
statistical analysis and the chances of detecting potential risk factors.  
This trend should be confirmed by prospective, randomized clinical trials on short 
implants not splinted to longer implants because a factor that might influence the 
relative SSRs of short and long implants is the use of splinting, and the majority of 
the short implants examined in this study were splinted to longer implants.  
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Much larger sample sizes than those involved in the current study would be 
required to ascertain the presence and size of any splinting effect. From a 
descriptive perspective, successful long-term osseointegration was observed with 
short implants in the present series, irrespective of whether the clinical situation 
dictated the use of splinting.  
Another limitation of this retrospective study could be that non-standardized 
radiographs are taken, and the resulting measurements could make it more 
difficult to compare peri-implant bone levels. Even so, the calibration of the 
measurement system used in the present study aims to minimize any dimensional 
image distortion, as reported previously by Romeo (161, 177). 
In a retrospective clinical study, Malò et al (230) tested the hypothesis that short 
implants in atrophied jaws might achieve much the same longterm implant SSRs 
as longer implants in larger bone volumes. They studied 237 consecutively treated 
patients with 408 short Bra nemark implants, of which 131 were 7 mm long and 
277 were 8.5 mm long. Eight implants failed in seven patients before the 6-month 
follow-up point, giving a cumulative SSR of 97.1% at 5 years, suggesting that short 
implants are a viable option in both jaws; however, only 88 of these implants had 
>5-year follow-up, and the power of these conclusions needs to be increased with 
longer-term results on a more significant sample. Regarding this last aspect, the 
findings of the present report are worthy of note because they span a period of 16 
years; conversely, implant mobility could not be assessed for partial and complete 
dentures (as in the previously mentioned study) because the prostheses were not 
removed to check this parameter. Only radiographs were used to identify any 
periimplant changes occurring during the follow-up.  
Sanchez-Garce et al. (231) described the performance of 273 implants 10 mm in 
length, placed in patients with severe alveolar bone resorption, with a follow-up in 
the range of 18 months to 12 years (mean of 81 months). In all, 20 failures were 
recorded (7.33%), with a global implant survival of 92.67%. The SSR was 92.82% 
for the 10-mm implants and 92.5% for the shorter implants; the failure rates were 
also similar in the two groups. The authors concluded that short implants ‘‘are a 
good treatment alternative for patients with severe alveolar resorption of both 
jaws.’’  
Another recent retrospective study with a mediumto long-term follow-up (8 years) 
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was conducted by Anitua and Orive (232) on 661 patients with 1,287 short 
implants (<8.5 mm). They reported overall SSRs of 99.3% and 98.8% for the 
implantbased and subject-based analyses, respectively. Nine of the 1,287 
implants were lost during the observation period. The authors concluded that 
treatment with short implants is safe and predictable, providing that strict clinical 
protocols are adopted. It is important to bear in mind, however, that the same 
amount of MBL occurring around a standard implant and around a short implant 
could implicate a greater risk of stability loss for the latter. A recent three-
dimensional finite element analysis by Ormianer et al (233) on stress and strain 
patterns of one-piece and two-piece implant systems in bone concluded that only 
small-diameter (3.0-mm) one-piece implants in low-density bone exhibited stress 
levels that might adversely affect MBL stability.  
In contrast, the influence of implant length and diameter on SSRs was discussed 
in a review by Renouard and Nisand (141) on a total of 53 human studies. They 
concluded that an adapted surgical preparation and the use of implants with a 
textured surface led to SSRs for short implants comparable with those achieved 
with longer ones. As for implant diameter, it was reported that, with an adapted 
surgical preparation, new implant designs, and adequate indications, there was no 
relationship between implant SSR and implant diameter.  
In the present clinical trial, comparable long-term prognostic rates were recorded 
for short implants with M and R surface treatments, as reported by Telleman et al. 
(234). Renouard and Nisand (141) found that results tended to be better if oxidized 
implants were used instead of M implants, but the 5% difference they identified 
was not statistically significant. Nevertheless, it should be noted that the eight 
cases of early failures reported here referred to both M (n = 4) and R (n = 4) 
implants: the small size of our sample prevents any additional comment on this 
aspect. With a larger sample of early failures, it would also be interesting to see 
whether shorter implants have more complications in the initial healing period 
attributable to the previously mentioned potential biomechanical disadvantage of a 
reduced boneto-implant contact. The review by Renouard and Nisand (141) on 
short implants also stated that no specific pattern was observable concerning the 
time of the failure of short implants.  
Conversely, when Feldman et al (235) compared the SSRs of short implants with 
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M and R surfaces, they demonstrated a statistically significant difference in the 
cumulative SSRs (91.6% for the M and 97.7% for the R implants). However, 
systematic reviews on short implants (141, 155, 233, 235) have come to the 
conclusion that an adapted surgical preparation and the use of acid-etched 
implants achieve SSRs for short implants that are comparable with those obtained 
with longer ones.  
An advantage of placing short implants is that it obviates the need for additional 
surgery; therefore, this treatment is simpler, with the patient able to undergo a 
single surgical procedure. The number of visits and the treatment costs are also 
substantially reduced, and this implant therapy could be more accessible to larger 
numbers of patients and dental surgeons.  
Additional investigations on the influence of bone quality and implant site 
(maxillary versus mandibular, anterior versus posterior) (236) will probably clarify 
the importance of the surface treatment of the fixture on the survival of short 
implants.  
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6. CONCLUSIONS 
The presented studies show the variety of approaches to the validation of the 
osseointegration process. Some conclusions can be drawn. The molecular 
treatment of the implant surface, which consequently takes on connotations of 
bioactive surface, seems to represent a key to get to osseointegration, wich is 
recognized as a complex phenomenon of cell interaction with dental implant 
surface. 
For example, data coming from the first presented study, suggest that combining 
data from TIRF analysis and blocking adhesion assays (Figs. 1.2 and 1.5), RGD 
and HVP functionalized surfaces engage human osteoblasts through different 
mechanisms. Indeed, RGDsp-grafted glass surfaces quickly induce strong and 
stable adhesion favouring the formation of focal contacts while HVPsp 
functionalized surfaces initially attach osteoblasts using proteoglycan-mediated 
weak binding and promote filopodia formation. Indeed, proteoglycans play a major 
role in cell adhesion to HVPsp grafted supports whereas the integrin αvβ3 is 
involved in osteoblasts attachment to both RGDsp and HVPsp functionalized 
surfaces (Fig. 1.5). These data suggest that HVPsp oriented peptide supports 
osteoblasts attachment through both mechanisms, each equally mandatory for 
osteoblasts adhesion and differentiation. Engineering materials functionalized with 
HVPsp peptide result in enhanced osteoblast binding and osteogenic activities that 
eventually will enhance the integration of biomaterials.  
Tissue engineering has show its validity in the second experiment on in vitro  
osseointegration, where a novel biomimetic alternative to in vivo animal models 
was presented. This tridimensional in vitro metodh could be useful to evaluate the 
dynamic of bone-implant interactions that lead to osseointegration, utilizing and 
comparing different dental implant surfaces. 
The surface treatment that leads to a moderate roughness (about Sa = 2 µm) of 
the implant surface promotes the process of peri-implant bone formation, which 
may find its limits related to the distance between the implant and the surrounding 
bone wall, being the latter artificially prepared or a component of a residual post 
extraction cavity. In fact, osteogenesis on the implant surface was obtained also 
when initial contact of the implant surface with the implant bed has deliberately 
been avoided. This phenomenon was influenced by the dimensions of the defect. 
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However, the degree of osseointegration was very low both at the small and the 
large defects compared to the control sites. 
The concept of contact osteogenesis does not seem to be confirmed for distances 
greater than 1.2 mm, prevailing the distance osteogenesis model.  
DBBM grafting of the artificial gap did not favor osteogenesis on the implant 
surface as well, and did not enhance the ability to bridge the distance in a defect 
wider than 1mm, even if graft particles were integrated into mature bone close to 
the implant surface. 
New bone formation and osseointegration have similar behaviour in artificial and 
natural peri-implant defect. The placement of implants in a lingual position into 
extraction sockets allowed, in the third animal study, a higher degree of bone 
formation at buccal alveolar dehiscence defects compared with a placement in a 
buccal position.  
The lack of statistically significant differences between for osseointegration 
parameter (BIC%) of immediate implants post extractive long (11mm) versus short 
(6mm) is of great importance from a clinical point of view. It is further validated the 
fact that the bone quality, in terms of entities osseointegration (BIC%) is inversely 
proportional to the bone density, given the same primary obtainable stability. 
"Shorts" implants can find more fields of clinical application, as confirmed by the 
last retrospective clinical study which shows high rates of survival rate (SSR) and 
success rate (SR) in the long term (follow-up 16 years) for both implant surfaces 
smooth surface (M) and rough (R). The M implants had a 16-year SSR of 95.7% 
and a 93.9% of corresponding SR, whereas the 16-year SSR and SR for the R 
implants were 97.2% and 95.2%, respectively. 
 
The future research on osseointegration, and the related clinical implications, will 
focus on the development of nanostructured and bioactive surfaces. Preclinical 
studies, given the reduction in the course of the testing on animals of medium and 
large size, will integrate three-dimensional models of tissue engineering in vitro, 
using cell lines dedicated to the study of implant interactions with hard tissues, but 
also with the oral soft tissues, that are the point of potential transition between the 
contaminated oral environment and the alveolar bone. 
The increasing need to treat edentulous patients of advanced age with bone 
defects of different nature, which involves the reduction of the size of the alveolar 
bone, associated with a tendency to minimally invasive treatments (not only from 
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the biological point of view, but also economical), lead increased use of reduced 
length implants. They have to date success and survival rates comparable to 
systems of greater length, demonstrated by clinical studies with long follow-up, 
such as the one presented here. The osseointegration of short implants and the 
ability to support the biomechanical masticatory load on the prosthesis connected 
to them, is certainly linked to the formation of a valid bone-implant interface. The 
maintenance of osseointegration along the implant surface, and in particular in the 
most coronal area, next to the prosthetic components projecting in the oral cavity, 
is nowadays one of the most important research field. The focus will be on the 
stability of the peri-implant soft tissues, which in turn is probably also related to 
host factors that are still not well defined. 
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APPENDIX 1 – TABLES AND FIGURES
Fig.1 Natural tooth and dental implant: a schematic comparison between 
the two conditions and a description of their major components
Fig. 2 Some examples of dental 
implant macroscopic design and 
surfaces. 
2
Fig. 3. General concepts of titanium implant modification.
Fig. 4. A diagram for contact 
angle as measured by sessile 
drop technique.
Fig. 5. Surface properties of titanium dental implants (from Le Guehennec 
L. et al, 2007).
3
Fig. 7. SEM micrographs of a TiO blasted surface (Astratech TiOblastTM)
(from Le Guehennec L. et al, 2007).
Fig. 8. SEM micrographs of an SLA surface on a titanium dental implant 
(SLA, Straumann AG, Switzerland) (from Le Guehennec L. et al, 2007).
Fig. 6. SEM micrographs of a titanium plasma-sprayed (TPS) surface (from 
Le Guehennec L. et al, 2007)
4
Fig. 10. SEM micrographs of a plasma-sprayed hydroxyapatite (HA) 
coating surface (Cam Implants BV) (from Le Guehennec L. et al, 2007)
.
Fig. 11. SEM micrographs of a biomimetic calcium phosphate coating 
(from Le Guehennec L. et al, 2007)
.
Fig. 9. SEM micrographs of treatment of titanium dental implants in a 
fluoride solution surface (Astratech OsseoSpeedTM) (from Le 
Guehennec L. et al, 2007)
.
5
Fig. 12. One of the dental implant surface used in 3 of the reported studies: 
ZirTi surface (Sweden & Martina, Due Carrare, Padova IT), obtained 
by sand-blasting with zirconium oxide and subsequent acid etching with 
mineral acids.
Fig. 13. Drawings from Davies JE (1998 and 2003) that show the 
initiation of distance osteogenesis (A) and contact osteogenesis (B) 
where differentiating osteogenic cells line either the old bone or implant 
surface respectively. The insets show the consequences of these two 
distinctly different patterns of bone formation. In the former the 
secretorily active osteoblasts, anchored into their extracellular matrix by 
their cell processes, become trapped between the bone they are forming 
and the surface of the implant. The only possible outcome is the death of 
these cells. On the contrary, in contact osteogenesis, de novo bone is 
formed directly on the implant surface, with the cement line in contact 
with the implant (insert).
6
Fig. 14. 
Cascade of 
events related 
to new bone 
formation on a 
dental implant 
surface 
(Berglundh et 
al, 2003).
A
B
Fig 15 a-e. Figures from “ De novo alveolar bone 
formation adjacent to endosseous implants A model 
study in the dog ” (Berglungdh et al, 2003). (a) 
Experimental implant device: screw shaped titanium 
implant, diameter 4.1 mm, length 10 mm with 
circumferential trough in the endosseous part. (b) 
Cross-section of the wound chambers provided by the 
device: a, pitches engaging the bone tissue walls; b, 
inner U-shaped wound chamber proper. The dotted line 
indicates the lateral wall of the chamber, i.e. the 
position of the cut bone surface. (c)  Wound chamber 
representing 2 weeks of healing. Decalcified section. 
Original mag. x 100. Mineralized bone coating the 
entire SLA chamber surface. (d) Detail of Fig. (c). 
Original mag. x 200. Woven bone continuous with 
parent bone (appositional bone formation), but newly 
formed bone also present on the SLA surface in areas 
remote of the parent bone (Contact osteogenesis). (d) 
Detail,  Original mag. x 400. Spindle-shaped cells and 
collagen fibrils present around the vasculature.
C D E
7
Table 1.1 The list of genes evaluated by quantitative RT-PCR.
Table 1.2 Atomic force microscopy analysis of glass surfaces.
Fig. 1.1 Topographic characterization of functionalized surfaces. AFM 
images of (a) silanized, (b) RGDsp, (c) HVPsp, (d) RAD, (e) RGDunsp 
and (f) HVPunsp grafted glass surfaces. Scale bar, 100 nm.
8
Fig. 1.2. Functionalized surfaces affect osteoblast behaviour. (a) 
Representative immunofluorescence analysis of osteoblast cells 
seeded for 2 h on differently functionalized glass surfaces and also for 
6 h in HVPsp grafted supports. Osteoblasts were fixed and incubated 
with anti-b actin antibody (red). Nuclei were stained with TOTO-3 
(blue). n = 3 per group. Scale bar, 37.5 lm. (b) Representative 
photomicrographs of TIRF microscopy performed on osteoblasts 
cultured on differently functionalized glass coverslips and probed with 
FM 1-43 fluorescent dye. Images were taken using a 2 megapixel CCD 
with CFl Plan Apochromat TIRF 60?/1.45 oil objective. n = 4 per group. 
Scale bar, 10 lm. 
9
Fig. 1.3. HVPsp functionalized surfaces induce filopodia in human 
osteoblasts. (a) Quantitative RT-PCR analysis of CDC42 mRNA levels
in human osteoblast cells seeded for 2 h onto unspecifically or 
specifically functionalized peptides and onto mutant peptide (mut). 
Data are reported as mean ± standard error of three independent
experiments. °P < 0.02. (b) Representative photomicrographs of TIRF 
microscopy analysis performed on osteoblasts cultured for 2 h on 
HVPsp functionalized glass surfaces and treated for 1 h at 37 °C with 
50 lM ML141, a pharma- cological inhibitor of Cdc42. n = 3 per group. 
Scale bar, 10 lm. 
10
Fig. 1.4. HVPsp grafted surface preferentially induces osteoblasts 
adhesion through proteoglycans involvement. (a) Fibroblast and 
osteoblast cells were cultured for 2 h onto silanized, RGDsp, HVPsp and 
mutant (mut) peptides. Cellular adhesion was evaluated by MTT test and 
quantified by plotting data to a standard curve constructed for each 
experiment. Data are expressed as the mean ± standard error of four 
independent experiments. ⁄P < 0.05 vs. silanized and mut surfaces. °P < 
0.02 vs. silanized and mut surfaces. (b) Osteoblasts were pre-treated with 
anti-avb3 integrin antibody (avb3Ab) or a mixture of glycosidase 
(GAGase) and then cultured for 2 h onto RGDsp, HVPsp or mutant (mut) 
grafted surfaces. Cell adhesion was evaluated by MTT test and quantified 
using a standard curve constructed for each experiment. Data are
reported as mean±standard error of four independent experiments. ⁄P < 
0.05 vs. non-treated osteoblasts seeded on mut surfaces; °P < 0.02 vs. 
non-treated osteoblasts seeded on mut surfaces. 
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Fig. 1.5. RGDsp and HVPsp grafted surfaces induce osteogenic 
phenotype. Human fibroblast and osteoblast cells were cultured for 24 h 
onto surfaces functionalized with RGDsp, HVPsp or mutant (mut) 
peptides. Specific mRNA levels of human alkaline phosphatase (ALPL, 
a), vitronectin (VTN, b), osteopontin (SPP1, c), and runt-related 
transcription factor 2 (RUNX2 (d) were determined by quantitative RT-
PCR analysis. Data are reported as mean ± standard error of three 
independent experiments. °P < 0.02 vs. cells cultured onto mut. 
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Fig.1. 6. RGDsp and HVPsp grafted surfaces differentially induce FAK 
activation. (a) Representative immunofluorescence analysis of 
osteoblast cells seeded on glass surfaces functionalized with RGDsp, 
HVPsp or mutant (mut) peptides. Osteoblasts were fixed and incubated 
with anti-pFAK antibody (green). n = 3 per group. Scale bar, 37.5 lm. (b) 
Representative Western blot analysis of p-FAK in protein extracts from 
osteoblasts cultured for 6 h on differentially functionalized surfaces. One 
representative blot of three is presented. b-actin was used as loading 
control. (c) Protein signals of p-FAK were determined by densitometric 
analysis of Western blotting (n = 3) using the VersaDoc Quantity One 
software (BioRad). Data are reported as the mean ± standard error. a.u. 
= arbitrary units. °P < 0.02 vs. osteoblasts cultured on mut functionalized 
surfaces. 
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Fig. 1.5. RGDsp and HVPsp grafted surfaces induce osteogenic 
phenotype. Human fibroblast and osteoblast cells were cultured for 24 h 
onto surfaces functionalized with RGDsp, HVPsp or mutant (mut) 
peptides. Specific mRNA levels of human alkaline phosphatase (ALPL, 
a), vitronectin (VTN, b), osteopontin (SPP1, c), and runt-related 
transcription factor 2 (RUNX2 (d) were determined by quantitative RT-
PCR analysis. Data are reported as mean ± standard error of three 
independent experiments. °P < 0.02 vs. cells cultured onto mut. 
Table 1.3. Evaluation of mRNA transcript levels in osteoblasts treated 
with FAK inhibitor. 
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Fig. 1.7. Evaluation of osteoblast behaviour on functionalized Ti 
surfaces. (a) Fibroblasts and osteoblasts were cultured for 2 h on non-
functionalized, RGDsp or HVPsp grafted Ti surfaces. Cellular 
adhesion was evaluated by MTT test and quantify by plotting data to a 
standard curve constructed for each experiment. Data are expressed 
as the mean ± standard error of three independent experiments. ⁄P < 
0.05 vs. osteoblasts seeded on non-functionalized Ti surface; °P < 
0.02 vs. osteoblasts seeded on non- functionalized Ti surface. (b) 
Osteoblasts were pre-treated with anti-v3 integrin antibody (v3Ab) or a 
mixture of glycosidase (GAGase) and then cultured for 2 h on non-
functionalized, RGDsp or HVPsp grafted Ti surfaces. Cell adhesion 
was evaluated by MTT test. Data are reported as mean ± standard 
error of three independent experiments. °P < 0.02 vs. non-treated 
osteoblasts seeded on non-functionalized surfaces. (c) Human 
osteoblast cells were pre-treated with v3Ab or GAGase and cultured 
for 24 h on non- functionalized, RGDsp or HVPsp grafted Ti surfaces. 
Osteopontin (SPP1) specific mRNA levels were determined by 
quantitative RT-PCR analysis. Data are reported as mean ± standard 
error of three independent experiments. °P < 0.02 vs. non-treated 
cells cultured on non-functionalized surfaces. 
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Table 1.4 mRNA transcript levels of cells cultured on functionalized Ti 
surfaces. 
Table 2.1. Human primer sequences.
Figure 2.1. a) Customized cylindrical implant; b) bovine bone block 
(left) and customized drilling guide (right); c) implant positioned in the 
bone block.
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Fig. 2.2 Pull-out tests of the implants from the bone blocks (tensile 
test). Immediately before the test, a mounter was attached to the 
extension pin of each implant. After alignment and positioning of the 
samples in the testing machine, implants were loaded.  
Fig. 2.3.  Study design to evaluate in vitro the osteointegrative 
properties of implants.
Design of the in vitro experiment. Phase 1: in vitro generation of a 
scaffold combined with an implant. Customized cylindrical implants 
were inserted in the bone blocks.  Phase 2: in vitro reconstruction of a 
3D bone like tissue. ADSc are seeded into a scaffold combined with 
the implant. Phase 3 Mechanical test: pull-out test. The pull-out test is 
performed in order to measure the force needed to extract an 
embedded insert from a concrete mass. 
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Fig. 2.4.  Real-time PCR analysis of ALPL, CD31, COL1A1, KDR, 
RUNX2, and PPARG. Grey bars indicate the expression level of the
selected genes in ADSCs seeded on the bone blocks around the dental 
implants in presence of osteo-endothelial differentiation medium for 30 
days. Black bars represent the gene expression level of the same
markers in ADSCs seeded on tissue culture polystyrene in osteo-
endothelial differentiation medium for 30 days. Gene expression levels 
are reported as ratios (R) with respect to the mRNA expression in ADSCs 
seeded on tissue culture polystyrene for 30 days in cDMEM (white bars). 
Data are mean and SD (n=3).
Figure 2.5. Average value and standard deviation of force (N, Newton) 
measured in the pull out tests, in different experimental conditions 
(cultivated: 7.66 N ±1.30; dry:  1.52 N ± 0.70 ; immersed: 1.96 ± 0.56). 
Dry vs Immersed (p=0.3664), Dry vs Cultivated (p=0.0002), Immersed vs 
Cultivated (p=0.0002).
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Fig. 2.6.  SEM analysis of the dental implant surface a) at 37x and 500x 
(inset) magnification extracted from a dry bone block; b)  afterpull-out in 
the cultivated group at 1000x magnification. A carpet of cells with an 
osteoblast morphology is visible on the implant surface.
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Fig. 3.1. (a) Customized cylindrical implant characterized by the 
absence of threads and the presence of a modified apical region 
which presented with two opposing flat surfaces. (b) Schematic 
drawing representing the implant placed within the prepared defect 
without any contact with the bony walls.
Fig.3. 2. (a, b) Customized PEEK baskets used for implant 
positioning within the defects. (a–c) Customized sterile titanium 
device used to hold the implants while tightening the cover screw to 
stabilize the fixation plate to the implant.
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Fig. 3.3. Clinical illustration of the surgical procedures. (a) Prepared 
large defect. (b) PEEK basket in place. Note the alignment of the two 
coronal notches with the mesio-distal plane and the flat surface in the 
bottom. (c) After the placement of the implant within the basket, an L-
shaped plate was modeled and adapted to the alveolar crest and then 
loosely attached to the implant with a cover screw. (d) The 
implant/plate assembly was repositioned in the recipient defects sites, 
and the plates fixed to the alveolar bone using three fixation screws.
Fig. 3.4. Schematic illustration of 
landmarks used for histological 
measurements. (IS) the shoulder of 
the implant; (B) the most coronal 
bone-to-implant contact; (S) the 
implant surface; (W) the bony walls 
of the implant bed. The red arrows 
indicating the zones were the width 
of the remaining defect (S–W) and 
the DCT width (Fig. 5) were 
measured.
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Fig. 3.5. Schematic illustration of the 
measurement of the width of the layer 
of dense connective tissue (DCT) 
adherent to the implant surface at 
small and large defects.
Fig. 3.6. Ground sections representing the result of healing at (a) small
defect, (b) large defect, and (c) control implants. Stevenel’s blue and 
alizarin red stain. Original magnification 912. A small amount of bone to 
implant contact was found at the defect sites. Cover screws were in 
place and no gaps were identifiable between the fixation plate and the 
implant shoulder as well as between the fixation plate and the cover 
screw.
Table 3.1. Histological measurements after 3 months of healing 
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Fig. 3.7. Ground sections representing the result of healing at the 
large defect sites after 3 months. Stevenel’s blue and alizarin red 
stain. The red arrows indicate bone marrow and fat cells mainly 
located at the periphery of the defect. (a) Apical region of the
implant site illustrating the remaining defect. Original magnification 
920. (b) Larger magnification (original 9200) of the left side of the 
apex represented in (a). Two connective tissues were included in
the defect, an internal dense tissue (DCT) adherent to the implant 
surface and low density external tissue, inter- posed between the 
DCT and the bony walls. (c) DCT was sometimes seen connected 
with the bony walls through a denser connective tissue. Original
magnification 940. (d) DCT was seen in continuity with a similar, but 
thicker tissue, above the level of the bony crest. Original 
magnification 920.
Table 3.2. Original size of the gap at implant installation and 
histological measurements after 3 months of healing. N=6
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Fig. 3.8. Ground sections representing the result of healing at the large
defect sites after 3 months. Stevenel’s blue and alizarin red stain. (a) 
Apical region of the implant site illustrating the remaining defect. A layer 
of dense connective tissue was found adherent to the implant surface, 
separated from the bony walls of the defect by a low den- sity 
connective tissue. Original magnification 9200. (b) Small amount of 
bone in contact with the implant surface. Original magnification 920. (c–
d) DCT was close to the implant margin and, sometimes, extending
above the level of the bony crest (yellow arrows). Original magnification 
920.
Table 3.3. Histological measurements after 3 months of healing .n=6 
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Fig. 3.9. (a) Ground sections (original magnification 940) at a control 
site illustrating the presence of a DCT layer in the apical region, similar 
to that found at the defect sites (b; original magnification 9100). 
Stevenel’s blue and aliza- rin red stain.
Fig. 4.1. Clinical illustration of the surgical procedures at a control site. 
(a) Prepared defect (5.2 mm wide and 8.2 mm deep). (b) PEEK basket 
in place. Note the alignment of the two coronal notches with the mesio-
distal plane. (c) After the placement of the implant within the basket, a 
straight-shaped plate was modeled, adapted to the alveo- lar bony crest, 
and then attached to the implant with a cover screw. (d) The basket was 
removed, the implant/plate assembly was repositioned in the recipient 
defect site, and the plate secured to the alveolar bone using three fixa-
tion screws.
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Fig. 4.2  a) Control site: coagulum fills the 1.2-mm-wide gap around the 
implant. (b) Test site: the gap is grafted with demineralized bovine bone 
matrix (DBBM).
Fig. 4.3. Schematic illustration of landmarks used for histological 
measurements. (IS) the shoulder of the implant; (b) the most coronal 
mineralized bone-to- implant contact; (S) the implant surface; (W) the 
bony walls of the implant bed. The red arrows indicate the zones were 
the width of the remaining defect (S-W), and the dense connective 
tissue width (wDCT; see Fig. 5) were measured.
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Fig. 4.4. Schematic illustration 
of the measurement of the width 
of the layer of dense connective 
tissue (DCT) adherent to the 
implant surface at test and 
control sites. The implant profile 
is on the left. The picture repre-
sents a detail of an histological 
image of a test site.
Fig.4.5. Overview of the six control implants (from a to f) and the 
corresponding six test implants (from g to l). Ground sections, 
Stevenel’s blue and alizarin red stain. Original magnification 912. A 
small amount of mineralized bone-to-implant contact was found in one 
control and in one test sites (see arrows indicating the respective B 
position in fig- ures f and h). No gaps were identifiable between fixation 
plate, implant shoulder, and cover screw. Two cover screws resulted to 
be slightly exposed to the oral cavity (e, f), while all the others were still 
covered by mucosa (including l).
Table 4.1. Histological linear measurements after 3 months of 
healing at the 1.2 mm wide defects
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Fig. 4.6. (a) Detail of the control site presenting MBIC (see Fig. 6f), 
magnification 920. (b) Detail of test site pre- senting MBIC (see Fig. 6h), 
magnification 9100. MB, Mineralized bone; DBBM, deproteinized bovine 
bone matrix. (c) Detail of the apical area of the control implant represented 
in Fig. 6a. DCT is lining the implant surface. No MBIC is observable. 
Mature bone resides in proximity of the implant surface, surrounded by 
bone marrow. Original magnification 940. (d) Detail of the apical area of 
the test implant represented in Fig. 6l. Original magnification 920.
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Fig. 4.7. Details of a test implant. DCT, dense connective tissue; DBBM, 
deproteinized bovine bone matrix; MB, min- eralized bone. (a) DBBM 
particles reside laterally to the implant without any contact with the 
implant surface. Mag- nification 940. Inset: (b) Larger magnification 
(9200). Only few DBBM particles are embedded in mature bone without 
any evidence of MBIC. DCT lines the implant surface. (c) Magnification 
940. Inset: (d) DBBM particles sur- rounded by connective tissue and 
separated from the implant surface only by a ~0.1 mm of DCT layer. The 
arrow indicates a dense connective tissue lining the graft surface. 
Magnification 9100.
Table 4.2. Morphometric measurements within the original dimensions 
of the defects (1.2 mm). Data expressed in percentage (%)
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Fig. 5.1. Buccal clinical view of the implants within the distal extraction 
sockets of the fourth mandibular premolar. A standardized triangular-
shaped buccal dehiscence defect, about 12 micro-threads deep 
(corresponding to about 2.7 mm) and 3.5 mm wide (like the diameter of 
the implant), was prepared in the coronal region. (a) Implant installed in a 
buccal position (test site). (b) Implant installed in a lingual position 
(control site).
Fig. 5.2. Diagrams depicting the landmarks for the histological 
evaluation. (a) PM, top of peri-implant mucosa; aJE, apical extension of 
the junctional epithelium; IS, shoulder of the implant; C, top of the 
adjacent bony crest; B, coro- nal end of osseointegration. S, implant 
surface at the top of the threads (dotted green line); OC, outer contour of 
the alveolar bony ridge (dotted yellow line). (b) BM, coronal extension of 
the bone-marrow-like tissue; B, coronal end of osseointegration. The 
measurements performed are reported in the text.
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Table 5.1. Coronal diameter and depth of extraction sockets and width 
of the buccal and lingual bony walls at 1 and 3 mm apically to the 
alveolar bony crest
Table 5.2. Histological measurements of the hard tissue dimensions 
after 4 months of healing
Fig. 5.3. Ground sections illustrating the healing after 4 months at the 
test (a) and control (b) sites. Stevenel’s blue and alizarin red. The 
implants appeared to be well integrated into mature bone. The buccal 
bony crest was more apically located at the implant placed more 
buccally (a, test) compared with that placed more lingually (b, control).
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Fig. 5.4. Ground section illustrating a remaining defect. Stevenel’s blue 
and alizarin red. (a) A soft tissue, similar to bone marrow, was often 
found occupying the apical portion of the defects and in close contact 
with the implant sur- face. This bone-marrow-like tissue was delimited in 
the coronal region by the peri-implant soft tissue (yellow arrow). In some 
specimens, in the coronal region of the defects, a layer of dense 
connective tissue was found inter- posed between the bone-marrow-like 
tissue and the implant surface (green arrows). Original magnification 940. 
(b) Larger magnification of the image in (a) at the level of the dense 
connective tissue layer. Original magnification 9100. (c) Larger
magnification of the image in (a) showing the similarity of the two soft 
tissues located above or below the coronal end of osseointegration 
(reference point B). Original magnification 9100.
Fig. 5.5. Graphic representing the mean values of S-OC0–5 at the test 
and control sites after 4 months of healing. A wider width of the bony 
ridge at the buccal aspect was found at the control than at the test sites. 
No sta- tistically significant differences were, however, found at any of 
the levels evaluated.
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Fig. 6.1. Clinical illustration of the implant positioning. (a) The implant 
was placed in the center of the alveolus, with the margin of the rough 
surface placed at the same level of the alveolar buccal bony crest. (b) A 
healing abut- ment was affixed to the implant.
Fig. 6.2. The following landmarks were identified 
(red circles): the implant shoulder (IS), the most 
coronal bone-to-implant contact (B), the top of the 
adjacent bony crest (C), the top of peri-implant 
mucosa (PM), the apical portion of the barrier 
(junctional) epithelium (aJE). The red arrow 
indicates how the vertical measure- ments were 
performed, parallel to the long axis of the implant 
(in the example the distance PM-B). The green 
line indicates the location of the linear 
measurements made on the surface of the 
abutment/implant unit.
Table 5.3. Histological measurements of soft tissue dimensions after 4 
months of healing
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Table 6.2. Clinical measurement after implant installation
Fig. 6.3. The implants appeared to be well integrated into mature bone. 
Stevenel’s blue and alizarin red stain. Original magnification 916. A 
higher loss of the buccal alveolar bony crest was observed at the test (a) 
compared with the control sites (b).
Table 6.1. Coronal diameter and depth of extraction sockets and width of 
the buccal and lingual bony walls at 1 and 3 mm apically to the alveolar 
bony crest
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Table 6.3. Histological measurements of the hard tissue after 4 months 
of healing
Fig. 6.4. The apical region of the implants presented newly formed bone 
attached to the surface, both at the test and control sites. Stevenel’s blue 
and alizarin red stain. (a) Apical portion of a test implant (short). Original 
magnifica- tion about 916. (b) Larger magnification of the apical region 
(originally 940). (c) Apical portion of a control implant (long). Original 
magnification about 916. (b) Larger magnification of the apical region 
(originally 940).
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Table 6.4. Histological measurements of the soft tissue after 4 months 
of healing
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Table 7.1. Prostheses and Short Implants Distributed by Type of 
Prosthesis.
* Numbers in parentheses indicate prostheses supported by both short 
and standard implants.
†Numbers in parentheses indicate short implants splinted to longer 
implants. Unloaded implants (seven) were excluded.
Table 7. 2 Implant 
Distribution by 
Length, Diameter, 
and Surface 
Treatment.
M = machined; R = 
rough. 
Fig. 7.1. A standardized measurement 
protocol was used, and the reference 
measurement was the implant neck 
diameter, i.e., 3.75 or 4 mm. The 
measurement system considered the 
perpendicular distance from the implant 
shoulder (IS) to the first visible bone-to-
implant contact (C) along an ideal line 
running parallel to the longitudinal axis of 
the fixture. Measurements were taken on 
the mesial and distal sides of each implant.
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Fig. 7.2. A and B) Standard M, threaded, 3.75 · 7–mm implant in site 31. 
A) Intraoral radiograph taken
at time of loading (1997). B) Intraoral radiograph taken at the latest follow-
up (2010). The short implant was splinted to a standard M, 3.75 · 10.5–
mm implant (in site 30). C and D) Standard M, 4 · 7–mm implant in site 19. 
C) Intraoral radiograph taken at time of loading (1997). D) Intraoral 
radiograph taken at the latest follow-up (2008). The short implant was 
splinted to a 4 · 10–mm implant (site 18). E and F) Two standard M, 4 · 7–
mm implants in sites 18 and 19. E) Radiograph taken at time of loading 
(1997). F) Radiograph taken at the latest follow-up (2008).
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Table 7.3. Implant Complications and Failures After Prosthetic Loading
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Table 4.
Multilevel Model With MBL as the Dependant Variable
Table 7.5. Mean – SD MBL (in mm) by Surface Treatment. M= 
machined; R= rough.
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Table 7.6. Short Implant Life Tables
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APPENDIX 3 DICHIARAZIONE DI CONFORMITÀ
